BOARDQBANKNPLEX Part II Clinical Sciences
2000 Questions
Phases 1–5Phase 5
Home
Time00:00:00
Font size 100%
Exam mode hides answers, disease reviews and diagnostic case titles until submission.
0 / 400 reviewed

No matching content found

Try a broader keyword such as “ECG,” “sepsis,” “stroke,” “pregnancy,” or “toxicity.”

NPLEX Part II • Phase 5 • Clinical Case 401

SCLERODERMA RENAL CRISISClinical Case 401

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 46-year-old woman with diffuse cutaneous systemic sclerosis presents with severe headache, blurred vision, dyspnea, and markedly reduced urine output.

During the previous month, she was prescribed prednisone 30 mg daily for inflammatory joint symptoms.

Vital signs:

  • BP: 218/126 mmHg
  • HR: 108/min
  • RR: 24/min
  • SpO₂: 93% on room air

Physical examination:

  • Tightened skin over the hands, forearms, chest, and face
  • Bibasilar crackles
  • Mild lower-extremity edema
  • Cotton-wool spots on retinal examination

Laboratory findings:

  • Creatinine: 286 µmol/L, previously 78 µmol/L
  • Hemoglobin: 92 g/L
  • Platelets: 84 × 10⁹/L
  • LDH: elevated
  • Haptoglobin: reduced
  • Blood smear: schistocytes
  • Urinalysis: mild proteinuria and hematuria
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: B. Scleroderma renal crisis

Abrupt severe hypertension, rapidly progressive acute kidney injury, retinal changes, pulmonary edema, and microangiopathic hemolytic anemia in a patient with diffuse systemic sclerosis are characteristic of scleroderma renal crisis.

Why the Other Options Are Incorrect

  • A. Lupus nephritis: Usually presents with immune-complex glomerulonephritis, active urinary sediment, low complement, and lupus serology.
  • C. Chronic essential hypertension: Does not explain the sudden renal failure and microangiopathic hemolysis.
  • D. Minimal-change disease: Causes nephrotic proteinuria without malignant hypertension or schistocytes.
  • E. Primary hyperaldosteronism: Usually causes hypertension with hypokalemia rather than acute renal failure and hemolysis.
Q2

What is the most appropriate immediate pharmacologic treatment?

Reveal answer and rationale
Correct answer: B. An angiotensin-converting enzyme inhibitor

An ACE inhibitor, commonly a rapidly titratable agent such as captopril, should be started immediately. Treatment should not be withheld merely because creatinine is elevated. EULAR recommendations identify immediate ACE-inhibitor therapy as the central treatment for scleroderma renal crisis.

Why the Other Options Are Incorrect

  • A. High-dose prednisone: Glucocorticoids can increase the risk of renal crisis.
  • C. Beta blocker alone: Does not address the disease’s renin-mediated vasoconstrictive process.
  • D. Spironolactone alone: Is inadequate for this emergency.
  • E. Cyclophosphamide: Is not a substitute for immediate blood-pressure control.
Q3

The patient requires temporary dialysis. What should generally happen to ACE-inhibitor therapy?

Reveal answer and rationale
Correct answer: B. Continue it when clinically tolerated

Dialysis may be required during the acute phase, but ACE-inhibitor treatment is generally continued when blood pressure and potassium permit because renal recovery may occur over time.

Q4

Which exposure in this case is an important recognized risk factor?

Reveal answer and rationale
Correct answer: A. Moderate-dose to high-dose systemic glucocorticoids

Systemic glucocorticoid exposure, particularly at higher doses, is associated with increased risk of scleroderma renal crisis. Patients receiving glucocorticoids require careful blood-pressure and renal monitoring.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Scleroderma renal crisis associated with diffuse systemic sclerosis.

Key differentials

  • Thrombotic thrombocytopenic purpura
  • Malignant essential hypertension
  • ANCA-associated glomerulonephritis
  • Lupus nephritis
  • Renal artery disease
  • Drug-induced thrombotic microangiopathy

Key investigations

  • Frequent blood-pressure measurements
  • CBC and peripheral smear
  • Creatinine and electrolytes
  • LDH, bilirubin, and haptoglobin
  • Urinalysis and urine protein measurement
  • ECG and cardiac biomarkers when indicated
  • Chest imaging for pulmonary edema

Treatment principles

  • Immediate ACE-inhibitor therapy
  • Controlled blood-pressure reduction
  • Close renal and electrolyte monitoring
  • Dialysis when indicated
  • Avoid unnecessary high-dose glucocorticoids
  • Specialist nephrology and rheumatology care

Botanical safety: Licorice may increase blood pressure and worsen sodium retention. It is contraindicated in this setting.

Clinical Pearl: Creatinine may initially continue to rise after ACE-inhibitor treatment; this alone is not an automatic reason to discontinue lifesaving treatment.

NPLEX Trap: Do not avoid ACE inhibitors simply because the patient already has severe acute kidney injury.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 402

MULTISYSTEM SARCOIDOSIS WITH HYPERCALCEMIAClinical Case 402

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 35-year-old woman presents with fatigue, dry cough, painful red eyes, excessive thirst, constipation, and recurrent renal stones.

Physical examination:

  • Bilateral tender red eyes
  • Photophobia
  • Enlarged parotid glands
  • Scattered erythema-nodosum-like lesions over the shins

Investigations:

  • Chest radiograph: bilateral hilar lymphadenopathy
  • Corrected calcium: 3.04 mmol/L
  • Parathyroid hormone: suppressed
  • 25-hydroxyvitamin D: low-normal
  • 1,25-dihydroxyvitamin D: elevated
  • Creatinine: mildly elevated
  • Urine calcium: elevated
Q1

What is the most likely unifying diagnosis?

Reveal answer and rationale
Correct answer: B. Multisystem sarcoidosis

Bilateral hilar lymphadenopathy, uveitis, skin lesions, parotid involvement, hypercalciuria, and PTH-independent hypercalcemia strongly suggest multisystem sarcoidosis.

Q2

What is the principal mechanism of hypercalcemia in sarcoidosis?

Reveal answer and rationale
Correct answer: B. Increased extrarenal conversion of 25-hydroxyvitamin D to active 1,25-dihydroxyvitamin D

Activated macrophages within granulomas can express 1-alpha-hydroxylase, increasing active vitamin D production and intestinal calcium absorption.

Q3

Which approach best establishes the diagnosis when tissue confirmation is required?

Reveal answer and rationale
Correct answer: A. Biopsy of the safest accessible involved site showing nonnecrotizing granulomas, with exclusion of alternative causes

The diagnosis rests on a compatible clinical presentation, nonnecrotizing granulomatous inflammation when tissue is required, and exclusion of infections, malignancy, occupational disease, and other granulomatous conditions.

Q4

Which counseling is most appropriate while the hypercalcemia is evaluated and treated?

Reveal answer and rationale
Correct answer: B. Avoid unnecessary calcium or vitamin D supplements and excessive ultraviolet exposure

Vitamin D supplementation and increased ultraviolet exposure can worsen calcium abnormalities in susceptible patients. Symptomatic hypercalcemia or organ-threatening sarcoidosis may require systemic treatment.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Sarcoidosis involving the lungs, eyes, skin, parotid glands, and calcium metabolism.

Key differentials

  • Tuberculosis
  • Fungal infection
  • Lymphoma
  • Berylliosis
  • Granulomatosis with polyangiitis
  • Primary hyperparathyroidism
  • Drug-induced granulomatous disease

Key investigations

  • Chest imaging
  • Serum calcium and creatinine
  • Liver enzymes and alkaline phosphatase
  • ECG
  • Ophthalmologic examination
  • Pulmonary-function testing
  • Tissue biopsy when required
  • Microbiologic testing to exclude infection

The ATS recommends baseline calcium assessment even in sarcoidosis patients without overt symptoms of abnormal calcium metabolism.

Treatment principles

  • Treat organ-threatening or significantly symptomatic disease
  • Urgent ophthalmologic treatment for uveitis
  • Hydration and treatment of clinically significant hypercalcemia
  • Glucocorticoids when appropriate
  • Steroid-sparing therapy for selected chronic disease
  • Monitor pulmonary, cardiac, ocular, hepatic, and renal involvement

Nutrition and supplement safety: Avoid indiscriminate vitamin D, calcium, or high-calcium supplementation until calcium metabolism has been assessed.

Clinical Pearl: A low 25-hydroxyvitamin D level does not automatically mean high-dose vitamin D is safe when 1,25-dihydroxyvitamin D and calcium are elevated.

NPLEX Trap: Serum ACE is neither sufficiently sensitive nor sufficiently specific to confirm sarcoidosis by itself.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 403

PROLIFERATIVE LUPUS NEPHRITISClinical Case 403

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 28-year-old woman with systemic lupus erythematosus presents with facial swelling, leg edema, fatigue, and dark urine.

Medications:

  • Hydroxychloroquine
  • Intermittent ibuprofen
  • Prednisone 5 mg daily

Vital signs:

  • BP: 158/96 mmHg
  • HR: 92/min

Laboratory findings:

  • Creatinine: 168 µmol/L, previously 72 µmol/L
  • Urine protein: 3.8 g/day
  • Urinalysis: dysmorphic erythrocytes and red-cell casts
  • C3 and C4: low
  • Anti-double-stranded DNA: markedly elevated
  • Albumin: reduced
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Active lupus nephritis

Proteinuria, hypertension, acute kidney dysfunction, hematuria, red-cell casts, hypocomplementemia, and rising anti-dsDNA antibodies indicate active immune-complex lupus nephritis.

Q2

What is the most important investigation for classifying renal involvement and directing immunosuppressive therapy?

Reveal answer and rationale
Correct answer: A. Kidney biopsy

Kidney biopsy identifies the histologic class, activity, chronicity, and additional renal lesions. These findings guide treatment and prognosis.

Q3

Which treatment approach is appropriate for active proliferative lupus nephritis?

Reveal answer and rationale
Correct answer: A. Glucocorticoid therapy combined with an appropriate immunosuppressive regimen

Proliferative lupus nephritis generally requires glucocorticoids plus immunosuppressive treatment such as mycophenolate-based or cyclophosphamide-based therapy. Current KDIGO guidance also incorporates selected combination regimens based on disease severity and patient factors.

Q4

The patient wants to become pregnant. Which medication requires particular preconception review because of teratogenicity?

Reveal answer and rationale
Correct answer: A. Mycophenolate

Mycophenolate is teratogenic and requires reliable contraception and planned transition to a pregnancy-compatible regimen before conception. Hydroxychloroquine is generally continued in lupus unless contraindicated.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Active lupus nephritis, with proliferative disease requiring exclusion by biopsy.

Key differentials

  • ANCA-associated glomerulonephritis
  • Antiphospholipid-associated nephropathy
  • Thrombotic microangiopathy
  • Infection-related glomerulonephritis
  • Drug-induced interstitial nephritis
  • Renal vein thrombosis

Key investigations

  • CBC
  • Creatinine and electrolytes
  • Urinalysis and microscopy
  • Protein-to-creatinine ratio or 24-hour urine protein
  • Complement levels
  • Anti-dsDNA
  • Antiphospholipid antibodies
  • Kidney biopsy
  • Pregnancy testing before teratogenic therapy

Treatment principles

  • Control blood pressure and proteinuria
  • Hydroxychloroquine unless contraindicated
  • Immunosuppressive induction according to biopsy class
  • Maintenance treatment after response
  • Infection prevention and vaccination review
  • Pregnancy planning
  • Monitor renal response and medication toxicity

Pharmacology safety: NSAIDs can worsen renal perfusion and should be avoided during active kidney injury.

Nutrition: Sodium moderation is appropriate for hypertension and edema. Extreme high-protein diets are inappropriate during significant renal disease.

Clinical Pearl: Lupus serology can support disease activity, but kidney biopsy determines the renal lesion and treatment strategy.

NPLEX Trap: Do not diagnose a urinary infection solely because blood and protein are present in the urine when red-cell casts indicate glomerular inflammation.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 404

SPONTANEOUS BACTERIAL PERITONITIS WITH HEPATORENAL SYNDROME–AKIClinical Case 404

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 62-year-old man with alcohol-related cirrhosis and tense ascites presents with fever, diffuse abdominal discomfort, confusion, and reduced urine output.

Vital signs:

  • BP: 88/54 mmHg
  • HR: 118/min
  • Temperature: 38.7°C

Laboratory findings:

  • Creatinine: 212 µmol/L, previously 86 µmol/L
  • Sodium: 126 mmol/L
  • Bilirubin: elevated
  • INR: prolonged
  • WBC: elevated

Diagnostic paracentesis:

  • Ascitic polymorphonuclear leukocytes: 680 cells/mm³
  • Culture: pending
Q1

What is the immediate diagnosis based on the ascitic-fluid result?

Reveal answer and rationale
Correct answer: A. Spontaneous bacterial peritonitis

An ascitic-fluid neutrophil count of at least 250 cells/mm³ supports spontaneous bacterial peritonitis and warrants immediate treatment, even when culture results are pending.

Q2

What is the most appropriate initial management?

Reveal answer and rationale
Correct answer: A. Begin appropriate intravenous antibiotics and consider intravenous albumin

SBP requires prompt antimicrobial therapy. Albumin is used in selected patients to reduce the risk of worsening renal dysfunction. Treatment must not wait for culture positivity.

Q3

After infection treatment, withdrawal of nephrotoxic medications, and appropriate albumin expansion, kidney function continues to worsen without shock or structural renal disease. What is the most likely renal diagnosis?

Reveal answer and rationale
Correct answer: A. Hepatorenal syndrome–acute kidney injury

HRS-AKI is a functional renal failure occurring in advanced cirrhosis after other causes of acute kidney injury, including hypovolemia, shock, nephrotoxicity, and structural renal disease, have been assessed.

Q4

What treatment principle applies to confirmed HRS-AKI?

Reveal answer and rationale
Correct answer: A. Vasoconstrictor therapy with albumin and urgent transplant assessment

Appropriate vasoconstrictor therapy combined with albumin is used for HRS-AKI. Liver transplantation is the definitive therapy for eligible patients.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnoses

  1. Spontaneous bacterial peritonitis
  2. Decompensated cirrhosis
  3. HRS-AKI

Key differentials for acute kidney injury

  • Hypovolemia
  • Septic acute tubular injury
  • Drug-induced nephrotoxicity
  • Abdominal-compartment physiology
  • Glomerulonephritis
  • Urinary obstruction

Key investigations

  • Diagnostic paracentesis
  • Ascitic cell count and culture
  • Blood cultures
  • CBC
  • Creatinine and electrolytes
  • Urinalysis and microscopy
  • Renal ultrasound when indicated
  • Assessment for gastrointestinal bleeding and other infection
  • Medication and supplement review

Treatment principles

  • Immediate antibiotics for SBP
  • Albumin in appropriate patients
  • Stop NSAIDs and other nephrotoxins
  • Temporarily reassess diuretics during hypotension or AKI
  • Treat HRS-AKI with albumin and appropriate vasoconstrictor therapy
  • Evaluate for liver transplantation
  • Secondary SBP prophylaxis after recovery when indicated

Botanical safety: Herbal diuretics can worsen effective circulating-volume depletion, sodium abnormalities, and kidney injury.

Clinical Pearl: SBP may present primarily with confusion, kidney injury, or hypotension rather than marked abdominal guarding.

NPLEX Trap: Do not wait for a positive ascitic culture when the neutrophil count is diagnostic.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 405

CATASTROPHIC ANTIPHOSPHOLIPID SYNDROMEClinical Case 405

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 38-year-old woman with systemic lupus erythematosus is admitted after abdominal surgery. During the next five days, she develops:

  • Painful swelling of the left leg
  • Sudden dyspnea
  • Retiform skin necrosis
  • Acute kidney injury
  • Confusion
  • Thrombocytopenia

Investigations demonstrate:

  • Proximal deep-vein thrombosis
  • Multiple pulmonary emboli
  • Renal cortical infarctions
  • Positive lupus anticoagulant
  • Strongly positive anticardiolipin antibodies
  • Schistocytes on blood smear
  • Mildly prolonged coagulation testing
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Catastrophic antiphospholipid syndrome

Rapid thrombosis involving several organ systems over a short period in a patient with antiphospholipid antibodies is characteristic of catastrophic antiphospholipid syndrome.

Q2

Which feature most strongly distinguishes catastrophic APS from an isolated venous thromboembolism?

Reveal answer and rationale
Correct answer: A. Rapid involvement of multiple organs through widespread thrombosis

CAPS produces rapidly developing small- and large-vessel thrombosis affecting three or more organ systems, commonly involving the kidneys, lungs, brain, skin, heart, or gastrointestinal tract.

Q3

What is the recommended initial treatment strategy?

Reveal answer and rationale
Correct answer: A. Therapeutic anticoagulation, high-dose glucocorticoids, and plasma exchange or intravenous immunoglobulin

First-line CAPS treatment uses combination therapy, often described as triple therapy: anticoagulation, glucocorticoids, and plasma exchange and/or IV immunoglobulin. The precipitating infection, surgery-related complication, or lupus flare must also be treated.

Q4

Which supplement history is especially important once therapeutic anticoagulation begins?

Reveal answer and rationale
Correct answer: A. High-dose ginkgo or garlic extracts

Products with potential antiplatelet activity may increase bleeding concerns when combined with therapeutic anticoagulation.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Catastrophic antiphospholipid syndrome triggered by surgery.

Common precipitants

  • Infection
  • Surgery
  • Withdrawal or interruption of anticoagulation
  • Pregnancy complications
  • Malignancy
  • Lupus flare
  • Certain medications

Key investigations

  • Vascular imaging based on affected organs
  • CBC and peripheral smear
  • Creatinine and urinalysis
  • Liver enzymes
  • Cardiac biomarkers and echocardiography
  • Coagulation studies
  • Lupus anticoagulant
  • Anticardiolipin antibodies
  • Anti-beta-2-glycoprotein I antibodies
  • Infection assessment

Treatment principles

  • Immediate therapeutic anticoagulation when not contraindicated
  • High-dose glucocorticoids
  • Plasma exchange and/or IV immunoglobulin
  • Treat the trigger
  • Intensive organ support
  • Consider additional immunomodulation in refractory disease

Clinical Pearl: Thrombocytopenia does not protect a patient from thrombosis and does not automatically exclude anticoagulation.

NPLEX Trap: Do not treat CAPS as an isolated DVT when the kidneys, lungs, skin, brain, and hematologic system are becoming involved simultaneously.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 406

GRANULOMATOSIS WITH POLYANGIITIS WITH PULMONARY–RENAL SYNDROMEClinical Case 406

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 47-year-old man presents with chronic sinus pain, recurrent otitis, nasal crusting, hemoptysis, dyspnea, fatigue, and dark urine.

Vital signs:

  • BP: 154/92 mmHg
  • HR: 110/min
  • RR: 28/min
  • SpO₂: 86% on room air

Investigations:

  • Hemoglobin: falling
  • Creatinine: 248 µmol/L
  • Urinalysis: dysmorphic erythrocytes and red-cell casts
  • Chest CT: bilateral nodules and diffuse ground-glass opacities
  • PR3-ANCA: strongly positive
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Granulomatosis with polyangiitis

Destructive upper-airway disease, pulmonary nodules or alveolar hemorrhage, rapidly progressive glomerulonephritis, and PR3-ANCA positivity strongly suggest granulomatosis with polyangiitis.

Q2

What is the most appropriate next management step?

Reveal answer and rationale
Correct answer: A. Emergency hospitalization and remission-induction treatment

Pulmonary hemorrhage and rapidly progressive glomerulonephritis are organ-threatening manifestations requiring immediate specialist treatment.

Q3

Which regimen is commonly used to induce remission in severe GPA?

Reveal answer and rationale
Correct answer: A. Rituximab plus glucocorticoid therapy

Rituximab or cyclophosphamide is used with glucocorticoids for severe GPA or microscopic polyangiitis. The ACR/Vasculitis Foundation guideline conditionally favors rituximab over cyclophosphamide for remission induction in severe disease.

Q4

Which preventive treatment should be considered during rituximab- or cyclophosphamide-based immunosuppression?

Reveal answer and rationale
Correct answer: A. Pneumocystis jirovecii pneumonia prophylaxis

Pneumocystis prophylaxis is generally recommended during cyclophosphamide or rituximab treatment and significant accompanying glucocorticoid exposure, unless contraindicated.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Severe granulomatosis with polyangiitis causing pulmonary–renal syndrome.

Key differentials

  • Anti-GBM disease
  • Microscopic polyangiitis
  • Lupus pulmonary–renal syndrome
  • Infective endocarditis
  • Severe pneumonia
  • Pulmonary embolism
  • Cocaine-induced midline destructive disease

Key investigations

  • CBC
  • Creatinine and electrolytes
  • Urinalysis and microscopy
  • Urine protein measurement
  • PR3-ANCA and MPO-ANCA
  • Anti-GBM antibodies
  • Chest CT
  • Bronchoscopy when indicated
  • Kidney or other involved-tissue biopsy
  • Infection screening before immunosuppression

Treatment principles

  • Stabilize oxygenation and ventilation
  • Urgent glucocorticoid treatment
  • Rituximab or cyclophosphamide for severe disease
  • Pneumocystis prophylaxis
  • Monitor for treatment-related infection
  • Maintenance immunosuppression after remission

Botanical safety: Immune-stimulating products should not replace immunosuppression and may be inappropriate in active autoimmune disease.

Clinical Pearl: A positive ANCA supports the diagnosis but does not replace clinical assessment and tissue confirmation when safely obtainable.

NPLEX Trap: Do not interpret hemoptysis, falling hemoglobin, and diffuse opacities as uncomplicated pneumonia when red-cell casts and acute kidney injury indicate a pulmonary–renal syndrome.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 407

DRESS SYNDROME CAUSED BY ALLOPURINOLClinical Case 407

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 52-year-old man presents with fever, facial swelling, diffuse rash, fatigue, and reduced urine output.

Six weeks earlier, allopurinol was started for asymptomatic hyperuricemia.

Physical examination:

  • Temperature: 39.2°C
  • Diffuse morbilliform eruption involving more than 50% of body surface area
  • Facial edema
  • Cervical lymphadenopathy
  • No extensive epidermal detachment

Laboratory findings:

  • Eosinophils: 2.4 × 10⁹/L
  • Atypical lymphocytes present
  • ALT: 624 U/L
  • Bilirubin: elevated
  • Creatinine: 196 µmol/L
  • Viral hepatitis testing: negative
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Drug reaction with eosinophilia and systemic symptoms

The delayed onset after a high-risk medication, fever, extensive rash, facial edema, eosinophilia, lymphadenopathy, hepatitis, and kidney injury indicate DRESS syndrome.

Q2

What is the most important immediate action?

Reveal answer and rationale
Correct answer: A. Stop allopurinol permanently and arrange urgent hospital assessment

Immediate and permanent withdrawal of the suspected medication is essential. Serious hepatic, renal, pulmonary, cardiac, or hematologic involvement requires urgent specialist management.

Q3

Which finding indicates severe systemic disease rather than a mild cutaneous drug eruption?

Reveal answer and rationale
Correct answer: A. Marked hepatitis and acute kidney injury

Internal-organ injury is a defining concern in DRESS. The liver is commonly affected, but renal, pulmonary, cardiac, neurologic, and hematologic complications can occur.

Q4

What treatment may be required when significant internal-organ involvement is present?

Reveal answer and rationale
Correct answer: A. Systemic glucocorticoid therapy with specialist-directed supportive care

Management is severity-based. Significant organ involvement commonly leads to systemic glucocorticoid treatment, although treatment must be individualized and infection carefully assessed. Contemporary EAACI work emphasizes clinical diagnosis and severity-based management.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Allopurinol-induced DRESS syndrome with hepatic and renal involvement.

Common culprit medications

  • Allopurinol
  • Aromatic antiseizure medications
  • Sulfonamide antibiotics
  • Vancomycin
  • Minocycline
  • Certain antiretroviral medications

Key differentials

  • Stevens–Johnson syndrome/toxic epidermal necrolysis
  • Acute generalized exanthematous pustulosis
  • Viral exanthem
  • Hypereosinophilic syndrome
  • Lymphoma
  • Systemic infection

Key investigations

  • CBC with differential
  • Peripheral smear
  • Liver enzymes and bilirubin
  • Creatinine and urinalysis
  • Electrolytes
  • ECG and cardiac biomarkers when indicated
  • Chest imaging when respiratory symptoms occur
  • Assessment using a validated diagnostic framework such as RegiSCAR
  • Evaluation for alternative infectious or autoimmune causes

Treatment principles

  • Immediate withdrawal of the culprit drug
  • Hospitalize significant systemic disease
  • Support affected organs
  • Consider systemic glucocorticoids for severe organ involvement
  • Monitor because symptoms may progress after drug withdrawal
  • Document the drug allergy clearly
  • Avoid future rechallenge

Botanical safety: “Liver detoxification” supplements can worsen hepatic injury and obscure the clinical course.

Clinical Pearl: DRESS frequently begins several weeks after medication initiation, so the responsible drug may appear unrelated to the current illness.

NPLEX Trap: Do not continue the culprit medication merely because the rash is being treated with antihistamines or topical corticosteroids.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 408

MULTIPLE MYELOMA WITH CAST NEPHROPATHYClinical Case 408

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 68-year-old man presents with fatigue, constipation, progressive back pain, weight loss, and reduced urine output.

Laboratory findings:

  • Hemoglobin: 82 g/L
  • Creatinine: 368 µmol/L
  • Corrected calcium: 3.18 mmol/L
  • Total protein: elevated
  • Albumin: reduced
  • Serum free lambda light chains: markedly elevated
  • Peripheral smear: rouleaux formation

Imaging demonstrates multiple punched-out lytic lesions and a vertebral compression fracture.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Multiple myeloma

Anemia, renal impairment, hypercalcemia, lytic bone lesions, a protein gap, rouleaux formation, and markedly elevated monoclonal light chains are characteristic of active multiple myeloma.

Q2

Which investigations are central to confirming and characterizing the plasma-cell disorder?

Reveal answer and rationale
Correct answer: A. Serum and urine immunofixation, free-light-chain measurement, and bone-marrow examination

Monoclonal-protein testing and bone-marrow evaluation establish the plasma-cell disorder. Whole-body imaging identifies lytic lesions and other skeletal complications.

Q3

What is the most important treatment principle for suspected myeloma cast nephropathy?

Reveal answer and rationale
Correct answer: A. Rapid initiation of effective anti-myeloma therapy with supportive renal care

Rapid reduction of nephrotoxic free light chains is critical. Bortezomib-based therapy and high-dose dexamethasone are central approaches in myeloma-related renal impairment, accompanied by hydration and withdrawal of nephrotoxins. Mechanical light-chain-removal procedures do not replace effective anti-myeloma therapy.

Q4

Which medication should be stopped or avoided because it may worsen the kidney injury?

Reveal answer and rationale
Correct answer: A. NSAIDs

NSAIDs can reduce renal perfusion and aggravate acute kidney injury. Contrast exposure and other nephrotoxins should also be minimized when possible.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Active multiple myeloma with hypercalcemia, anemia, lytic bone disease, and probable cast nephropathy.

Key differentials

  • Metastatic bone malignancy
  • Monoclonal gammopathy of undetermined significance
  • Smoldering myeloma
  • AL amyloidosis
  • Primary hyperparathyroidism
  • Lymphoma
  • Waldenström macroglobulinemia

Key investigations

  • CBC
  • Calcium, albumin, and creatinine
  • Serum protein electrophoresis with immunofixation
  • Urine protein electrophoresis with immunofixation
  • Serum free-light-chain assay
  • Bone-marrow biopsy
  • Whole-body low-dose CT, PET-CT, or MRI
  • Cytogenetic and molecular risk assessment

Treatment principles

  • Prompt hematology referral
  • Immediate anti-myeloma treatment when organ damage is present
  • Appropriate hydration
  • Treat hypercalcemia
  • Avoid NSAIDs and unnecessary contrast
  • Renally adjust supportive medications
  • Dialysis for standard urgent indications
  • Manage fractures, infection risk, and thrombosis risk

Nutrition and supplement safety: High-dose calcium or vitamin D is inappropriate during hypercalcemia. Unregulated “bone-building” products may contain calcium or vitamin D.

Clinical Pearl: A urine dipstick may underestimate light-chain protein because it detects albumin more effectively than free light chains.

NPLEX Trap: Do not dismiss severe renal failure because the routine urine dipstick shows only modest protein.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 409

SYSTEMIC LIGHT-CHAIN AMYLOIDOSISClinical Case 409

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 61-year-old man presents with progressive leg edema, exertional dyspnea, dizziness when standing, numbness of the feet, and unintentional weight loss.

Physical examination:

  • BP: 108/68 mmHg supine and 78/46 mmHg standing
  • Elevated jugular venous pressure
  • Bilateral edema
  • Enlarged tongue
  • Periorbital purpura
  • Reduced vibration sensation in both feet

Investigations:

  • Urine protein: 6.2 g/day
  • Albumin: markedly reduced
  • NT-proBNP: markedly elevated
  • Echocardiogram: thickened ventricular walls with restrictive filling
  • ECG: low voltage
  • Serum free-light-chain ratio: abnormal
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Systemic light-chain amyloidosis

Nephrotic proteinuria, restrictive cardiomyopathy, autonomic neuropathy, peripheral neuropathy, macroglossia, periorbital purpura, and a monoclonal light-chain abnormality strongly suggest systemic AL amyloidosis.

Q2

Which screening tests should be performed when AL amyloidosis is suspected?

Reveal answer and rationale
Correct answer: A. Serum and urine immunofixation plus serum free-light-chain testing

A combination of serum immunofixation, urine immunofixation, and serum free-light-chain testing improves detection of the underlying monoclonal protein. Serum protein electrophoresis alone is insufficient. The 2026 ASH diagnostic guideline emphasizes comprehensive paraprotein testing in suspected AL amyloidosis.

Q3

How is amyloid deposition confirmed and accurately typed?

Reveal answer and rationale
Correct answer: A. Tissue biopsy with Congo-red staining followed by reliable amyloid typing

Congo-red-positive deposits showing characteristic birefringence confirm amyloid. Accurate typing, preferably using a validated method such as mass spectrometry, is essential because treatment differs greatly between AL and transthyretin amyloidosis.

Q4

What is the fundamental treatment strategy for AL amyloidosis?

Reveal answer and rationale
Correct answer: A. Rapid clone-directed plasma-cell therapy combined with organ-specific supportive care

Treatment aims to suppress production of the pathogenic light chain while cautiously managing cardiac, renal, neurologic, gastrointestinal, and other organ complications.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Systemic AL amyloidosis involving the heart, kidneys, autonomic nervous system, peripheral nerves, and soft tissues.

Key differentials

  • Transthyretin amyloidosis
  • Multiple myeloma
  • Hypertrophic cardiomyopathy
  • Hypertensive cardiac remodeling
  • Diabetic nephropathy
  • Constrictive pericarditis
  • Light-chain deposition disease

Key investigations

  • Serum immunofixation
  • Urine immunofixation
  • Serum free-light-chain assay
  • Cardiac biomarkers
  • Echocardiography with strain imaging
  • Cardiac MRI when appropriate
  • Tissue biopsy with Congo-red staining
  • Definitive amyloid typing
  • Bone-marrow examination
  • Renal, hepatic, and neurologic assessment

Treatment principles

  • Urgent hematology referral
  • Plasma-cell-directed treatment
  • Careful diuretic therapy for congestion
  • Avoid excessive reduction in preload
  • Manage orthostatic hypotension
  • Renally adjust medication
  • Evaluate suitability for stem-cell transplantation in selected patients

Pharmacology safety: Standard heart-failure medications may be poorly tolerated because of low blood pressure, restrictive physiology, conduction disease, and autonomic dysfunction.

Botanical safety: Stimulant or vasodilating herbs may worsen arrhythmia or hypotension.

Clinical Pearl: Increased ventricular-wall thickness on echocardiography combined with low ECG voltage is a major clue to cardiac amyloidosis.

NPLEX Trap: Do not assume a positive monoclonal protein proves that all cardiac amyloidosis is AL; tissue typing and an integrated diagnostic assessment remain essential.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 410

SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSISClinical Case 410

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 34-year-old man presents with persistent fever, profound fatigue, abdominal fullness, bruising, and progressive confusion following an Epstein–Barr virus-like illness.

Physical examination:

  • Temperature: 40.0°C
  • Marked splenomegaly
  • Hepatomegaly
  • Petechiae
  • Altered mental status

Laboratory findings:

  • Hemoglobin: 76 g/L
  • Platelets: 38 × 10⁹/L
  • Neutrophils: 0.7 × 10⁹/L
  • Ferritin: 38,000 µg/L
  • Triglycerides: markedly elevated
  • Fibrinogen: reduced
  • AST and ALT: elevated
  • Soluble interleukin-2 receptor: elevated
  • Bone-marrow sample: no definite hemophagocytosis on the first specimen
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Secondary hemophagocytic lymphohistiocytosis

Persistent high fever, splenomegaly, pancytopenia, extreme hyperferritinemia, hypertriglyceridemia, hypofibrinogenemia, hepatitis, and neurologic dysfunction strongly suggest HLH.

Q2

How can HLH be diagnosed using the HLH-2004 framework?

Reveal answer and rationale
Correct answer: A. A pathogenic molecular diagnosis or fulfillment of at least five of eight clinical and laboratory criteria

The HLH-2004 framework permits diagnosis through a compatible molecular finding or fulfillment of at least five of eight criteria, including fever, splenomegaly, cytopenias, triglyceride or fibrinogen abnormalities, hemophagocytosis, reduced NK-cell activity, elevated ferritin, and elevated soluble CD25.

Q3

Does the absence of hemophagocytosis on the first bone-marrow examination exclude HLH?

Reveal answer and rationale
Correct answer: A. No

Hemophagocytosis may be absent early, can be missed during sampling, and is not specific to HLH. Treatment should not be delayed in a critically ill patient whose overall clinical pattern strongly supports the diagnosis.

Q4

What is the most appropriate management principle?

Reveal answer and rationale
Correct answer: A. Immediate hematology-directed treatment of hyperinflammation and the underlying trigger

Adult HLH is a medical emergency. Treatment may include dexamethasone, etoposide, or other targeted immunomodulatory therapy depending on severity and the precipitating infection, malignancy, or autoimmune disease. The Histiocyte Society’s adult recommendations stress rapid diagnosis, control of hyperinflammation, and treatment of the trigger.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Secondary HLH, probably triggered by infection, with neurologic, hepatic, and hematologic involvement.

Common triggers

  • Epstein–Barr virus
  • Other severe infections
  • Lymphoma and leukemia
  • Autoimmune or autoinflammatory disease
  • Immunosuppressive treatment
  • Immune therapies
  • Post-transplant complications

Key investigations

  • CBC
  • Ferritin
  • Triglycerides
  • Fibrinogen
  • Liver enzymes and coagulation profile
  • Soluble interleukin-2 receptor
  • NK-cell-function testing when available
  • Bone-marrow examination
  • Viral PCR and infection evaluation
  • Imaging and biopsy to assess occult malignancy
  • Calculation of an HScore in appropriate adults

Treatment principles

  • Urgent hematology involvement
  • Treat the precipitating infection, malignancy, or autoimmune disease
  • Suppress dangerous hyperinflammation
  • Provide blood-product and organ support
  • Monitor for DIC, liver failure, neurologic deterioration, and shock
  • Consider hematopoietic stem-cell transplantation in selected primary, recurrent, or refractory disease

Nutrition and supplement safety: Extreme ferritin elevation reflects inflammation and iron sequestration; it is not an indication for empiric high-dose iron.

Clinical Pearl: Ferritin values in HLH may be extremely high, but no single ferritin threshold confirms the diagnosis in every adult.

NPLEX Trap: Do not wait for visible hemophagocytosis or fulfillment of every possible criterion before escalating a rapidly deteriorating patient.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 411

ADULT-ONSET STILL DISEASE WITH MACROPHAGE ACTIVATION SYNDROMEClinical Case 411

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 31-year-old woman presents with three weeks of daily high-spiking fever, severe fatigue, sore throat, joint pain, and a faint salmon-coloured rash that appears during febrile episodes.

During the last two days, she has developed confusion, jaundice, and increasing shortness of breath.

Physical examination:

  • Temperature: 40.1°C
  • HR: 132/min
  • BP: 94/58 mmHg
  • Evanescent salmon-coloured rash over the trunk
  • Synovitis of both wrists and knees
  • Hepatosplenomegaly

Laboratory findings:

  • Ferritin: 28,000 µg/L
  • Hemoglobin: 86 g/L
  • Platelets: 54 × 10⁹/L
  • Neutrophils: 1.1 × 10⁹/L
  • Triglycerides: elevated
  • Fibrinogen: reduced
  • AST and ALT: markedly elevated
  • ESR: unexpectedly falling
  • ANA and rheumatoid factor: negative
  • Blood cultures: negative to date
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Adult-onset Still disease complicated by macrophage activation syndrome

Daily spiking fever, inflammatory arthritis, sore throat, an evanescent salmon-coloured rash, marked hyperferritinemia, and negative ANA and rheumatoid factor suggest Still disease. The subsequent cytopenias, hepatitis, hypofibrinogenemia, hypertriglyceridemia, neurologic deterioration, and extreme ferritin elevation indicate macrophage activation syndrome.

Q2

Which laboratory trend most strongly suggests that macrophage activation syndrome has developed?

Reveal answer and rationale
Correct answer: A. Falling platelet count and fibrinogen with rising ferritin and liver enzymes

MAS produces uncontrolled macrophage and T-cell activation. Cytopenias, falling fibrinogen, liver dysfunction, coagulopathy, hypertriglyceridemia, and rapidly rising ferritin are major warning findings.

Q3

Why may the ESR fall despite worsening systemic inflammation?

Reveal answer and rationale
Correct answer: A. Reduced fibrinogen can lower the erythrocyte-sedimentation rate

ESR depends partly on fibrinogen. During MAS, fibrinogen may fall because of consumption and liver dysfunction, producing a paradoxically low or falling ESR despite severe inflammation.

Q4

What is the most appropriate management principle?

Reveal answer and rationale
Correct answer: A. Urgent specialist treatment of MAS with high-dose anti-inflammatory therapy and consideration of cytokine-directed treatment

MAS is a life-threatening hyperinflammatory emergency. Management commonly includes high-dose glucocorticoids and rapid consideration of cytokine-directed treatment, particularly IL-1 inhibition, while infection and other triggers are investigated and treated.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Adult-onset Still disease complicated by macrophage activation syndrome.

Key differentials

  • Secondary HLH
  • Severe bacterial infection
  • Viral infection
  • Hematologic malignancy
  • Systemic lupus erythematosus
  • Drug hypersensitivity
  • Catastrophic antiphospholipid syndrome

Key investigations

  • Serial CBC
  • Ferritin
  • Fibrinogen and triglycerides
  • Liver enzymes and coagulation profile
  • Soluble IL-2 receptor when available
  • Bone-marrow assessment when appropriate
  • Cultures and infection testing
  • Imaging and malignancy assessment when indicated

Treatment principles

  • Emergency rheumatology and hematology involvement
  • High-dose glucocorticoid therapy
  • Consider IL-1-directed therapy
  • Treat identified infections or other precipitants
  • Manage coagulopathy and organ failure
  • Do not delay treatment solely for bone-marrow confirmation

Botanical safety: Immune-stimulating supplements are inappropriate during uncontrolled systemic hyperinflammation.

Clinical Pearl: A falling ESR can be an ominous sign when fibrinogen is being consumed.

NPLEX Trap: Extreme ferritin elevation does not mean the patient needs iron supplementation.

Current EULAR/PReS recommendations emphasize early recognition of MAS and rapid cytokine-directed and glucocorticoid-based treatment for severe Still disease.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 412

EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITISClinical Case 412

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 48-year-old woman with adult-onset asthma and chronic sinusitis presents with worsening dyspnea, painful numbness of the right foot, weakness of the left hand, and a purpuric rash.

Physical examination:

  • Diffuse wheezing
  • Nonblanching palpable purpura over both legs
  • Right foot drop
  • Reduced left-hand grip
  • Mild peripheral edema

Laboratory findings:

  • Eosinophils: 6.4 × 10⁹/L
  • Creatinine: mildly elevated
  • Urinalysis: hematuria and proteinuria
  • Troponin: elevated
  • Chest CT: transient bilateral pulmonary infiltrates
  • MPO-ANCA: positive

Cardiac MRI suggests myocarditis.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Eosinophilic granulomatosis with polyangiitis

Adult-onset asthma, sinus disease, marked eosinophilia, transient pulmonary infiltrates, palpable purpura, mononeuritis multiplex, renal abnormalities, and myocarditis are characteristic of EGPA.

Q2

Which finding makes this organ-threatening disease?

Reveal answer and rationale
Correct answer: A. Myocarditis and mononeuritis multiplex

Cardiac involvement can cause arrhythmia, heart failure, and death. Progressive vasculitic neuropathy also represents significant organ damage requiring urgent treatment.

Q3

What is an appropriate induction strategy for severe EGPA?

Reveal answer and rationale
Correct answer: A. High-dose glucocorticoid therapy combined with an appropriate immunosuppressive agent

Severe EGPA generally requires systemic glucocorticoids plus an induction agent such as cyclophosphamide or rituximab. Mepolizumab is particularly useful in selected nonsevere, relapsing, or eosinophilic disease but is not a substitute for intensive induction treatment in life-threatening vasculitis.

Q4

Which statement about ANCA testing is correct?

Reveal answer and rationale
Correct answer: A. A negative ANCA test would not exclude EGPA

Only a subset of patients with EGPA are ANCA-positive. Diagnosis depends on the complete clinical pattern rather than ANCA testing alone.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Severe EGPA involving the lungs, peripheral nerves, skin, kidneys, and heart.

Key differentials

  • Hypereosinophilic syndrome
  • Parasitic infection
  • Drug-induced eosinophilia
  • Allergic bronchopulmonary aspergillosis
  • GPA
  • Eosinophilic pneumonia
  • Hematologic malignancy

Key investigations

  • CBC with eosinophil count
  • ANCA testing
  • Creatinine and urinalysis
  • Troponin, ECG, echocardiography, or cardiac MRI
  • Chest CT
  • Nerve-conduction testing
  • Tissue biopsy when appropriate
  • Parasite and medication assessment

Treatment principles

  • Treat severe disease urgently
  • Systemic glucocorticoids
  • Cyclophosphamide or rituximab for organ-threatening disease
  • Mepolizumab in selected nonsevere or relapsing disease
  • Treat asthma and sinus disease
  • Monitor cardiac and neurologic recovery

Botanical safety: Ephedra and other stimulants may worsen tachycardia and cardiac stress.

Clinical Pearl: Cardiac EGPA may occur even when ANCA is negative.

NPLEX Trap: Do not classify marked eosinophilia with neuropathy, purpura, and myocarditis as uncomplicated allergic asthma.

The ACR/Vasculitis Foundation guideline distinguishes severe EGPA requiring glucocorticoid-based immunosuppressive induction from nonsevere disease in which mepolizumab may be used.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 413

POLYARTERITIS NODOSA ASSOCIATED WITH HEPATITIS BClinical Case 413

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 44-year-old man presents with severe postprandial abdominal pain, weight loss, muscle pain, painful skin nodules, and progressive right-foot weakness.

Vital signs:

  • BP: 192/112 mmHg
  • HR: 106/min

Physical examination:

  • Livedo reticularis
  • Tender subcutaneous nodules
  • Right foot drop
  • Diffuse abdominal tenderness without guarding

Laboratory findings:

  • Creatinine: elevated
  • Urinalysis: mild proteinuria but no red-cell casts
  • Hepatitis B surface antigen: positive
  • Hepatitis B viral load: elevated
  • ANCA: negative

Mesenteric and renal angiography demonstrates multiple microaneurysms and irregular narrowing of medium-sized arteries.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Hepatitis B-associated polyarteritis nodosa

Medium-vessel disease causing mesenteric ischemia, renovascular hypertension, skin nodules, livedo reticularis, mononeuritis multiplex, and angiographic microaneurysms is characteristic of PAN.

Q2

Which finding supports PAN rather than microscopic polyangiitis?

Reveal answer and rationale
Correct answer: A. Medium-vessel microaneurysms without glomerulonephritis

PAN affects medium and small muscular arteries but typically spares glomerular capillaries. Hematuria may occur from renal ischemia, but an active glomerulonephritic sediment is not typical.

Q3

Which test can establish the diagnosis when an involved accessible tissue is present?

Reveal answer and rationale
Correct answer: A. Biopsy of symptomatic skin, nerve, or muscle

Biopsy may show necrotizing inflammation of medium or small muscular arteries. Angiography is particularly useful when abdominal or renal arterial involvement is suspected.

Q4

What additional management is essential in hepatitis B-associated PAN?

Reveal answer and rationale
Correct answer: A. Specialist-directed antiviral treatment for hepatitis B

Treatment must address both the vasculitis and active hepatitis B. Antiviral therapy is central, with carefully selected short-term immunosuppression and plasma exchange in some severe presentations.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Hepatitis B-associated systemic PAN.

Key manifestations

  • Mesenteric ischemia
  • Renovascular hypertension
  • Mononeuritis multiplex
  • Livedo reticularis
  • Skin nodules
  • Myalgia
  • Testicular pain
  • Renal infarction

Key investigations

  • Hepatitis B and C testing
  • Renal and liver function
  • Urinalysis
  • Nerve-conduction testing
  • Angiography
  • Biopsy of involved tissue
  • Assessment for bowel ischemia and perforation

Treatment principles

  • Urgent treatment for severe organ involvement
  • Glucocorticoids and immunosuppression when indicated
  • Antiviral treatment for hepatitis B
  • Plasma exchange in selected severe HBV-associated cases
  • Blood-pressure control
  • Management of ischemic complications

Physical medicine safety: Deep massage over painful nodules or ischemic limbs is inappropriate.

Clinical Pearl: Severe hypertension in PAN is often caused by renal arterial ischemia rather than glomerulonephritis.

NPLEX Trap: Pulmonary capillaritis and glomerulonephritis suggest another vasculitis, not classic PAN.

The ACR/Vasculitis Foundation PAN guideline supports tissue biopsy or vascular imaging and severity-based immunosuppressive treatment.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 414

ANTI-MDA5 DERMATOMYOSITIS WITH RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASEClinical Case 414

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 42-year-old woman presents with painful hand lesions, fatigue, dry cough, and rapidly worsening shortness of breath.

Physical examination:

  • Violaceous papules over the knuckles
  • Painful palmar papules
  • Ulceration near the fingernails
  • Faint heliotrope discoloration around the eyelids
  • Minimal objective muscle weakness
  • Bilateral fine inspiratory crackles

Investigations:

  • Creatine kinase: normal
  • Ferritin: markedly elevated
  • Anti-MDA5 antibody: positive
  • HRCT: bilateral ground-glass and organizing-pneumonia-like opacities
  • Oxygen saturation: 86% on room air
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Anti-MDA5-positive clinically amyopathic dermatomyositis with rapidly progressive ILD

Characteristic dermatomyositis skin findings, little muscle weakness, normal CK, anti-MDA5 positivity, hyperferritinemia, and rapidly progressive ILD indicate this high-risk phenotype.

Q2

Which feature does not exclude dermatomyositis?

Reveal answer and rationale
Correct answer: A. A normal creatine kinase level

Anti-MDA5 disease may be clinically amyopathic, meaning classic skin and systemic manifestations occur without substantial muscle weakness or CK elevation.

Q3

What is the most appropriate management principle?

Reveal answer and rationale
Correct answer: A. Urgent combined immunosuppressive treatment rather than slow sequential monotherapy

Rapidly progressive anti-MDA5 ILD carries substantial mortality. Current guidance supports early combination immunosuppression, often involving glucocorticoids plus additional agents, rather than waiting for failure of prolonged monotherapy.

Q4

Which investigation is most useful for defining the pulmonary pattern and extent?

Reveal answer and rationale
Correct answer: A. High-resolution CT of the chest

HRCT identifies ground-glass opacity, consolidation, organizing-pneumonia patterns, and fibrotic change. Pulmonary-function testing and oxygen assessment provide additional severity information.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Anti-MDA5 dermatomyositis with rapidly progressive ILD.

Key differentials

  • Antisynthetase syndrome
  • Viral pneumonia
  • Pneumocystis pneumonia
  • Hypersensitivity pneumonitis
  • Systemic sclerosis-associated ILD
  • Idiopathic organizing pneumonia
  • Drug-induced pneumonitis

Key investigations

  • HRCT
  • Oxygen saturation and blood gases
  • Pulmonary-function testing
  • Myositis-antibody panel
  • CK, aldolase, AST, and LDH
  • Ferritin
  • Infection evaluation
  • Malignancy assessment based on phenotype and age

Treatment principles

  • Emergency respiratory and rheumatology assessment
  • Early combination immunosuppression
  • Infection prophylaxis when indicated
  • Screen for treatment-associated infection
  • Consider transplant-centre involvement in refractory respiratory failure
  • Avoid delaying treatment because CK is normal

Nutrition and rehabilitation: Exercise may be useful after stabilization but is not appropriate during severe hypoxemic respiratory deterioration.

Clinical Pearl: Skin ulceration and painful palmar papules are important clues to anti-MDA5 disease.

NPLEX Trap: Normal muscle enzymes do not exclude life-threatening dermatomyositis-associated lung disease.

The ACR/CHEST ILD guideline conditionally recommends upfront combination treatment for rapidly progressive autoimmune ILD, with triple therapy considered when anti-MDA5 disease is suspected.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 415

BEHÇET SYNDROME WITH CEREBRAL VENOUS SINUS THROMBOSISClinical Case 415

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 29-year-old man presents with severe progressive headache, vomiting, and transient double vision.

History:

  • Recurrent painful oral ulcers
  • Recurrent genital ulcers
  • Previous episode of anterior uveitis
  • Painful nodules over the legs

Physical examination:

  • Papilledema
  • Right sixth-nerve palsy
  • Healing oral and genital ulcers
  • Erythema-nodosum-like lesions

MRI venography demonstrates superior sagittal sinus thrombosis.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Neuro-Behçet syndrome with cerebral venous sinus thrombosis

Recurrent oral and genital ulcers, uveitis, inflammatory skin lesions, and cerebral venous thrombosis form a characteristic Behçet pattern.

Q2

What mechanism principally causes the thrombosis?

Reveal answer and rationale
Correct answer: A. Inflammation of the vessel wall

Thrombosis in Behçet syndrome is strongly associated with vascular inflammation. Management therefore focuses on controlling inflammation rather than viewing the event as an ordinary unprovoked clot.

Q3

What is the primary acute treatment approach?

Reveal answer and rationale
Correct answer: A. High-dose glucocorticoid treatment with specialist-directed immunosuppression

Acute cerebral venous involvement generally requires rapid control of vascular inflammation. Additional immunosuppressive treatment is individualized according to severity, recurrence, and other organ involvement.

Q4

What should be considered before anticoagulation is used?

Reveal answer and rationale
Correct answer: A. Evaluation for pulmonary-artery aneurysm or another major bleeding risk

Anticoagulation is individualized in Behçet thrombosis. Pulmonary-artery aneurysms can cause catastrophic hemorrhage, so vascular imaging and specialist assessment may be required before anticoagulation.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Behçet syndrome with nonparenchymal neurologic involvement caused by cerebral venous sinus thrombosis.

Key differentials

  • Antiphospholipid syndrome
  • Infection-related cerebral thrombosis
  • Inflammatory bowel disease
  • Multiple sclerosis
  • Sarcoidosis
  • Malignancy
  • Inherited thrombophilia

Key investigations

  • MRI with venography
  • Ophthalmologic examination
  • Assessment for pulmonary-artery aneurysm
  • Inflammatory markers
  • Thrombosis and bleeding-risk evaluation
  • Lumbar puncture only when safe and clinically needed
  • Assessment for other systemic vascular involvement

Treatment principles

  • High-dose glucocorticoids
  • Immunosuppression based on disease severity
  • Manage raised intracranial pressure
  • Individualize anticoagulation
  • Treat ocular and other organ involvement
  • Long-term rheumatology and neurology follow-up

Botanical safety: Products with antiplatelet effects may complicate anticoagulation and bleeding-risk assessment.

Clinical Pearl: Behçet thrombosis is closely linked to inflamed vessel walls.

NPLEX Trap: Do not treat the clot while ignoring the underlying systemic vasculitis.

EULAR recommendations prioritize immunosuppressive control of vascular inflammation and individualized decisions regarding anticoagulation.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 416

WILSON DISEASE PRESENTING WITH ACUTE LIVER FAILUREClinical Case 416

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 21-year-old woman presents with jaundice, confusion, abdominal swelling, and profound fatigue.

Laboratory findings:

  • Bilirubin: markedly elevated
  • Alkaline phosphatase: disproportionately low
  • AST: greater than ALT
  • INR: 4.1
  • Hemoglobin: 68 g/L
  • Direct antiglobulin test: negative
  • Reticulocytes: elevated
  • Haptoglobin: undetectable
  • Creatinine: elevated
  • Ceruloplasmin: low

Slit-lamp examination identifies Kayser–Fleischer rings.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Wilson disease causing acute liver failure and Coombs-negative hemolysis

Acute liver failure in a young patient, disproportionately low alkaline phosphatase, Coombs-negative hemolytic anemia, renal dysfunction, low ceruloplasmin, and Kayser–Fleischer rings strongly suggest Wilson disease.

Q2

What is the most important immediate management step?

Reveal answer and rationale
Correct answer: A. Urgent transfer to a liver-transplant centre

Wilson-related acute liver failure can progress rapidly and carries a poor prognosis without transplantation. Transplant evaluation must not be delayed for completion of every confirmatory test.

Q3

Which additional tests support the diagnosis?

Reveal answer and rationale
Correct answer: A. Twenty-four-hour urinary copper and quantitative hepatic copper assessment when appropriate

Diagnosis integrates clinical findings, ceruloplasmin, urinary copper, eye examination, hepatic copper when safe, and ATP7B genetic testing. No single test is sufficient in every patient.

Q4

Which intervention may be used as a bridge while transplantation is arranged?

Reveal answer and rationale
Correct answer: A. Specialist-directed extracorporeal copper-removal or plasma-exchange therapy

Plasma exchange and other extracorporeal support may reduce circulating copper and stabilize selected patients while urgent transplantation is arranged. They do not replace transplant assessment.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Wilson disease presenting as acute liver failure with intravascular hemolysis.

Key differentials

  • Autoimmune hepatitis
  • Viral hepatitis
  • Acetaminophen toxicity
  • Acute fatty liver of pregnancy
  • Budd–Chiari syndrome
  • Hemolytic-uremic syndrome
  • Drug-induced liver injury

Key investigations

  • Ceruloplasmin
  • Serum and urinary copper
  • Slit-lamp examination
  • CBC and hemolysis studies
  • Liver enzymes, bilirubin, glucose, INR
  • Renal function
  • ATP7B testing
  • Hepatic copper when safe and appropriate

Treatment principles

  • Immediate intensive-care management
  • Urgent transplant-centre referral
  • Correct hypoglycemia and coagulopathy as clinically indicated
  • Manage cerebral edema and renal failure
  • Consider plasma exchange as a bridge
  • Screen siblings after diagnosis

Nutrition: Dietary copper restriction is supportive in chronic management but cannot treat acute liver failure.

Clinical Pearl: Coombs-negative hemolysis can result from sudden copper release from damaged hepatocytes.

NPLEX Trap: Do not manage Wilson-related acute liver failure with outpatient chelation or zinc alone.

AASLD and EASL guidance emphasize multidisciplinary diagnosis and immediate transplant-centre evaluation for Wilson-related acute liver failure.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 417

ACUTE INTERMITTENT PORPHYRIAClinical Case 417

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 27-year-old woman presents with severe diffuse abdominal pain, vomiting, constipation, anxiety, and progressive weakness.

She recently began a very-low-carbohydrate weight-loss diet and was prescribed a new antiseizure medication.

Vital signs:

  • BP: 176/104 mmHg
  • HR: 124/min

Examination:

  • Abdomen is mildly tender without guarding
  • Proximal muscle weakness
  • Reduced reflexes
  • No skin blistering

Laboratory findings:

  • Sodium: 118 mmol/L
  • Urinalysis: initially normal
  • Urine becomes dark reddish-brown after standing
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Acute intermittent porphyria

Severe neurovisceral abdominal pain, autonomic instability, psychiatric symptoms, motor neuropathy, hyponatremia, medication exposure, fasting, and darkening urine suggest an acute hepatic porphyria.

Q2

What is the best initial biochemical test during the attack?

Reveal answer and rationale
Correct answer: A. Random urine porphobilinogen normalized to creatinine

Urinary porphobilinogen is markedly elevated during most acute attacks and is the key initial diagnostic test. Samples should be protected from light.

Q3

What is the appropriate treatment for a severe attack with neurologic manifestations?

Reveal answer and rationale
Correct answer: A. Intravenous hemin with supportive treatment

Severe attacks require intravenous hemin, withdrawal of precipitating medications, carbohydrate support, careful correction of hyponatremia, pain control, and respiratory monitoring.

Q4

Which advice is most appropriate for prevention?

Reveal answer and rationale
Correct answer: A. Avoid prolonged fasting and verify medication safety before starting new drugs

Fasting, severe carbohydrate restriction, alcohol, hormonal changes, illness, and porphyrinogenic medications can precipitate attacks. Medication safety should be checked using a reliable porphyria-drug resource.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Acute intermittent porphyria causing a severe neurovisceral attack.

Key differentials

  • Bowel obstruction
  • Appendicitis
  • Guillain–Barré syndrome
  • Lead toxicity
  • Hyponatremic encephalopathy
  • Psychiatric illness
  • Opioid withdrawal

Key investigations

  • Urinary porphobilinogen and aminolevulinic acid
  • Electrolytes
  • Renal and liver function
  • ECG
  • Respiratory-force monitoring
  • Genetic testing after biochemical confirmation
  • Medication and supplement review

Treatment principles

  • Discontinue triggering drugs
  • Intravenous hemin for severe attacks
  • Glucose or carbohydrate support in selected mild disease
  • Correct fluid and sodium disturbances carefully
  • Treat pain, nausea, hypertension, and tachycardia safely
  • Monitor for bulbar or respiratory weakness

Botanical safety: Herbal products may contain unrecognized porphyrinogenic compounds or induce hepatic enzymes.

Clinical Pearl: Severe abdominal pain can occur with a relatively benign abdominal examination.

NPLEX Trap: AIP does not characteristically cause photosensitive blistering skin lesions.

AGA guidance identifies urinary porphobilinogen testing during symptoms, removal of triggers, carbohydrate support, and intravenous hemin as central management principles.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 418

ACUTE TUMOUR LYSIS SYNDROMEClinical Case 418

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 58-year-old man with high-grade lymphoma develops nausea, muscle cramps, weakness, reduced urine output, and palpitations 24 hours after beginning chemotherapy.

Laboratory findings:

  • Potassium: 6.8 mmol/L
  • Phosphate: 2.9 mmol/L
  • Corrected calcium: 1.76 mmol/L
  • Uric acid: markedly elevated
  • Creatinine: rapidly rising
  • LDH: markedly elevated

ECG demonstrates peaked T waves.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Acute tumour lysis syndrome

Rapid tumour-cell breakdown releases potassium, phosphate, nucleic acids, and intracellular contents, causing hyperkalemia, hyperphosphatemia, secondary hypocalcemia, hyperuricemia, and acute kidney injury.

Q2

Which medication rapidly lowers existing uric acid?

Reveal answer and rationale
Correct answer: A. Rasburicase

Rasburicase enzymatically converts existing uric acid into a more soluble metabolite. Allopurinol prevents formation of additional uric acid but does not rapidly remove uric acid already present.

Q3

In which patient is rasburicase contraindicated?

Reveal answer and rationale
Correct answer: A. A patient with glucose-6-phosphate dehydrogenase deficiency

Rasburicase can cause severe oxidative hemolysis and methemoglobinemia in G6PD deficiency.

Q4

How should asymptomatic hypocalcemia generally be approached?

Reveal answer and rationale
Correct answer: A. Avoid routine calcium unless clinically necessary because calcium-phosphate precipitation may worsen

Calcium is administered when significant symptoms such as tetany, seizure, or dangerous arrhythmia are present. Unnecessary calcium can increase tissue and renal calcium-phosphate deposition.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Acute tumour lysis syndrome with cardiac and renal complications.

Key risk factors

  • High-grade lymphoma or leukemia
  • Large tumour burden
  • High LDH
  • Highly treatment-sensitive malignancy
  • Pre-existing kidney disease
  • Dehydration
  • Elevated baseline uric acid

Key investigations

  • Potassium
  • Phosphate
  • Calcium
  • Uric acid
  • Creatinine
  • LDH
  • ECG
  • Continuous cardiac monitoring in severe disease
  • Frequent repeat metabolic testing

Treatment principles

  • Aggressive but individualized intravenous hydration
  • Immediate hyperkalemia treatment
  • Rasburicase when appropriate
  • Allopurinol for selected prophylaxis
  • Manage phosphate and symptomatic hypocalcemia
  • Nephrology consultation
  • Dialysis for refractory electrolyte abnormalities, volume overload, severe acidosis, or uremia

Nutrition and supplement safety: Potassium, phosphate, calcium, and vitamin D supplements should not be given without reviewing current laboratory abnormalities.

Clinical Pearl: Hyperphosphatemia may become a major driver of ongoing kidney injury.

NPLEX Trap: Allopurinol prevents new uric-acid formation but does not remove existing uric acid.

Current TLS guidance emphasizes risk-based prevention, hydration, frequent biochemical monitoring, and rapid treatment with uric-acid-lowering therapy.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 419

MALIGNANT HYPERTHERMIAClinical Case 419

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 24-year-old man undergoing elective surgery receives succinylcholine and a volatile inhalational anesthetic.

Within minutes:

  • End-tidal CO₂ rises rapidly despite increased ventilation
  • HR increases to 158/min
  • Generalized muscle rigidity develops
  • Temperature rises to 40.3°C
  • Potassium becomes elevated
  • Urine becomes dark
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Malignant hyperthermia

Acute hypermetabolism after exposure to succinylcholine or a volatile anesthetic, with rapidly increasing CO₂, rigidity, tachycardia, acidosis, hyperkalemia, rhabdomyolysis, and hyperthermia, is characteristic of malignant hyperthermia.

Q2

What is the first specific medication?

Reveal answer and rationale
Correct answer: A. Intravenous dantrolene

Dantrolene reduces abnormal skeletal-muscle calcium release. It should be administered immediately while triggering agents are discontinued and resuscitative care begins.

Q3

Which finding is often an early clue?

Reveal answer and rationale
Correct answer: A. Unexpected rapid increase in end-tidal CO₂

Hypercapnia despite increased minute ventilation is often an early manifestation. Marked hyperthermia may develop later.

Q4

Which long-term advice is essential after recovery?

Reveal answer and rationale
Correct answer: A. Refer for malignant-hyperthermia susceptibility assessment and avoid triggering anesthetics

The patient and close relatives may require genetic or contracture testing. The event must be documented clearly, and future anesthesia should use nontriggering techniques.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Malignant hyperthermia triggered by succinylcholine and volatile anesthetic exposure.

Key triggers

  • Succinylcholine
  • Volatile inhalational anesthetics

Key manifestations

  • Rapidly increasing end-tidal CO₂
  • Muscle rigidity
  • Tachycardia
  • Metabolic and respiratory acidosis
  • Hyperkalemia
  • Rhabdomyolysis
  • Hyperthermia
  • Arrhythmia
  • Acute kidney injury
  • DIC

Treatment principles

  • Stop triggering agents
  • Give 100% oxygen and hyperventilate
  • Administer dantrolene promptly
  • Active cooling when hyperthermia is present
  • Treat hyperkalemia and acidosis
  • Monitor CK, electrolytes, coagulation, urine output, and recurrence
  • Continue post-crisis monitoring

Naturopathic safety: No supplement or antipyretic substitutes for dantrolene and anesthetic-crisis management.

Clinical Pearl: Hyperthermia is not always the first abnormality.

NPLEX Trap: Acetaminophen does not correct malignant-hyperthermia physiology.

MHAUS identifies immediate trigger discontinuation, hyperventilation, cooling when indicated, and rapid dantrolene administration as the core emergency response.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 420

ANTI-NMDA RECEPTOR ENCEPHALITISClinical Case 420

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 22-year-old woman develops insomnia, paranoia, agitation, and bizarre behaviour over ten days. She subsequently develops seizures, mutism, repetitive lip-smacking movements, limb dyskinesias, and episodes of severe tachycardia and blood-pressure fluctuation.

Investigations:

  • Toxicology testing: negative
  • Brain MRI: mild nonspecific changes
  • EEG: diffuse slowing
  • CSF: lymphocytic pleocytosis
  • Pelvic ultrasound: ovarian mass
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Anti-NMDA receptor encephalitis associated with ovarian teratoma

Rapid psychiatric change followed by seizures, speech dysfunction, dyskinesias, reduced consciousness, and autonomic instability strongly suggests anti-NMDA receptor encephalitis.

Q2

Which test best confirms the diagnosis?

Reveal answer and rationale
Correct answer: A. CSF anti-NMDA receptor antibody testing

CSF antibody testing is central to confirmation. Serum testing alone can produce misleading results and should be interpreted cautiously.

Q3

What is the appropriate initial treatment?

Reveal answer and rationale
Correct answer: A. Tumour removal when present plus corticosteroids, IV immunoglobulin, or plasma exchange

Early immunotherapy and removal of an associated ovarian teratoma improve the likelihood of recovery. Second-line immunotherapy is considered when first-line treatment is inadequate.

Q4

Which complication requires intensive monitoring?

Reveal answer and rationale
Correct answer: A. Autonomic instability and central hypoventilation

Patients may develop arrhythmia, severe blood-pressure fluctuations, fever, respiratory failure, aspiration, and prolonged seizures.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Anti-NMDA receptor autoimmune encephalitis associated with an ovarian teratoma.

Key differentials

  • Viral encephalitis
  • Toxic ingestion
  • Primary psychotic illness
  • Neuroleptic malignant syndrome
  • Serotonin syndrome
  • Status epilepticus
  • Lupus cerebritis

Key investigations

  • CSF cell count, protein, oligoclonal bands, and antibody testing
  • EEG
  • Brain MRI
  • Infectious encephalitis testing
  • Pelvic imaging
  • Age- and sex-appropriate tumour assessment
  • Continuous cardiac and respiratory monitoring in severe disease

Treatment principles

  • Stabilize airway and seizures
  • Treat autonomic instability
  • Remove associated tumour
  • First-line immunotherapy
  • Escalate to second-line treatment when necessary
  • Begin rehabilitation early
  • Avoid assuming the illness is purely psychiatric

Pharmacology safety: Antipsychotic medications may worsen rigidity, autonomic instability, or movement disorders and require cautious use.

Clinical Pearl: Brain MRI can be normal despite severe disease.

NPLEX Trap: New psychosis accompanied by seizures and dyskinesias requires neurologic investigation.

Canadian and international guidance supports early immunotherapy, CSF antibody testing, tumour screening, and tumour removal when applicable.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 421

CARCINOID SYNDROME WITH CARCINOID HEART DISEASEClinical Case 421

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 59-year-old woman presents with episodic facial flushing, watery diarrhea, wheezing, weight loss, and progressive leg swelling.

Examination:

  • Facial telangiectasia
  • Elevated jugular venous pressure
  • Systolic murmur increasing with inspiration
  • Hepatomegaly
  • Peripheral edema

Imaging identifies an ileal neuroendocrine tumour with multiple liver metastases.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Carcinoid syndrome with right-sided carcinoid heart disease

Flushing, secretory diarrhea, bronchospasm, metastatic neuroendocrine tumour, tricuspid or pulmonary valve disease, and right-sided heart failure indicate carcinoid syndrome with cardiac involvement.

Q2

Which biochemical test supports the diagnosis?

Reveal answer and rationale
Correct answer: A. Twenty-four-hour urinary or plasma 5-hydroxyindoleacetic acid

5-HIAA is the principal serotonin metabolite and is commonly elevated in serotonin-secreting neuroendocrine tumours. Medication and dietary interference must be considered.

Q3

What is the principal medication for controlling flushing and diarrhea?

Reveal answer and rationale
Correct answer: A. A somatostatin analogue

Octreotide or lanreotide reduces mediator release and improves carcinoid-syndrome symptoms. Additional tumour-directed treatment depends on tumour location, extent, and progression.

Q4

Which nutritional deficiency can occur because tryptophan is diverted into serotonin production?

Reveal answer and rationale
Correct answer: A. Niacin deficiency

Substantial tryptophan diversion may reduce niacin synthesis and produce pellagra-like dermatitis, diarrhea, and neurocognitive symptoms.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Metastatic small-bowel neuroendocrine tumour causing carcinoid syndrome and carcinoid heart disease.

Key differentials

  • Menopause
  • Pheochromocytoma
  • Mast-cell disease
  • Medullary thyroid carcinoma
  • VIPoma
  • Medication-induced flushing
  • Inflammatory bowel disease

Key investigations

  • Urine or plasma 5-HIAA
  • Chromogranin testing when appropriate
  • Cross-sectional and somatostatin-receptor imaging
  • Echocardiography
  • NT-proBNP
  • Liver and renal function
  • Nutritional assessment

Treatment principles

  • Somatostatin analogue
  • Tumour-directed surgery or systemic therapy when appropriate
  • Manage right-sided heart failure
  • Evaluate for valve surgery in advanced cardiac disease
  • Prevent perioperative carcinoid crisis
  • Monitor nutrition and fat-soluble vitamin status

Botanical safety: Serotonergic supplements such as 5-HTP may complicate symptoms and biochemical interpretation.

Clinical Pearl: Carcinoid heart disease predominantly damages right-sided valves because vasoactive substances are normally inactivated in the lungs.

NPLEX Trap: Antidiarrheal medication alone does not treat serotonin secretion or the underlying tumour.

ENETS guidance recommends biochemical assessment, somatostatin-analogue treatment, cardiac surveillance, and multidisciplinary management of carcinoid heart disease.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 422

IgG4-RELATED DISEASE WITH AUTOIMMUNE PANCREATITIS AND RETROPERITONEAL FIBROSISClinical Case 422

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 63-year-old man presents with painless jaundice, weight loss, dry mouth, bilateral salivary-gland enlargement, and dull flank pain.

Investigations:

  • Pancreas: diffusely enlarged with a capsule-like rim
  • Common bile duct: narrowed
  • CT abdomen: soft-tissue encasement of the abdominal aorta and ureters
  • Bilateral hydronephrosis
  • Serum IgG4: elevated
  • Creatinine: increasing
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. IgG4-related disease involving the pancreas, salivary glands, biliary tract, and retroperitoneum

Autoimmune pancreatitis, salivary-gland enlargement, biliary involvement, and retroperitoneal fibrosis causing ureteral obstruction are classic manifestations of systemic IgG4-related disease.

Q2

Which finding is characteristic on tissue biopsy?

Reveal answer and rationale
Correct answer: A. Lymphoplasmacytic inflammation with storiform fibrosis and obliterative phlebitis

Characteristic histology and IgG4-positive plasma-cell infiltration support the diagnosis. Histology varies by organ and must be interpreted in the full clinical context.

Q3

Why is tissue diagnosis important before treatment when feasible?

Reveal answer and rationale
Correct answer: A. Malignancy and other inflammatory diseases can closely mimic IgG4-related disease

Pancreatic, biliary, lymph-node, and retroperitoneal malignancies can resemble IgG4-related disease. Elevated serum IgG4 is neither completely sensitive nor specific.

Q4

What is the appropriate management?

Reveal answer and rationale
Correct answer: A. Relieve obstructive complications and begin specialist-directed glucocorticoid treatment

Active organ-threatening disease generally requires glucocorticoid induction. Ureteral or biliary obstruction may require immediate drainage or stenting. Rituximab or other strategies may be used for selected relapsing or refractory disease.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Multiorgan IgG4-related disease.

Potentially involved organs

  • Pancreas
  • Bile ducts
  • Salivary and lacrimal glands
  • Kidneys
  • Retroperitoneum
  • Aorta
  • Lungs
  • Lymph nodes
  • Thyroid
  • Pituitary gland

Key investigations

  • Serum IgG4
  • Pancreatic and biliary imaging
  • Renal function and urinalysis
  • Tissue biopsy when feasible
  • Assessment for malignancy
  • Whole-body assessment for additional organ involvement

Treatment principles

  • Treat organ-threatening disease promptly
  • Glucocorticoid induction
  • Relieve mechanical obstruction
  • Consider B-cell-directed therapy for selected patients
  • Monitor for relapse and fibrotic damage
  • Manage treatment-related infection and metabolic effects

Botanical safety: Diuretic herbs cannot relieve fibrotic ureteral obstruction.

Clinical Pearl: Serum IgG4 can be normal in some affected patients and elevated in unrelated conditions.

NPLEX Trap: Do not label a pancreatic mass as autoimmune disease without adequately excluding malignancy.

Revised diagnostic criteria combine clinical or radiologic disease, serologic findings, and characteristic pathology rather than relying on serum IgG4 alone.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 423

D-LACTIC ACIDOSIS IN SHORT-BOWEL SYNDROMEClinical Case 423

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 37-year-old man with extensive small-bowel resection and an intact colon presents with episodic confusion, slurred speech, irritability, and unsteady gait.

His symptoms commonly begin several hours after consuming large amounts of sweetened beverages and refined carbohydrates.

Laboratory findings during an episode:

  • Bicarbonate: 12 mmol/L
  • Anion gap: elevated
  • Standard serum L-lactate: normal
  • Glucose: normal
  • Renal function: stable
  • Toxicology testing: negative
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. D-lactic acidosis

Short-bowel syndrome with colonic continuity, carbohydrate-triggered neurologic symptoms, and unexplained high-anion-gap acidosis with a normal routine lactate level strongly suggest D-lactic acidosis.

Q2

Why may the standard lactate result be normal?

Reveal answer and rationale
Correct answer: A. Routine assays primarily measure L-lactate rather than D-lactate

D-lactate requires a specialized assay. Failure to recognize this limitation can delay diagnosis.

Q3

What is the most appropriate acute management?

Reveal answer and rationale
Correct answer: A. Reduce carbohydrate substrate, provide fluid and acid-base support, and consider targeted antibiotic therapy

Treatment reduces fermentable carbohydrate reaching colonic bacteria, corrects dehydration and acidosis, and may use antibiotics to reduce D-lactate-producing organisms.

Q4

Which dietary strategy helps reduce recurrence?

Reveal answer and rationale
Correct answer: A. Individualized restriction of rapidly absorbed simple carbohydrates

Large carbohydrate loads provide substrate for colonic bacterial production of D-lactate. Nutrition must still provide adequate calories and micronutrients under specialist supervision.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Recurrent D-lactic acidosis caused by short-bowel syndrome.

Key differentials

  • Wernicke encephalopathy
  • Hepatic encephalopathy
  • Sepsis
  • Toxic alcohol exposure
  • Diabetic ketoacidosis
  • Stroke
  • Medication toxicity
  • Small-intestinal bacterial overgrowth

Key investigations

  • Electrolytes and anion gap
  • Blood gas
  • Standard lactate
  • Specialized D-lactate assay
  • Glucose and ketones
  • Renal and liver function
  • Nutritional assessment
  • Medication and dietary history

Treatment principles

  • Temporarily reduce enteral carbohydrate during acute episodes
  • Correct dehydration and acidosis
  • Consider antibiotics targeting responsible intestinal bacteria
  • Provide thiamine when clinically indicated
  • Develop a long-term individualized nutrition plan
  • Avoid unnecessary prolonged fasting

Probiotic safety: Probiotic use should be individualized because some organisms may contribute to D-lactate production.

Clinical Pearl: Neurologic findings can resemble alcohol intoxication.

NPLEX Trap: A normal routine lactate does not exclude D-lactic acidosis.

Reviews of D-lactic acidosis emphasize carbohydrate restriction, correction of acidosis and dehydration, and selective alteration of intestinal bacteria.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 424

HEPATITIS C-ASSOCIATED MIXED CRYOGLOBULINEMIC VASCULITISClinical Case 424

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 56-year-old woman with untreated chronic hepatitis C presents with fatigue, joint pain, painful numbness of the feet, and a purpuric rash over both legs.

Physical examination:

  • Palpable purpura
  • Mild leg edema
  • Reduced distal sensation
  • Hypertension

Laboratory findings:

  • Creatinine: increasing
  • Urinalysis: hematuria, proteinuria, and red-cell casts
  • C4: markedly reduced
  • Rheumatoid factor: positive
  • Hepatitis C RNA: positive
  • Serum cryoglobulin: initially reported negative

Kidney biopsy shows membranoproliferative glomerulonephritis with immune-complex deposition.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Hepatitis C-associated mixed cryoglobulinemic vasculitis

The combination of chronic hepatitis C, palpable purpura, arthralgia, neuropathy, low C4, positive rheumatoid factor, and immune-complex glomerulonephritis is characteristic of mixed cryoglobulinemic vasculitis.

Q2

Why might the cryoglobulin result be falsely negative?

Reveal answer and rationale
Correct answer: A. The blood sample was not kept warm before serum separation

Cryoglobulins may precipitate before laboratory processing if the sample is not maintained at an appropriate warm temperature, producing a falsely negative result.

Q3

What is the central treatment for clinically significant hepatitis C-associated disease?

Reveal answer and rationale
Correct answer: A. Direct-acting antiviral therapy

Eradication of hepatitis C treats the underlying antigenic driver. Mild-to-moderate disease may improve substantially after effective antiviral treatment.

Q4

What additional treatment may be required for rapidly progressive glomerulonephritis or another life-threatening manifestation?

Reveal answer and rationale
Correct answer: A. Rituximab-based immunosuppression with possible plasma exchange

Severe renal, neurologic, pulmonary, gastrointestinal, or hyperviscosity manifestations may require urgent immunosuppression and plasma exchange in addition to antiviral therapy.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: HCV-associated mixed cryoglobulinemic vasculitis with membranoproliferative glomerulonephritis and neuropathy.

Key manifestations

  • Palpable purpura
  • Arthralgia
  • Weakness
  • Peripheral neuropathy
  • Glomerulonephritis
  • Skin ulceration
  • Mesenteric ischemia
  • Pulmonary hemorrhage in severe disease

Key investigations

  • Hepatitis C antibody and RNA
  • Cryoglobulin testing with correct handling
  • C3 and C4
  • Rheumatoid factor
  • Urinalysis and protein quantification
  • Kidney function
  • Kidney biopsy when indicated
  • Assessment for B-cell lymphoproliferative disease

Treatment principles

  • Direct-acting antiviral treatment
  • Rituximab for severe vasculitis
  • Plasma exchange for selected life-threatening disease
  • Glucocorticoid use individualized to severity
  • Control blood pressure and renal complications
  • Monitor after viral eradication because vasculitis may persist or relapse

Botanical safety: Supplements marketed for “immune stimulation” or liver cleansing can interact with antiviral and immunosuppressive treatment.

Clinical Pearl: Low C4 is a strong laboratory clue in mixed cryoglobulinemia.

NPLEX Trap: One negative cryoglobulin test does not exclude disease when collection and processing were inadequate.

HCV-associated cryoglobulinemic vasculitis requires treatment of the infection, with rituximab and plasma exchange considered for severe organ-threatening disease.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 425

POEMS SYNDROMEClinical Case 425

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 52-year-old man presents with progressive numbness, burning pain, and weakness of both legs. He has difficulty climbing stairs and has recently begun using a cane.

Additional findings:

  • Hepatosplenomegaly
  • Gynecomastia
  • Hypothyroidism
  • Hyperpigmentation
  • Hemangioma-like skin lesions
  • Peripheral edema
  • Papilledema
  • Thrombocytosis

Investigations:

  • Nerve conduction: demyelinating polyneuropathy
  • Serum immunofixation: small monoclonal lambda protein
  • VEGF: markedly elevated
  • CT: several sclerotic bone lesions
  • Bone marrow: clonal plasma-cell disorder
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. POEMS syndrome

Polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma-cell disease, skin changes, elevated VEGF, edema, thrombocytosis, papilledema, and sclerotic bone lesions form the classic POEMS syndrome pattern.

Q2

Which two findings are mandatory major criteria?

Reveal answer and rationale
Correct answer: A. Polyneuropathy and a monoclonal plasma-cell proliferative disorder

The diagnostic framework requires both polyneuropathy and a monoclonal plasma-cell disorder, plus additional major and minor criteria.

Q3

Which biomarker is particularly useful for supporting diagnosis and monitoring response?

Reveal answer and rationale
Correct answer: A. Vascular endothelial growth factor

VEGF is frequently markedly elevated and reflects disease activity. It is interpreted alongside the clinical and hematologic findings.

Q4

What is the fundamental treatment principle?

Reveal answer and rationale
Correct answer: A. Eradicate or suppress the underlying plasma-cell clone

Localized disease driven by an isolated sclerotic plasmacytoma may be treated with radiation. Diffuse or marrow-based disease generally requires systemic plasma-cell-directed therapy, with autologous stem-cell transplantation considered in eligible patients.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: POEMS syndrome caused by an underlying lambda-restricted plasma-cell neoplasm.

Mandatory major criteria

  • Polyneuropathy
  • Monoclonal plasma-cell proliferative disorder

Additional major criteria

  • Sclerotic bone lesion
  • Castleman disease
  • Elevated VEGF

Minor criteria include

  • Organomegaly
  • Extravascular volume overload
  • Endocrinopathy
  • Skin changes
  • Papilledema
  • Thrombocytosis or polycythemia

Key investigations

  • Nerve-conduction testing
  • Serum and urine immunofixation
  • Free-light-chain assessment
  • VEGF
  • Bone-marrow examination
  • Whole-body imaging for sclerotic lesions
  • Endocrine evaluation
  • Pulmonary and cardiac assessment

Treatment principles

  • Local radiation for appropriately selected isolated disease
  • Systemic plasma-cell-directed therapy for disseminated disease
  • Consider autologous stem-cell transplantation
  • Manage thrombosis risk, edema, endocrine abnormalities, pain, and rehabilitation
  • Monitor VEGF, neurologic status, and hematologic response

Supplement safety: High-dose pyridoxine can itself cause sensory neuropathy and should not be used indiscriminately.

Clinical Pearl: POEMS usually causes sclerotic rather than classic punched-out lytic bone lesions.

NPLEX Trap: Do not diagnose CIDP alone when neuropathy is accompanied by monoclonal lambda protein, endocrinopathy, organomegaly, skin changes, and elevated VEGF.

Contemporary diagnostic frameworks require polyneuropathy and a monoclonal plasma-cell disorder, with therapy directed at the underlying plasma-cell clone.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 426

SYSTEMIC MASTOCYTOSIS WITH RECURRENT ANAPHYLAXISClinical Case 426

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 46-year-old man presents after developing flushing, generalized pruritus, abdominal cramping, wheezing, and syncope following a wasp sting.

He reports several previous unexplained episodes of flushing and lightheadedness. Examination after stabilization reveals multiple brown macules that become raised and pruritic when rubbed.

Investigations:

  • Baseline serum tryptase: persistently elevated
  • Acute tryptase: significantly increased from baseline
  • Bone-marrow biopsy: dense mast-cell aggregates
  • KIT D816V mutation: detected
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Systemic mastocytosis with mast-cell-mediated anaphylaxis

Recurrent systemic mast-cell symptoms, persistently elevated baseline tryptase, characteristic skin lesions, clonal mast-cell aggregates, and a KIT mutation support systemic mastocytosis.

Q2

What is the first-line treatment during the acute hypotensive reaction?

Reveal answer and rationale
Correct answer: A. Intramuscular epinephrine

Anaphylaxis requires immediate intramuscular epinephrine. Antihistamines and other mediator-directed treatments are adjuncts and must not delay epinephrine.

Q3

Which change in serum tryptase supports acute systemic mast-cell activation?

Reveal answer and rationale
Correct answer: A. An increase exceeding the patient’s baseline by approximately 20% plus 2 ng/mL

Comparison with the individual baseline is more informative than applying one universal acute tryptase threshold.

Q4

Which long-term safety measure is essential?

Reveal answer and rationale
Correct answer: A. Carry epinephrine auto-injectors and receive trigger-specific emergency education
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • Baseline and event-related tryptase
  • CBC and metabolic testing
  • KIT mutation testing
  • Bone-marrow evaluation
  • Assessment for organ involvement
  • Allergy assessment, including venom allergy when relevant

Treatment principles

  • Epinephrine for anaphylaxis
  • H1 and H2 antihistamines for mediator symptoms
  • Additional mediator-directed therapy when indicated
  • Venom immunotherapy for appropriate venom allergy
  • Disease-modifying treatment for advanced systemic disease

Botanical safety: Alcohol, heat, stimulants, and some botanical products may trigger mediator release in susceptible patients.

Clinical Pearl: A persistently elevated baseline tryptase suggests an underlying mast-cell disorder but is not diagnostic by itself.

NPLEX Trap: Do not substitute antihistamines for epinephrine during cardiovascular or respiratory anaphylaxis.

Reference basis: Consensus reviews emphasize clonal assessment, event-related tryptase interpretation, and epinephrine-based emergency management.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 427

HEREDITARY ANGIOEDEMA WITH LARYNGEAL ATTACKClinical Case 427

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 23-year-old woman presents with progressive tongue swelling, throat tightness, hoarseness, and difficulty swallowing.

She has no urticaria or pruritus. Previous episodes involved severe abdominal pain and swelling of the hands. Her father died unexpectedly during an episode of throat swelling.

Laboratory findings from a previous assessment:

  • C4: reduced
  • C1 inhibitor functional activity: reduced
  • C1 inhibitor level: reduced
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Hereditary angioedema caused by C1-inhibitor deficiency

Recurrent nonpruritic angioedema, abdominal attacks, absent urticaria, a family history, low C4, and reduced C1-inhibitor quantity and function indicate type 1 hereditary angioedema.

Q2

What is the immediate priority?

Reveal answer and rationale
Correct answer: A. Protect the airway and administer specific on-demand HAE treatment

Laryngeal HAE can rapidly become fatal. Airway planning and immediate bradykinin-directed treatment are essential.

Q3

Which therapy is appropriate for an acute attack?

Reveal answer and rationale
Correct answer: A. C1-inhibitor concentrate or an approved bradykinin/kallikrein-directed treatment
Q4

Which medication can worsen bradykinin-mediated angioedema?

Reveal answer and rationale
Correct answer: A. An ACE inhibitor
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: Type 1 hereditary angioedema with an acute upper-airway attack.

Key investigations

  • C4
  • C1-inhibitor antigen level
  • C1-inhibitor functional activity
  • C1q when acquired angioedema is suspected
  • Genetic testing in selected cases

Treatment principles

  • Treat attacks as early as possible
  • Secure the airway when progression threatens ventilation
  • Ensure access to more than one on-demand treatment dose
  • Consider long-term prophylaxis based on attack burden
  • Provide procedure-related prophylaxis when indicated

Pharmacology safety: Antihistamines, corticosteroids, and epinephrine generally do not reverse the core bradykinin-mediated process, although epinephrine may be given when the diagnosis is uncertain and anaphylaxis remains possible.

Clinical Pearl: The absence of urticaria strongly supports a bradykinin-mediated process.

NPLEX Trap: Do not wait for visible respiratory distress before treating progressive laryngeal swelling.

Reference basis: WAO/EAACI guidance recommends early on-demand treatment with C1 inhibitor, icatibant, or ecallantide where available.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 428

STRONGYLOIDES HYPERINFECTION AFTER CORTICOSTEROID THERAPYClinical Case 428

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 67-year-old man who previously lived in Southeast Asia receives high-dose prednisone for presumed COPD exacerbation.

Ten days later, he develops:

  • Severe abdominal pain
  • Vomiting and diarrhea
  • Cough and hemoptysis
  • Hypoxemic respiratory failure
  • Gram-negative bacteremia
  • Diffuse pulmonary infiltrates

Eosinophils are normal. Larvae are identified in sputum and stool.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Strongyloides hyperinfection syndrome

Corticosteroid exposure can accelerate Strongyloides autoinfection, producing massive gastrointestinal and pulmonary larval burden, respiratory failure, and enteric bacteremia.

Q2

Which medication is first-line treatment?

Reveal answer and rationale
Correct answer: A. Ivermectin
Q3

Why does gram-negative bacteremia occur?

Reveal answer and rationale
Correct answer: A. Migrating larvae can carry enteric organisms across the intestinal wall
Q4

Which statement about eosinophilia is correct?

Reveal answer and rationale
Correct answer: A. Its absence does not exclude hyperinfection
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Risk factors

  • Corticosteroid exposure
  • HTLV-1 infection
  • Hematologic malignancy
  • Transplantation
  • Other significant immunosuppression

Key investigations

  • Serial stool examination
  • Sputum examination
  • Strongyloides serology
  • Blood cultures
  • Chest imaging
  • Respiratory and organ-function assessment

Treatment principles

  • Stop or reduce immunosuppression when feasible
  • Administer ivermectin daily for hyperinfection
  • Continue until stool and sputum remain negative for an appropriate period
  • Treat associated bacterial sepsis
  • Screen at-risk patients before immunosuppression when feasible

Botanical safety: No antiparasitic botanical preparation should replace ivermectin in hyperinfection.

Clinical Pearl: Eosinophilia may disappear during severe disseminated disease.

NPLEX Trap: Do not give repeated corticosteroids to an at-risk patient without considering latent Strongyloides infection.

Reference basis: CDC guidance identifies ivermectin as first-line therapy and recommends daily treatment in hyperinfection until parasitologic clearance.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 429

DISSEMINATED HISTOPLASMOSIS DURING TNF-INHIBITOR THERAPYClinical Case 429

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 54-year-old man with Crohn disease treated with infliximab presents with fever, weight loss, cough, diarrhea, oral ulcers, and profound fatigue.

He recently renovated an old barn containing bird and bat droppings.

Findings:

  • Hypotension
  • Hepatosplenomegaly
  • Pancytopenia
  • Elevated liver enzymes
  • Diffuse pulmonary nodules
  • Positive urine Histoplasma antigen
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Progressive disseminated histoplasmosis

TNF inhibition, environmental exposure, systemic illness, cytopenias, hepatosplenomegaly, pulmonary abnormalities, and positive antigen testing indicate disseminated histoplasmosis.

Q2

What is appropriate initial treatment for severe disease?

Reveal answer and rationale
Correct answer: A. Liposomal amphotericin B
Q3

What should happen to infliximab during severe active infection?

Reveal answer and rationale
Correct answer: A. It should generally be withheld while the infection is treated
Q4

Which test is useful for monitoring treatment response?

Reveal answer and rationale
Correct answer: A. Serial Histoplasma antigen measurement
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • Urine and serum antigen testing
  • Blood and fungal cultures
  • Bone-marrow or tissue examination when needed
  • CBC and liver tests
  • Chest and abdominal imaging
  • Assessment for adrenal and CNS involvement

Treatment principles

  • Liposomal amphotericin B for severe disseminated disease
  • Step down to prolonged itraconazole after stabilization
  • Monitor itraconazole concentrations and interactions
  • Withhold significant immunosuppression when appropriate
  • Monitor antigen levels for response and recurrence

Pharmacology safety: Itraconazole has substantial CYP-mediated interactions and can worsen heart failure in susceptible patients.

Clinical Pearl: TNF is important for granuloma maintenance, making TNF inhibitors a major risk factor for disseminated fungal disease.

NPLEX Trap: Do not intensify immunosuppression for a presumed inflammatory-disease flare before excluding invasive fungal infection.

Reference basis: IDSA guidance and updated reviews identify TNF inhibitors as a major risk factor and amphotericin-to-itraconazole therapy as standard for severe disseminated disease.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 430

WHIPPLE DISEASEClinical Case 430

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 49-year-old man presents with years of migratory joint pain followed by chronic diarrhea, abdominal pain, weight loss, and cognitive changes.

Examination reveals:

  • Generalized lymphadenopathy
  • Hyperpigmentation
  • Muscle wasting
  • Supranuclear gaze abnormality

Small-bowel biopsy demonstrates periodic-acid–Schiff-positive foamy macrophages. PCR detects Tropheryma whipplei.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Whipple disease
Q2

Which early historical feature commonly precedes gastrointestinal symptoms?

Reveal answer and rationale
Correct answer: A. Migratory arthralgia
Q3

Why must treatment adequately penetrate the central nervous system?

Reveal answer and rationale
Correct answer: A. Neurologic infection can persist or relapse
Q4

What is an appropriate treatment approach?

Reveal answer and rationale
Correct answer: A. Initial CNS-active intravenous antibiotic therapy followed by prolonged oral therapy
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key manifestations

  • Migratory arthralgia
  • Weight loss
  • Diarrhea and malabsorption
  • Lymphadenopathy
  • Endocarditis
  • Cognitive or ocular-motor abnormalities

Key investigations

  • Duodenal biopsy
  • PAS staining
  • Tissue-specific PCR
  • CSF testing when neurologic disease is suspected
  • Echocardiography and blood-culture-negative endocarditis evaluation

Treatment principles

  • Use therapy effective in the CNS
  • Continue prolonged eradication treatment
  • Monitor for relapse
  • Recognize immune-reconstitution inflammatory syndrome after treatment begins

Nutrition: Correct malnutrition and micronutrient deficits, but nutritional therapy does not eradicate infection.

Clinical Pearl: Arthritis may precede intestinal manifestations by years.

NPLEX Trap: Do not begin immunosuppression for presumed seronegative arthritis before reconsidering chronic infection in a patient with weight loss and malabsorption.

Reference basis: Clinical trials and contemporary reviews support an initial ceftriaxone- or meropenem-based phase followed by prolonged oral treatment.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 431

NEUROMYELITIS OPTICA SPECTRUM DISORDERClinical Case 431

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 36-year-old woman presents with severe bilateral visual loss and progressive leg weakness.

MRI shows:

  • Bilateral optic-nerve enhancement involving the chiasm
  • A spinal-cord lesion extending from C3 to T2

She reports persistent vomiting and hiccups two months earlier. Serum aquaporin-4 IgG is positive.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Aquaporin-4-positive neuromyelitis optica spectrum disorder
Q2

What is appropriate acute treatment?

Reveal answer and rationale
Correct answer: A. High-dose intravenous glucocorticoids with early plasma exchange for severe or poorly responsive attacks
Q3

Which earlier symptom is particularly characteristic of area-postrema involvement?

Reveal answer and rationale
Correct answer: A. Persistent hiccups and vomiting
Q4

Why is long-term relapse prevention important?

Reveal answer and rationale
Correct answer: A. Individual attacks can produce major irreversible disability
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • Serum aquaporin-4 IgG using an appropriate cell-based assay
  • MOG-IgG when indicated
  • MRI brain, optic nerves, and entire spinal cord
  • CSF testing
  • Autoimmune-disease assessment

Treatment principles

  • Treat acute relapse immediately
  • Use plasma exchange early in severe attacks
  • Begin relapse-prevention immunotherapy
  • Avoid assuming that every demyelinating disorder should receive conventional MS therapy

Clinical Pearl: Longitudinally extensive transverse myelitis spans at least three vertebral segments.

NPLEX Trap: Do not delay plasma exchange until all glucocorticoid doses are completed when a severe attack is rapidly progressing.

Reference basis: Current NMOSD recommendations support high-dose glucocorticoids and early apheresis for acute attacks.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 432

LAMBERT–EATON MYASTHENIC SYNDROMEClinical Case 432

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 63-year-old man with a 45-pack-year smoking history presents with proximal leg weakness, dry mouth, erectile dysfunction, and difficulty rising from a chair.

Examination:

  • Reduced reflexes
  • Leg strength briefly improves after repeated contraction
  • Minimal ocular involvement

Testing demonstrates P/Q-type voltage-gated calcium-channel antibodies and an incremental response on high-frequency repetitive nerve stimulation.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Lambert–Eaton myasthenic syndrome
Q2

Which associated malignancy must be investigated?

Reveal answer and rationale
Correct answer: A. Small-cell lung carcinoma
Q3

Which finding helps distinguish LEMS from myasthenia gravis?

Reveal answer and rationale
Correct answer: A. Reduced reflexes with temporary facilitation after exercise
Q4

Which medication is used for symptomatic improvement?

Reveal answer and rationale
Correct answer: A. Amifampridine
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • P/Q-type calcium-channel antibodies
  • Repetitive nerve stimulation
  • Chest CT and appropriate cancer imaging
  • Continued malignancy surveillance when initial evaluation is negative

Treatment principles

  • Treat the underlying cancer
  • Amifampridine for symptomatic weakness
  • Consider immunotherapy for significant autoimmune disease
  • Monitor swallowing and respiratory function in severe presentations

Pharmacology safety: Amifampridine can increase seizure risk and requires individualized dosing.

Clinical Pearl: Strength and reflexes may transiently improve after brief exercise.

NPLEX Trap: Do not diagnose myasthenia gravis automatically when autonomic symptoms and absent reflexes are prominent.

Reference basis: Amifampridine is an approved symptomatic treatment, and contemporary criteria emphasize electrophysiology, calcium-channel antibodies, and SCLC investigation.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 433

NATALIZUMAB-ASSOCIATED PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHYClinical Case 433

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 42-year-old woman with multiple sclerosis treated with natalizumab develops progressive right-arm clumsiness, expressive-language difficulty, visual-field loss, and personality change over three weeks.

MRI shows asymmetric subcortical white-matter lesions without substantial mass effect. CSF JC-virus PCR is positive.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Progressive multifocal leukoencephalopathy
Q2

What causes PML?

Reveal answer and rationale
Correct answer: A. Reactivation of JC polyomavirus during impaired cellular immunity
Q3

What is the central management principle?

Reveal answer and rationale
Correct answer: A. Stop the responsible immunosuppressive therapy and restore immune function
Q4

What complication can occur during immune recovery?

Reveal answer and rationale
Correct answer: A. Immune-reconstitution inflammatory syndrome
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • Brain MRI
  • CSF JC-virus PCR
  • Repeat ultrasensitive PCR when suspicion remains high
  • Brain biopsy in selected unresolved cases
  • HIV and immune-status assessment

Treatment principles

  • Discontinue natalizumab or other implicated therapy
  • Accelerate drug removal in selected cases
  • Monitor and treat PML-IRIS
  • Provide seizure, swallowing, and rehabilitation care

Clinical Pearl: CSF PCR can initially be negative when viral burden is low.

NPLEX Trap: A slowly progressive, atypical neurologic syndrome during natalizumab treatment should not automatically be labelled an MS relapse.

Reference basis: Diagnostic guidance emphasizes MRI plus CSF JC-virus PCR and restoration of immune surveillance.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 434

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WITH BUDD–CHIARI SYNDROMEClinical Case 434

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 35-year-old woman presents with abdominal pain, jaundice, ascites, fatigue, and dark morning urine.

Laboratory findings:

  • Hemoglobin: reduced
  • LDH: markedly elevated
  • Haptoglobin: undetectable
  • Direct antiglobulin test: negative
  • Pancytopenia
  • Doppler ultrasound: hepatic-vein thrombosis

Flow cytometry shows a large population of blood cells lacking CD55 and CD59.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Paroxysmal nocturnal hemoglobinuria with Budd–Chiari syndrome
Q2

What is the definitive diagnostic test?

Reveal answer and rationale
Correct answer: A. Flow cytometry demonstrating loss of GPI-anchored proteins
Q3

Which treatment targets the underlying complement-mediated process?

Reveal answer and rationale
Correct answer: A. Complement-inhibitor therapy
Q4

Which preventive consideration is essential before terminal-complement inhibition?

Reveal answer and rationale
Correct answer: A. Meningococcal vaccination and infection-risk planning
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key manifestations

  • Complement-mediated intravascular hemolysis
  • Cytopenias
  • Smooth-muscle symptoms
  • Kidney dysfunction
  • Thrombosis at unusual venous sites

Treatment principles

  • Complement-inhibitor therapy
  • Therapeutic anticoagulation when appropriate
  • Manage hepatic-vein thrombosis
  • Monitor marrow-failure syndromes
  • Consider stem-cell transplantation in selected severe marrow failure

Clinical Pearl: Unexplained hepatic, portal, cerebral, or abdominal venous thrombosis should prompt consideration of PNH.

NPLEX Trap: A negative direct antiglobulin test does not mean hemolysis is absent.

Reference basis: Contemporary hematology reviews identify unusual-site thrombosis as a major PNH manifestation and complement inhibition plus anticoagulation as central treatment.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 435

WALDENSTRÖM MACROGLOBULINEMIA WITH HYPERVISCOSITYClinical Case 435

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 69-year-old man presents with headache, blurred vision, dizziness, spontaneous nosebleeds, and confusion.

Examination:

  • Dilated, segmented retinal veins
  • Retinal hemorrhages
  • Peripheral neuropathy
  • Lymphadenopathy

Laboratory findings:

  • IgM monoclonal protein: markedly elevated
  • Serum viscosity: elevated
  • Anemia
  • Bone marrow: lymphoplasmacytic lymphoma
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Waldenström macroglobulinemia with hyperviscosity syndrome
Q2

What is the immediate treatment?

Reveal answer and rationale
Correct answer: A. Plasma exchange
Q3

Why may packed red-cell transfusion require caution before plasma exchange?

Reveal answer and rationale
Correct answer: A. It can increase whole-blood viscosity
Q4

Why may plasma exchange be performed before rituximab in a patient with very high IgM?

Reveal answer and rationale
Correct answer: A. Rituximab can initially cause an IgM flare
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Hyperviscosity manifestations

  • Neurologic change
  • Visual disturbance
  • Mucosal bleeding
  • Heart failure
  • Retinal venous engorgement

Treatment principles

  • Urgent plasma exchange
  • Treat the underlying lymphoplasmacytic lymphoma
  • Delay viscosity-increasing transfusion when clinically possible
  • Monitor IgM flare with selected therapy

Clinical Pearl: Symptoms, funduscopic findings, and clinical urgency are more important than one universal viscosity threshold.

NPLEX Trap: Plasma exchange provides rapid stabilization but does not eradicate the underlying clone.

Reference basis: Hematology and emergency guidance identifies plasmapheresis as the acute treatment of symptomatic IgM hyperviscosity.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 436

SICKLE-CELL ACUTE CHEST SYNDROMEClinical Case 436

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 25-year-old man with sickle-cell disease is hospitalized for severe rib and back pain.

On the second day, he develops fever, cough, chest pain, tachypnea, and worsening hypoxemia. Chest radiograph shows a new multilobar infiltrate.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Acute chest syndrome
Q2

Which intervention helps prevent and treat atelectasis?

Reveal answer and rationale
Correct answer: A. Incentive spirometry
Q3

What is appropriate initial management?

Reveal answer and rationale
Correct answer: A. Oxygen when hypoxemic, antibiotics, careful analgesia, spirometry, and transfusion assessment
Q4

When is exchange transfusion particularly appropriate?

Reveal answer and rationale
Correct answer: A. Rapid progression, severe hypoxemia, or failure to respond to simpler measures
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Potential causes

  • Infection
  • Fat embolism
  • Pulmonary infarction
  • Hypoventilation and atelectasis

Key investigations

  • Chest imaging
  • CBC and reticulocytes
  • Blood cultures when febrile
  • Oxygenation and blood gas when severe
  • Type and crossmatch

Treatment principles

  • Oxygen
  • Broad antimicrobial coverage
  • Adequate but respiratory-safe analgesia
  • Incentive spirometry
  • Avoid excessive fluid administration
  • Simple or exchange transfusion based on severity

Clinical Pearl: Acute chest syndrome may develop after admission for an uncomplicated pain crisis.

NPLEX Trap: Do not attribute new hypoxemia to opioid use alone without obtaining chest imaging.

Reference basis: Sickle-cell guidance recommends incentive spirometry, antimicrobial therapy, oxygen support, and early transfusion for hypoxic or progressive disease.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 437

G6PD DEFICIENCY WITH OXIDATIVE HEMOLYSIS AND METHEMOGLOBINEMIAClinical Case 437

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 28-year-old man develops jaundice, fatigue, dyspnea, and dark urine after beginning dapsone.

Findings:

  • Oxygen saturation: 84% despite supplemental oxygen
  • Arterial PaO₂: normal
  • Chocolate-brown blood
  • Hemoglobin: rapidly falling
  • Indirect bilirubin and LDH: elevated
  • Haptoglobin: reduced
  • Blood smear: bite cells and Heinz bodies
Q1

What is the most likely underlying condition?

Reveal answer and rationale
Correct answer: A. G6PD deficiency with oxidative hemolysis
Q2

What explains the low pulse-oximeter reading with a normal PaO₂?

Reveal answer and rationale
Correct answer: A. Methemoglobinemia
Q3

Which commonly used methemoglobinemia treatment can worsen hemolysis in G6PD deficiency?

Reveal answer and rationale
Correct answer: A. Methylene blue
Q4

What is the first management step?

Reveal answer and rationale
Correct answer: A. Stop the oxidant medication and provide urgent supportive care
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Potential triggers

  • Dapsone
  • Primaquine
  • Rasburicase
  • Certain sulfonamides
  • Infection
  • Fava beans
  • Naphthalene

Key investigations

  • CBC and reticulocytes
  • Hemolysis markers
  • Peripheral smear
  • Co-oximetry
  • G6PD activity, repeated after recovery if initially normal

Treatment principles

  • Stop the trigger
  • Treat infection
  • Oxygen and supportive care
  • Transfuse severe symptomatic anemia
  • Use expert-guided alternatives for significant methemoglobinemia

Clinical Pearl: G6PD testing during an acute hemolytic episode may be falsely normal because older, enzyme-deficient cells have already been destroyed.

NPLEX Trap: Do not reflexively give methylene blue to a patient with suspected G6PD deficiency.

Reference basis: Current reviews emphasize trigger withdrawal, supportive care, and avoidance of oxidant exposures.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 438

STATIN-ASSOCIATED IMMUNE-MEDIATED NECROTIZING MYOPATHYClinical Case 438

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 64-year-old woman presents with progressive proximal muscle weakness and difficulty swallowing.

Atorvastatin was discontinued two months ago, but her weakness and CK elevation continue to worsen.

Findings:

  • CK: 11,800 U/L
  • Anti-HMGCR antibodies: positive
  • Muscle biopsy: myofibre necrosis with relatively limited inflammation
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Anti-HMGCR immune-mediated necrotizing myopathy
Q2

Which feature distinguishes this disorder from ordinary statin muscle toxicity?

Reveal answer and rationale
Correct answer: A. Progressive weakness and CK elevation despite statin withdrawal
Q3

What is the appropriate treatment principle?

Reveal answer and rationale
Correct answer: A. Immunotherapy, often including IV immunoglobulin and another immunosuppressive strategy
Q4

Which supplement should be avoided?

Reveal answer and rationale
Correct answer: A. Red yeast rice

Red yeast rice may contain monacolin K, which is chemically identical to lovastatin and may perpetuate statin-like exposure.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • CK and aldolase
  • Anti-HMGCR and anti-SRP antibodies
  • EMG
  • Muscle MRI
  • Muscle biopsy
  • Swallowing and respiratory assessment

Treatment principles

  • Stop statin and statin-like supplements
  • Begin immunotherapy
  • Consider IV immunoglobulin early in anti-HMGCR disease
  • Use rehabilitation after inflammation is controlled
  • Monitor swallowing and respiratory involvement

Clinical Pearl: Persistent progression after statin discontinuation is the critical diagnostic clue.

NPLEX Trap: Do not tell a patient to “exercise through” severe active necrotizing myopathy.

Reference basis: Contemporary reviews support immunotherapy, with anti-HMGCR disease often responding to IV immunoglobulin.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 439

ANTISYNTHETASE SYNDROME WITH INTERSTITIAL LUNG DISEASEClinical Case 439

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 45-year-old woman presents with progressive dyspnea, dry cough, inflammatory polyarthritis, Raynaud phenomenon, and proximal weakness.

Examination:

  • Hyperkeratotic cracked skin along the fingers
  • Fine bibasilar crackles
  • Symmetric proximal weakness

Investigations:

  • CK: elevated
  • Anti-Jo-1 antibody: positive
  • HRCT: organizing-pneumonia and nonspecific-interstitial-pneumonia pattern
  • Pulmonary-function testing: restrictive defect with reduced diffusion capacity
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Antisynthetase syndrome with interstitial lung disease
Q2

What are the finger findings called?

Reveal answer and rationale
Correct answer: A. Mechanic’s hands
Q3

Which complication most strongly influences prognosis?

Reveal answer and rationale
Correct answer: A. Interstitial lung disease
Q4

What is an appropriate treatment approach?

Reveal answer and rationale
Correct answer: A. Glucocorticoid treatment combined with an appropriate steroid-sparing immunosuppressive agent
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Core features

  • Myositis
  • ILD
  • Inflammatory arthritis
  • Raynaud phenomenon
  • Mechanic’s hands
  • Fever

Key investigations

  • Myositis-antibody panel
  • CK and aldolase
  • HRCT
  • Pulmonary-function testing
  • Cardiac and swallowing assessment when indicated

Treatment principles

  • Treat ILD early
  • Add steroid-sparing therapy
  • Escalate rapidly for progressive lung disease
  • Provide infection prophylaxis when indicated
  • Monitor PFTs and imaging

Clinical Pearl: ILD can dominate the presentation even when muscle weakness is modest.

NPLEX Trap: Do not exclude inflammatory myositis because pulmonary symptoms appeared first.

Reference basis: ACR/CHEST guidance and contemporary reviews support immunosuppressive treatment and close monitoring for myositis-associated ILD.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 440

RELAPSING POLYCHONDRITIS WITH AIRWAY COLLAPSEClinical Case 440

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 51-year-old woman presents with recurrent painful swelling of both ears, nasal pain, hoarseness, cough, and worsening dyspnea.

Examination:

  • Inflamed auricular cartilage with sparing of the ear lobes
  • Saddle-nose deformity
  • Inspiratory stridor
  • Expiratory wheeze

Dynamic airway imaging demonstrates tracheobronchomalacia.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Relapsing polychondritis with airway involvement
Q2

Which auricular finding is characteristic?

Reveal answer and rationale
Correct answer: A. Inflammation of cartilage with sparing of the lobule
Q3

What is the immediate priority in this patient?

Reveal answer and rationale
Correct answer: A. Urgent airway assessment and stabilization
Q4

Which treatment principle applies?

Reveal answer and rationale
Correct answer: A. Systemic anti-inflammatory and immunosuppressive therapy with interventional airway management when necessary
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Potential involvement

  • Auricular and nasal cartilage
  • Larynx, trachea, and bronchi
  • Eyes
  • Audiovestibular system
  • Joints
  • Heart valves and aorta

Key investigations

  • Dynamic inspiratory and expiratory CT
  • Pulmonary-flow studies
  • Bronchoscopy in selected controlled settings
  • Echocardiography
  • Evaluation for associated autoimmune or hematologic disease

Treatment principles

  • Stabilize threatened airway
  • Systemic glucocorticoids
  • Steroid-sparing or biologic treatment for significant disease
  • Airway dilation, stenting, or surgery when required

Physical medicine safety: Cervical manipulation and forceful airway techniques are inappropriate during active airway compromise.

Clinical Pearl: Wheezing in relapsing polychondritis may reflect dynamic central-airway collapse rather than asthma.

NPLEX Trap: Do not perform routine spirometry or bronchoscopy without considering the risk of critical airway deterioration.

Reference basis: Airway involvement is a major cause of morbidity and may require early immunosuppression and interventional management.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 441

AUTOIMMUNE HEPATITIS–PRIMARY BILIARY CHOLANGITIS OVERLAPClinical Case 441

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 48-year-old woman presents with fatigue, pruritus, jaundice, and right-upper-quadrant discomfort.

Laboratory findings:

  • ALT and AST: markedly elevated
  • Alkaline phosphatase: markedly elevated
  • IgG: elevated
  • IgM: elevated
  • Antimitochondrial antibody: positive
  • Anti-smooth-muscle antibody: positive

Liver biopsy demonstrates interface hepatitis and destructive bile-duct lesions.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Autoimmune hepatitis–PBC overlap syndrome
Q2

Which finding supports the autoimmune-hepatitis component?

Reveal answer and rationale
Correct answer: A. Interface hepatitis with increased IgG
Q3

Which finding supports the PBC component?

Reveal answer and rationale
Correct answer: A. Antimitochondrial antibodies and destructive cholangitis
Q4

What treatment is generally appropriate?

Reveal answer and rationale
Correct answer: A. Ursodeoxycholic acid combined with immunosuppressive treatment when significant hepatitis is present
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • Liver enzymes and bilirubin
  • IgG and IgM
  • ANA, smooth-muscle antibody, and antimitochondrial antibody
  • Liver biopsy
  • Imaging to exclude mechanical biliary obstruction
  • Bone and fat-soluble-vitamin assessment

Treatment principles

  • Ursodeoxycholic acid for cholestatic disease
  • Glucocorticoid-based immunosuppression for active interface hepatitis
  • Monitor biochemical response
  • Screen for cirrhosis-related complications

Botanical safety: Kava, concentrated green-tea extract, and other hepatotoxic supplements should be discontinued during active liver injury.

Clinical Pearl: Overlap is a clinical phenotype requiring evidence of both parent diseases, not merely one positive antibody.

NPLEX Trap: Do not treat severe interface hepatitis with ursodeoxycholic acid alone.

Reference basis: Hepatology guidance supports combined UDCA and immunosuppressive treatment when both cholestatic and hepatitis features are present.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 442

ACUTE FATTY LIVER OF PREGNANCYClinical Case 442

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 29-year-old woman at 36 weeks’ gestation presents with vomiting, epigastric pain, jaundice, confusion, and reduced fetal movement.

Laboratory findings:

  • Glucose: 2.4 mmol/L
  • Bilirubin: elevated
  • AST and ALT: moderately elevated
  • INR: prolonged
  • Creatinine: elevated
  • WBC: elevated
  • Platelets: mildly reduced
  • Ammonia: elevated
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Acute fatty liver of pregnancy
Q2

Which finding particularly supports AFLP rather than uncomplicated preeclampsia?

Reveal answer and rationale
Correct answer: A. Hypoglycemia with hepatic synthetic dysfunction
Q3

What is the definitive management principle?

Reveal answer and rationale
Correct answer: A. Maternal stabilization followed by prompt delivery
Q4

Which neonatal consideration may be appropriate?

Reveal answer and rationale
Correct answer: A. Assessment for a fetal fatty-acid oxidation disorder
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • Glucose
  • CBC and platelets
  • Liver enzymes and bilirubin
  • INR, fibrinogen, and DIC assessment
  • Creatinine, uric acid, and ammonia
  • Fetal monitoring
  • Swansea-criteria assessment

Treatment principles

  • Correct hypoglycemia
  • Treat coagulopathy
  • Stabilize maternal circulation
  • Expedite delivery
  • Continue intensive monitoring after delivery
  • Consider transplant-centre assessment for persistent failure

Clinical Pearl: Aminotransferase levels may be only moderately elevated despite severe liver failure.

NPLEX Trap: Do not delay delivery while waiting for liver biopsy.

Reference basis: Obstetric and hepatology literature identifies prompt delivery and intensive supportive care as the key interventions.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 443

HELLP SYNDROME WITH SUBCAPSULAR HEPATIC HEMATOMAClinical Case 443

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 34-year-old woman at 35 weeks’ gestation presents with severe right-upper-quadrant pain radiating to the shoulder, nausea, and headache.

Findings:

  • BP: 186/116 mmHg
  • Platelets: 42 × 10⁹/L
  • AST and ALT: markedly elevated
  • LDH: elevated
  • Schistocytes present
  • Hemoglobin: falling

Urgent imaging demonstrates a large subcapsular hepatic hematoma.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. HELLP syndrome complicated by subcapsular hepatic hematoma
Q2

What does HELLP represent?

Reveal answer and rationale
Correct answer: A. Hemolysis, elevated liver enzymes, and low platelets
Q3

What is the immediate management priority?

Reveal answer and rationale
Correct answer: A. Maternal resuscitation, blood-product preparation, blood-pressure control, and multidisciplinary delivery planning
Q4

What finding suggests hematoma rupture?

Reveal answer and rationale
Correct answer: A. Sudden hemodynamic collapse with hemoperitoneum
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Treatment principles

  • Activate obstetric, anesthesia, surgery, interventional-radiology, and transfusion teams
  • Control severe hypertension
  • Administer magnesium when indicated
  • Correct coagulopathy
  • Deliver after maternal stabilization
  • Manage rupture with surgery or embolization when required

Physical examination safety: Avoid repeated forceful palpation over a suspected hepatic hematoma.

Clinical Pearl: Severe epigastric or right-upper-quadrant pain in HELLP may precede catastrophic rupture.

NPLEX Trap: Do not attribute severe upper-abdominal pain to reflux without checking blood pressure, platelets, and liver enzymes.

Reference basis: ACOG-associated evidence emphasizes hemodynamic monitoring, transfusion support, delivery planning, and intervention for rupture.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 444

ECLAMPSIA WITH POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROMEClinical Case 444

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 30-year-old woman at 38 weeks’ gestation develops severe headache, flashing lights, confusion, and a generalized seizure.

Findings:

  • BP: 210/122 mmHg
  • Proteinuria
  • Hyperreflexia and clonus

MRI demonstrates bilateral parieto-occipital vasogenic edema.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Eclampsia with posterior reversible encephalopathy syndrome
Q2

What is the first-line medication for seizure treatment and prevention of recurrence?

Reveal answer and rationale
Correct answer: A. Magnesium sulfate
Q3

What additional maternal intervention is urgently required?

Reveal answer and rationale
Correct answer: A. Controlled treatment of severe hypertension
Q4

What is the definitive obstetric treatment after stabilization?

Reveal answer and rationale
Correct answer: A. Delivery
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • Glucose
  • CBC and platelets
  • Liver and renal function
  • Urine protein
  • Coagulation testing
  • Brain imaging for atypical or persistent neurologic findings

Treatment principles

  • Protect airway and prevent injury
  • Magnesium sulfate
  • Treat severe hypertension
  • Evaluate HELLP and other complications
  • Deliver after stabilization
  • Continue postpartum monitoring

Clinical Pearl: PRES reflects vasogenic edema and is often reversible when the precipitating disorder is treated promptly.

NPLEX Trap: Do not delay magnesium and blood-pressure treatment while waiting for MRI.

Reference basis: ACOG guidance supports magnesium sulfate, urgent severe-hypertension treatment, and delivery after maternal stabilization.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 445

AMNIOTIC-FLUID EMBOLISM WITH DISSEMINATED INTRAVASCULAR COAGULATIONClinical Case 445

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 37-year-old woman develops sudden respiratory distress, cyanosis, hypotension, and loss of consciousness during labour immediately after membrane rupture.

Minutes later, she develops severe uterine and venipuncture-site bleeding.

Laboratory findings:

  • Platelets: rapidly falling
  • Fibrinogen: markedly reduced
  • PT and aPTT: prolonged
  • D-dimer: markedly elevated
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Amniotic-fluid embolism
Q2

Which clinical triad is characteristic?

Reveal answer and rationale
Correct answer: A. Sudden hypoxemia, cardiovascular collapse, and coagulopathy
Q3

What is the appropriate management?

Reveal answer and rationale
Correct answer: A. Immediate advanced resuscitation with oxygenation, circulatory support, and massive-hemorrhage management
Q4

How is the diagnosis established?

Reveal answer and rationale
Correct answer: A. Clinically, after considering and excluding other causes of sudden obstetric collapse
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key differentials

  • Massive pulmonary embolism
  • Hemorrhagic shock
  • Eclampsia
  • Anaphylaxis
  • Sepsis
  • High spinal block
  • Peripartum cardiomyopathy

Treatment principles

  • Immediate CPR when required
  • Optimize oxygenation and ventilation
  • Support right and left ventricular function
  • Activate massive-transfusion protocol
  • Replace fibrinogen and other blood components
  • Control uterine bleeding
  • Consider urgent delivery during maternal arrest when appropriate

Clinical Pearl: AFE is an anaphylactoid obstetric syndrome rather than a simple mechanical blockage by amniotic material.

NPLEX Trap: Do not wait for pathologic confirmation before resuscitation.

Reference basis: Obstetric emergency literature emphasizes immediate cardiopulmonary resuscitation and aggressive treatment of DIC and hemorrhage.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 446

FAMILIAL CHYLOMICRONEMIA SYNDROME WITH RECURRENT PANCREATITISClinical Case 446

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 24-year-old woman presents with severe epigastric pain radiating to the back.

She has had several pancreatitis episodes since adolescence despite fibrate therapy.

Findings:

  • Triglycerides: 38 mmol/L
  • Lipemic serum
  • Eruptive xanthomas
  • Lipemia retinalis
  • Lipoprotein-lipase activity: markedly reduced
  • No diabetes, obesity, alcohol use, or secondary medication cause
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Familial chylomicronemia syndrome
Q2

Which complication is the major clinical threat?

Reveal answer and rationale
Correct answer: A. Recurrent acute pancreatitis
Q3

What is the cornerstone of long-term treatment?

Reveal answer and rationale
Correct answer: A. A specialist-supervised very-low-fat diet
Q4

Which statement distinguishes FCS from common multifactorial hypertriglyceridemia?

Reveal answer and rationale
Correct answer: A. It often begins early and responds poorly to standard triglyceride-lowering medications
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • Fasting triglycerides
  • Repeat measurements
  • Secondary-cause assessment
  • ApoB and lipoprotein characterization
  • Genetic testing
  • Nutritional assessment

Treatment principles

  • Very-low-fat diet
  • Avoid alcohol
  • Avoid triglyceride-raising medications when possible
  • Ensure adequate essential fatty acids and fat-soluble vitamins
  • Treat pancreatitis conventionally
  • Consider specialist-directed targeted therapy

Supplement safety: Fish oil and medium-chain triglycerides should not be prescribed casually; use must be individualized within the patient’s total-fat plan.

Clinical Pearl: Eruptive xanthomas and lipemia retinalis indicate extreme chylomicronemia.

NPLEX Trap: Do not recommend a ketogenic diet to a patient with familial chylomicronemia.

Reference basis: National Lipid Association guidance identifies lifelong severe fat restriction as the foundation of FCS management.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 447

MELAS WITH AN ACUTE STROKE-LIKE EPISODEClinical Case 447

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 19-year-old woman with short stature, sensorineural hearing loss, migraines, and exercise intolerance presents with seizures, vomiting, confusion, and right-sided visual loss.

Laboratory findings:

  • Serum lactate: elevated
  • MRI: cortical lesions crossing conventional vascular territories
  • Magnetic-resonance spectroscopy: lactate peak
  • Genetic testing: mitochondrial m.3243A>G variant

Her mother and maternal uncle have hearing loss and diabetes.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. MELAS syndrome with a stroke-like episode
Q2

Which inheritance pattern is characteristic?

Reveal answer and rationale
Correct answer: A. Maternal mitochondrial inheritance
Q3

Which imaging feature supports a stroke-like episode rather than an arterial ischemic stroke?

Reveal answer and rationale
Correct answer: A. Lesions that do not respect a single vascular territory
Q4

What is the appropriate management principle?

Reveal answer and rationale
Correct answer: A. Urgent seizure control, metabolic support, and mitochondrial-specialist management
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Potential manifestations

  • Stroke-like episodes
  • Seizures
  • Lactic acidosis
  • Hearing loss
  • Diabetes
  • Cardiomyopathy
  • Migraine
  • Short stature
  • Myopathy

Key investigations

  • Lactate and metabolic testing
  • MRI and MR spectroscopy
  • EEG
  • Cardiac assessment
  • Hearing and endocrine assessment
  • Mitochondrial genetic testing

Treatment principles

  • Treat seizures promptly
  • Maintain hydration, glucose, oxygenation, and temperature
  • Avoid prolonged fasting
  • Review medications for mitochondrial toxicity
  • Use individualized specialist protocols for arginine or other metabolic therapy

Clinical Pearl: Heteroplasmy explains why disease severity varies among maternal relatives.

NPLEX Trap: Do not assume every acute focal deficit in MELAS is a thromboembolic stroke.

Reference basis: A 2026 international consensus provides updated diagnostic and management recommendations for MELAS and stroke-like episodes.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 448

REFEEDING SYNDROMEClinical Case 448

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 55-year-old man with alcohol-use disorder and severe malnutrition is admitted after eating almost nothing for 12 days.

Twenty-four hours after high-calorie tube feeding begins, he develops weakness, confusion, edema, tachycardia, and respiratory distress.

Laboratory findings:

  • Phosphate: 0.28 mmol/L
  • Potassium: reduced
  • Magnesium: reduced
  • Glucose: elevated
  • Lactate: elevated
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Refeeding syndrome
Q2

What is the hallmark electrolyte abnormality?

Reveal answer and rationale
Correct answer: A. Hypophosphatemia
Q3

What should be administered before or with initial feeding in a high-risk patient?

Reveal answer and rationale
Correct answer: A. Thiamine
Q4

What is the best prevention strategy?

Reveal answer and rationale
Correct answer: A. Begin nutrition cautiously with close phosphate, potassium, magnesium, fluid, and cardiac monitoring
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Pathophysiology

Carbohydrate feeding increases insulin, driving phosphate, potassium, and magnesium into cells while increasing thiamine demand and sodium-water retention.

Potential complications

  • Respiratory-muscle failure
  • Arrhythmia
  • Heart failure
  • Seizures
  • Rhabdomyolysis
  • Wernicke encephalopathy

Treatment principles

  • Slow or temporarily reduce feeding
  • Replace phosphate, potassium, and magnesium
  • Administer thiamine
  • Manage fluid balance
  • Monitor glucose and cardiac status
  • Advance nutrition gradually

Clinical Pearl: Total-body electrolyte stores can be profoundly depleted despite initially normal serum levels.

NPLEX Trap: Do not “catch up” calories rapidly in a severely malnourished patient.

Reference basis: Consensus nutrition guidance recommends risk screening, thiamine, cautious caloric introduction, and intensive electrolyte monitoring.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 449

ZINC-INDUCED COPPER-DEFICIENCY MYELONEUROPATHYClinical Case 449

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 62-year-old man presents with progressive gait instability, numb feet, hand clumsiness, and fatigue.

He has taken 150 mg of elemental zinc daily for two years to “boost immunity.”

Examination:

  • Loss of vibration and joint-position sense
  • Sensory ataxia
  • Spastic legs
  • Positive Romberg test

Laboratory findings:

  • Anemia
  • Neutropenia
  • Serum copper: very low
  • Ceruloplasmin: low
  • Serum zinc: elevated
  • Vitamin B12: normal

MRI shows increased signal in the posterior cervical spinal cord.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Copper-deficiency myeloneuropathy caused by excessive zinc
Q2

How does excessive zinc cause copper deficiency?

Reveal answer and rationale
Correct answer: A. It induces intestinal metallothionein, which preferentially binds and traps copper
Q3

Which hematologic pattern supports the diagnosis?

Reveal answer and rationale
Correct answer: A. Anemia with neutropenia
Q4

What is the appropriate treatment?

Reveal answer and rationale
Correct answer: A. Stop excess zinc and replace copper under medical supervision
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Other causes

  • Bariatric or gastric surgery
  • Malabsorption
  • Prolonged parenteral nutrition without copper
  • Excess denture-cream zinc
  • Severe restrictive diet

Key investigations

  • Serum copper and ceruloplasmin
  • Zinc
  • CBC
  • Vitamin B12 and folate
  • Iron studies
  • Spinal MRI
  • Malabsorption assessment

Treatment principles

  • Remove the cause
  • Replace copper
  • Correct accompanying deficiencies
  • Provide neurologic rehabilitation
  • Monitor blood counts and copper levels

Clinical Pearl: Hematologic recovery is often faster and more complete than neurologic recovery.

NPLEX Trap: Do not assume every posterior-column syndrome is caused by vitamin B12 deficiency.

Reference basis: NIH nutritional resources recognize copper’s hematologic and neurologic roles and excessive zinc as a clinically important cause of deficiency.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 450

CHRONIC VITAMIN A TOXICITY WITH INTRACRANIAL HYPERTENSION AND LIVER INJURYClinical Case 450

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 33-year-old woman presents with persistent headache, pulsatile tinnitus, blurred vision, nausea, dry peeling skin, hair loss, and bone pain.

She takes:

  • A high-potency vitamin A supplement
  • Cod-liver oil
  • A “skin and immunity” product containing retinyl palmitate
  • Recently prescribed isotretinoin

Examination reveals papilledema.

Laboratory findings:

  • AST and ALT: elevated
  • Alkaline phosphatase: elevated
  • Triglycerides: elevated
  • Pregnancy test: negative
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Chronic preformed vitamin A toxicity with intracranial hypertension and hepatic injury
Q2

Which ingredient is principally responsible for classic hypervitaminosis A?

Reveal answer and rationale
Correct answer: A. Preformed retinol or retinyl esters
Q3

What is the most important immediate management step?

Reveal answer and rationale
Correct answer: A. Stop all vitamin A-containing supplements and isotretinoin and arrange urgent ophthalmologic assessment
Q4

Why is preformed vitamin A particularly dangerous during pregnancy?

Reveal answer and rationale
Correct answer: A. Excess intake is teratogenic
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Potential manifestations

  • Intracranial hypertension
  • Headache and papilledema
  • Hepatotoxicity
  • Dry skin and alopecia
  • Bone and joint pain
  • Hypertriglyceridemia
  • Teratogenicity

Key investigations

  • Complete supplement and medication inventory
  • Liver tests and INR
  • Lipid profile
  • Pregnancy testing
  • Ophthalmologic assessment
  • Neuroimaging and lumbar-puncture assessment when appropriate

Treatment principles

  • Stop excess preformed vitamin A and interacting retinoids
  • Protect vision
  • Manage intracranial hypertension
  • Monitor liver recovery
  • Avoid pregnancy during and after teratogenic retinoid exposure according to medication guidance

Supplement safety: Multiple products may contain overlapping vitamin A doses. Cod-liver oil must be included in the total intake calculation.

Clinical Pearl: Serum retinol may not reliably reflect total tissue toxicity.

NPLEX Trap: Do not assume all “natural” vitamin products are safe when several retinol-containing products are combined.

Reference basis: Established nutrition guidance sets an adult tolerable upper intake level for preformed vitamin A and recognizes liver injury and teratogenicity as principal toxicity concerns.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 451

STEVENS–JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSISClinical Case 451

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 32-year-old woman presents with fever, malaise, painful skin, mouth ulceration, red eyes, and difficulty swallowing.

Three weeks earlier, lamotrigine was started and rapidly increased for bipolar disorder.

Examination reveals:

  • Dusky atypical target lesions
  • Epidermal blistering and detachment over approximately 18% of body surface area
  • Positive Nikolsky sign
  • Hemorrhagic crusting of the lips
  • Conjunctival inflammation
  • Vulvovaginal erosions
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: B. Stevens–Johnson syndrome/TEN overlap

Painful epidermal necrosis, prominent mucosal involvement, medication exposure, and skin detachment involving 10–30% of body surface area indicate SJS/TEN overlap. SJS involves less than 10%, while TEN involves more than 30%.

Q2

What is the most important immediate action?

Reveal answer and rationale
Correct answer: C. Stop the suspected medication and arrange emergency specialist admission

Prompt withdrawal of the causative medication may improve survival. The patient requires multidisciplinary care in an intensive-care, burn, or specialized dermatology environment.

Q3

Which consultation is urgent even when visual acuity is initially preserved?

Reveal answer and rationale
Correct answer: A. Ophthalmology

Early ocular inflammation may progress to corneal ulceration, scarring, symblepharon, dry-eye disease, and permanent visual impairment.

Q4

Which future action is inappropriate?

Reveal answer and rationale
Correct answer: D. Rechallenging with lamotrigine to confirm causation

Intentional rechallenge after SJS/TEN is dangerous and generally contraindicated.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • Full medication timeline
  • CBC, electrolytes, glucose, renal and liver function
  • Skin biopsy when diagnosis is uncertain
  • Blood and wound cultures when infection is suspected
  • Ophthalmologic, genital, respiratory, and gastrointestinal assessment
  • Severity assessment such as SCORTEN

Treatment principles

  • Immediately stop the culprit medication
  • Support airway, fluid balance, temperature, nutrition, and pain control
  • Use nonadherent wound care
  • Prevent pressure injury and infection
  • Obtain early ophthalmology involvement
  • Consider specialist-directed immunomodulatory treatment

Botanical safety: Newly introduced herbs and supplements must also be reviewed as possible triggers. No “detoxification” therapy should delay hospital care.

Clinical Pearl: Skin pain may precede obvious blistering or detachment.

NPLEX Trap: Antihistamines do not treat epidermal necrosis.

Prompt withdrawal and intensive supportive care are central to SJS/TEN management.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 452

SEROTONIN SYNDROMEClinical Case 452

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 39-year-old man taking sertraline begins linezolid for pneumonia. He also uses dextromethorphan and St. John’s wort.

Within 12 hours, he develops agitation, diarrhea, sweating, tremor, and fever.

Examination:

  • Temperature: 39.3°C
  • HR: 138/min
  • BP: 174/98 mmHg
  • Dilated pupils
  • Ocular clonus
  • Inducible ankle clonus
  • Marked lower-limb hyperreflexia
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: C. Serotonin syndrome

Rapid onset following serotonergic medication interaction, together with agitation, autonomic hyperactivity, diarrhea, clonus, and hyperreflexia, indicates serotonin toxicity.

Q2

Which finding most strongly favours serotonin syndrome over neuroleptic malignant syndrome?

Reveal answer and rationale
Correct answer: B. Clonus and hyperreflexia

Neuromuscular excitation, particularly clonus and hyperreflexia, is characteristic of serotonin syndrome. NMS more commonly produces generalized lead-pipe rigidity and reduced or normal reflexes.

Q3

What is the first management step?

Reveal answer and rationale
Correct answer: A. Discontinue serotonergic agents and begin supportive care

All serotonergic contributors must be stopped. Benzodiazepine sedation, intravenous fluids, oxygenation, active cooling, and management of complications are central.

Q4

Which botanical product contributed to this patient’s risk?

Reveal answer and rationale
Correct answer: D. St. John’s wort

St. John’s wort has serotonergic activity and can interact with antidepressants and other serotonergic medications.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Potential triggers

  • SSRIs and SNRIs
  • MAO inhibitors
  • Linezolid
  • Tramadol
  • Dextromethorphan
  • Lithium
  • MDMA and some stimulants
  • St. John’s wort
  • Multiple interacting serotonergic agents

Treatment principles

  • Stop causative agents
  • Benzodiazepine sedation
  • Intravenous fluids and cooling
  • Treat severe agitation and seizures
  • Intubation and nondepolarizing paralysis for extreme hyperthermia
  • Consider cyproheptadine in selected cases, recognizing that evidence is limited

Pharmacology safety: Physical restraints without adequate sedation can increase muscle activity, acidosis, and hyperthermia.

Clinical Pearl: Serotonin syndrome often begins within hours of a dose increase, overdose, or drug interaction.

NPLEX Trap: Antipyretics do not correct medication-induced muscular hyperactivity.

Hunter-type neuromuscular findings and rapid supportive management are central to diagnosis and treatment.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 453

ETHYLENE GLYCOL POISONINGClinical Case 453

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 44-year-old man is found confused beside an open container of automotive antifreeze.

Laboratory findings:

  • pH: 7.08
  • Bicarbonate: 7 mmol/L
  • High anion gap
  • Elevated osmolar gap
  • Ionized calcium: reduced
  • Creatinine: increasing
  • Urine microscopy: envelope-shaped calcium-oxalate crystals
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Ethylene glycol poisoning

Antifreeze exposure, severe high-anion-gap acidosis, osmolar-gap elevation, hypocalcemia, kidney injury, and calcium-oxalate crystals indicate ethylene glycol toxicity.

Q2

Which metabolite principally causes renal injury?

Reveal answer and rationale
Correct answer: B. Oxalic acid

Oxalate binds calcium and deposits as calcium oxalate within renal tissue, contributing to hypocalcemia and acute kidney injury.

Q3

Which antidote should be administered promptly?

Reveal answer and rationale
Correct answer: C. Fomepizole

Fomepizole blocks alcohol dehydrogenase and prevents formation of toxic glycolate and oxalate metabolites.

Q4

Which finding supports urgent hemodialysis?

Reveal answer and rationale
Correct answer: D. Severe acidosis with kidney failure

Dialysis removes ethylene glycol and its metabolites while correcting severe acidosis, electrolyte abnormalities, and renal failure.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • Blood gas
  • Electrolytes and calculated anion gap
  • Measured serum osmolality and osmolar gap
  • Ethylene glycol concentration when available
  • Calcium and renal function
  • Urinalysis and microscopy
  • ECG

Treatment principles

  • Immediate poison-centre or toxicology consultation
  • Fomepizole
  • Sodium bicarbonate for significant acidosis
  • Thiamine and pyridoxine as metabolic cofactors
  • Hemodialysis for severe toxicity
  • Monitor calcium and renal function

Clinical Pearl: The osmolar gap may fall as the toxic alcohol is metabolized while the anion gap and organ injury worsen.

NPLEX Trap: Calcium-oxalate crystals support the diagnosis but may be absent.

CDC toxicology guidance supports early fomepizole and hemodialysis for severe acidosis or renal failure.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 454

CYANIDE POISONING AFTER SMOKE INHALATIONClinical Case 454

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 36-year-old man is rescued from an enclosed-space industrial fire.

He is confused and hypotensive and develops cardiovascular collapse despite high-concentration oxygen.

Findings:

  • Soot around the mouth
  • Severe lactic acidosis
  • Lactate: 14 mmol/L
  • Normal methemoglobin
  • Carboxyhemoglobin: moderately elevated
Q1

What is the most likely additional toxic exposure?

Reveal answer and rationale
Correct answer: D. Cyanide

Enclosed-space combustion of synthetic materials can release cyanide. Profound lactic acidosis, altered consciousness, hypotension, and cardiovascular collapse are important clues.

Q2

What is cyanide’s principal toxic mechanism?

Reveal answer and rationale
Correct answer: A. Inhibition of mitochondrial cytochrome oxidase

Cyanide prevents cells from using oxygen for oxidative phosphorylation, producing histotoxic hypoxia and severe lactic acidosis.

Q3

Which antidote is generally preferred in a smoke-inhalation patient?

Reveal answer and rationale
Correct answer: B. Hydroxocobalamin

Hydroxocobalamin binds cyanide to form cyanocobalamin. It does not induce methemoglobinemia and is therefore useful when concurrent carbon-monoxide exposure is possible.

Q4

Should treatment wait for a cyanide level?

Reveal answer and rationale
Correct answer: C. No; treatment is clinical when severe poisoning is strongly suspected

Cyanide assays are generally not available rapidly enough to direct emergency treatment.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Potential sources

  • Enclosed-space fire smoke
  • Industrial chemicals
  • Metal processing
  • Certain laboratory exposures
  • Improperly processed cassava

Treatment principles

  • Remove from exposure
  • High-concentration oxygen
  • Support airway and circulation
  • Hydroxocobalamin
  • Consider sodium thiosulfate in selected cases
  • Treat concurrent carbon-monoxide and burn injuries

Clinical Pearl: A normal arterial oxygen tension does not exclude cyanide toxicity because oxygen delivery may be intact while cellular use is blocked.

NPLEX Trap: Do not use nitrite-based antidotes casually when concurrent carbon-monoxide poisoning may already impair oxygen carriage.

Hydroxocobalamin is a recommended antidote for acute cyanide poisoning.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 455

AMATOXIN MUSHROOM POISONINGClinical Case 455

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A family eats wild mushrooms collected in a forest. Twelve hours later, a 41-year-old woman develops severe vomiting and profuse watery diarrhea.

Her symptoms briefly improve, but 36 hours after ingestion she develops jaundice, hypoglycemia, confusion, and coagulopathy.

Laboratory findings:

  • AST and ALT: rapidly rising
  • INR: 3.8
  • Glucose: 2.6 mmol/L
  • Creatinine: increasing
  • Lactate: elevated
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: B. Amatoxin poisoning

Delayed gastrointestinal symptoms followed by a deceptive improvement and subsequent acute hepatic failure are characteristic of amatoxin-containing mushrooms such as Amanita phalloides.

Q2

What cellular process is inhibited by amatoxin?

Reveal answer and rationale
Correct answer: A. RNA polymerase II-dependent protein synthesis
Q3

What is the most appropriate management?

Reveal answer and rationale
Correct answer: C. Immediate toxicology care, aggressive support, and early transplant-centre involvement

Patients can deteriorate after an apparent recovery. Serial liver tests, INR, glucose, lactate, renal function, and mental status are essential.

Q4

What is the definitive treatment for progressive irreversible acute liver failure?

Reveal answer and rationale
Correct answer: D. Liver transplantation
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Clinical phases

  1. Latent asymptomatic period
  2. Severe gastrointestinal illness
  3. Apparent clinical improvement
  4. Progressive hepatic and possible renal failure

Treatment principles

  • Immediate poison-centre consultation
  • Fluid, electrolyte, and glucose support
  • Repeated activated charcoal in selected patients
  • Consider intravenous silibinin where available
  • Consider N-acetylcysteine
  • Serial prognostic assessment
  • Early transplant-centre referral

Botanical safety: Commercial milk-thistle supplements are not equivalent to intravenous silibinin protocols studied in amatoxin poisoning.

Clinical Pearl: Delayed onset of diarrhea after mushroom ingestion is more concerning than immediate gastrointestinal upset.

NPLEX Trap: Symptomatic improvement does not mean hepatic toxicity has resolved.

Severe amatoxin poisoning requires aggressive supportive treatment and early transplant assessment.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 456

FOODBORNE BOTULISMClinical Case 456

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 57-year-old woman develops blurred vision, diplopia, dry mouth, dysphagia, and generalized weakness after eating home-canned vegetables.

Examination:

  • Bilateral ptosis
  • Fixed or poorly reactive pupils
  • Dysarthria
  • Symmetric descending weakness
  • Reduced reflexes
  • Normal sensation
  • Clear mental status
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: C. Foodborne botulism

Acute bilateral cranial-nerve palsies followed by symmetric descending flaccid paralysis, autonomic symptoms, normal sensation, and preserved consciousness indicate botulism.

Q2

What is the immediate management priority?

Reveal answer and rationale
Correct answer: A. Respiratory monitoring and early airway support

Respiratory-muscle failure can develop rapidly. Serial vital capacity and inspiratory-force assessment are important.

Q3

When should botulinum antitoxin be administered?

Reveal answer and rationale
Correct answer: B. As early as possible on clinical suspicion

Antitoxin neutralizes circulating toxin but cannot reverse toxin already bound to nerve terminals. Laboratory confirmation must not delay treatment.

Q4

Which finding argues against organophosphate poisoning?

Reveal answer and rationale
Correct answer: D. Dry mouth without bronchorrhea or diaphoresis
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • Clinical neurologic examination
  • Respiratory-force measurements
  • Serum, stool, or food toxin testing through public health
  • EMG when diagnosis is uncertain
  • Evaluation of exposed meal companions

Treatment principles

  • Notify public health immediately
  • Administer antitoxin early
  • Support ventilation and swallowing
  • Prevent aspiration and pressure injury
  • Debride and treat infected wounds in wound botulism

Clinical Pearl: Patients generally remain alert and afebrile unless a secondary complication occurs.

NPLEX Trap: Do not delay antitoxin while awaiting toxin-assay results.

CDC guidelines identify early antitoxin and respiratory support as the principal treatments.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 457

GENERALIZED TETANUSClinical Case 457

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 62-year-old man presents with jaw stiffness, painful swallowing, neck rigidity, and recurrent whole-body spasms.

Two weeks earlier, he punctured his foot on a rusty farm implement. He has no reliable vaccination history.

Examination:

  • Trismus
  • Risus sardonicus
  • Opisthotonus during stimulation
  • Autonomic instability
  • Consciousness preserved between spasms
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Generalized tetanus
Q2

What does tetanus immune globulin accomplish?

Reveal answer and rationale
Correct answer: B. Neutralizes circulating unbound toxin
Q3

Which treatment combination is appropriate?

Reveal answer and rationale
Correct answer: A. TIG, wound debridement, antimicrobial therapy, spasm control, and airway support
Q4

Does recovery from tetanus provide reliable future immunity?

Reveal answer and rationale
Correct answer: C. No; vaccination is still required

The toxin dose capable of causing disease is too small to produce dependable immunity.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Treatment principles

  • Minimize stimulation
  • Maintain airway and ventilation
  • Give tetanus immune globulin
  • Debride the wound
  • Administer appropriate antimicrobial therapy
  • Control spasms and autonomic instability
  • Begin or complete tetanus vaccination

Clinical Pearl: Consciousness is usually preserved despite severe spasms.

NPLEX Trap: Tetanus immune globulin cannot reverse toxin already bound to neural tissue.

CDC clinical guidance supports TIG, wound care, airway management, spasm control, and vaccination.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 458

NECROTIZING FASCIITISClinical Case 458

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 58-year-old man with diabetes presents with rapidly worsening leg pain after a minor abrasion.

Findings:

  • Severe pain extending beyond visible erythema
  • Rapid edema and violaceous discoloration
  • Hemorrhagic bullae
  • Skin anesthesia over the central area
  • Crepitus
  • Hypotension and confusion
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: D. Necrotizing fasciitis
Q2

What is the most important next step?

Reveal answer and rationale
Correct answer: C. Immediate surgical exploration and debridement

Necrotizing soft-tissue infection is primarily a surgical emergency. Imaging must not delay operative management when clinical suspicion is high.

Q3

What antimicrobial approach is initially appropriate?

Reveal answer and rationale
Correct answer: A. Broad-spectrum intravenous coverage, including MRSA and anaerobic organisms
Q4

Which physical intervention is contraindicated?

Reveal answer and rationale
Correct answer: B. Vigorous massage over the painful area
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Warning features

  • Pain out of proportion
  • Rapid progression
  • Systemic toxicity
  • Bullae or ecchymosis
  • Skin anesthesia
  • Crepitus
  • Hypotension
  • Laboratory evidence of organ dysfunction

Treatment principles

  • Immediate surgical exploration
  • Repeated debridement as needed
  • Broad-spectrum intravenous antibiotics
  • Clindamycin when toxin-producing streptococcal or clostridial disease is suspected
  • Sepsis resuscitation
  • Intensive-care support

Clinical Pearl: Skin findings may appear modest early because the infection spreads along deeper fascial planes.

NPLEX Trap: A low-risk laboratory score cannot safely rule out necrotizing fasciitis.

CDC guidance identifies early aggressive surgery plus broad parenteral antibiotic treatment as essential.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 459

STREPTOCOCCAL TOXIC SHOCK SYNDROMEClinical Case 459

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 43-year-old woman presents with severe arm pain two days after a small skin injury.

Vital signs:

  • BP: 72/38 mmHg
  • HR: 142/min
  • Temperature: 39.5°C

Laboratory findings:

  • Creatinine: elevated
  • Platelets: reduced
  • AST and ALT: elevated
  • Lactate: 6.2 mmol/L
  • CK: elevated

Surgical exploration reveals necrotic fascia. Blood and tissue cultures grow group A Streptococcus.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: B. Streptococcal toxic shock syndrome
Q2

Which antimicrobial combination is preferred once group A streptococcal infection is confirmed?

Reveal answer and rationale
Correct answer: A. Penicillin plus clindamycin

Penicillin is active against GAS, while clindamycin suppresses bacterial protein and toxin production and remains active during stationary-phase growth.

Q3

What additional treatment is frequently essential?

Reveal answer and rationale
Correct answer: A. Surgical source control
Q4

Which intervention may be considered in selected severe cases but does not replace surgery or antibiotics?

Reveal answer and rationale
Correct answer: C. Intravenous immunoglobulin
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnostic pattern

  • Group A streptococcal infection
  • Hypotension
  • Multiorgan dysfunction
  • Frequently associated necrotizing fasciitis, myositis, or another deep focus

Treatment principles

  • Immediate shock resuscitation
  • Penicillin plus clindamycin
  • Surgical source control
  • Organ support
  • Consider IV immunoglobulin for selected critically ill patients

Clinical Pearl: A diffuse rash may be absent in streptococcal toxic shock.

NPLEX Trap: Hemodynamic stabilization must occur simultaneously with—not instead of—urgent source control.

CDC guidance recommends penicillin, clindamycin, organ support, and surgery when a removable source is present.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 460

MENINGOCOCCEMIA WITH PURPURA FULMINANSClinical Case 460

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A previously healthy 19-year-old university resident presents with fever, severe myalgia, vomiting, confusion, and rapidly spreading purple skin lesions.

Findings:

  • BP: 68/34 mmHg
  • HR: 148/min
  • Nonblanching petechiae and ecchymoses
  • Cool extremities
  • No marked neck stiffness

Laboratory findings:

  • Platelets: 32 × 10⁹/L
  • INR and aPTT: prolonged
  • Fibrinogen: reduced
  • Lactate: 7.1 mmol/L
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: C. Meningococcemia with purpura fulminans
Q2

What is the appropriate immediate antibiotic?

Reveal answer and rationale
Correct answer: B. Intravenous ceftriaxone or cefotaxime

Suspected invasive meningococcal disease requires immediate parenteral treatment. Antibiotics must not be delayed for imaging, lumbar puncture, or culture results.

Q3

What causes the rapidly progressive skin necrosis?

Reveal answer and rationale
Correct answer: A. Disseminated intravascular coagulation and microvascular thrombosis
Q4

What is required for close contacts?

Reveal answer and rationale
Correct answer: C. Prompt public-health-directed antimicrobial chemoprophylaxis
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Treatment principles

  • Droplet precautions
  • Immediate ceftriaxone or cefotaxime
  • Sepsis resuscitation
  • Vasopressors and organ support
  • Treat DIC and bleeding
  • Notify public health
  • Provide close-contact prophylaxis
  • Review vaccination indications

Clinical Pearl: Meningococcemia may cause fatal shock without prominent meningitis.

NPLEX Trap: Do not perform lumbar puncture before stabilizing an unstable patient.

CDC guidance emphasizes immediate third-generation cephalosporin therapy and public-health management of contacts.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 461

SEVERE BABESIOSIS IN AN ASPLENIC PATIENTClinical Case 461

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 66-year-old asplenic man from Ontario presents with high fever, drenching sweats, jaundice, dark urine, dyspnea, and confusion after hiking in a wooded area.

Laboratory findings:

  • Hemoglobin: 67 g/L
  • Platelets: 46 × 10⁹/L
  • Bilirubin and LDH: elevated
  • Haptoglobin: undetectable
  • Creatinine: elevated
  • Parasitemia: 14%
  • Blood smear: intraerythrocytic ring forms and Maltese-cross formations
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Severe babesiosis
Q2

Which feature most strongly supports Babesia rather than malaria?

Reveal answer and rationale
Correct answer: C. Maltese-cross tetrads without malarial pigment
Q3

What treatment should be considered because of the high parasitemia and organ dysfunction?

Reveal answer and rationale
Correct answer: B. Red-cell exchange transfusion
Q4

Which patients are at increased risk of severe or relapsing babesiosis?

Reveal answer and rationale
Correct answer: C. Asplenic, older, or significantly immunocompromised patients
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • Manual peripheral blood smears
  • Babesia PCR
  • CBC and hemolysis studies
  • Renal and liver function
  • Quantification of parasitemia
  • Evaluation for Lyme disease and anaplasmosis coinfection

Treatment principles

  • Hospitalize severe disease
  • Use specialist-directed combination antimicrobial therapy
  • Monitor smears frequently
  • Consider red-cell exchange when parasitemia exceeds approximately 10% or severe hemolysis or organ dysfunction is present
  • Use prolonged treatment in selected immunocompromised patients

Clinical Pearl: Babesiosis may be acquired through transfusion as well as tick exposure.

NPLEX Trap: A single negative smear does not exclude low-level infection; repeat microscopy or PCR may be required.

CDC guidance supports exchange transfusion for high-grade parasitemia or serious organ compromise.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 462

SEVERE FALCIPARUM MALARIAClinical Case 462

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 34-year-old man returns to Toronto from West Africa without taking malaria prophylaxis.

He presents with fever, confusion, jaundice, vomiting, and reduced urine output.

Findings:

  • Glucose: 2.8 mmol/L
  • Lactate: elevated
  • Creatinine: elevated
  • Hemoglobin: reduced
  • Parasitemia: 8%
  • Blood smear: multiple delicate ring forms in erythrocytes and banana-shaped gametocytes
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: D. Severe Plasmodium falciparum malaria
Q2

What is the preferred immediate treatment?

Reveal answer and rationale
Correct answer: B. Intravenous artesunate
Q3

What should follow intravenous artesunate when the patient can tolerate oral therapy?

Reveal answer and rationale
Correct answer: B. A complete effective oral antimalarial regimen
Q4

Which delayed adverse effect should be monitored after artesunate?

Reveal answer and rationale
Correct answer: A. Delayed hemolysis
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Severe-malaria findings may include

  • Altered consciousness
  • Shock
  • Severe anemia
  • Acute kidney injury
  • Pulmonary edema
  • Acidosis
  • Hypoglycemia
  • High parasite burden
  • Significant jaundice with another organ complication

Treatment principles

  • Start intravenous artesunate immediately
  • Do not delay for transfer or complete species confirmation
  • Monitor glucose, parasitemia, renal function, hemoglobin, and lactate
  • Follow with a complete oral regimen
  • Monitor for delayed hemolysis

Clinical Pearl: Nonimmune travellers can deteriorate rapidly even with a relatively short symptom history.

NPLEX Trap: Exchange transfusion is not routine treatment when effective intravenous artesunate is available.

Current CDC guidance identifies intravenous artesunate as the treatment for severe malaria.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 463

HANTAVIRUS PULMONARY SYNDROMEClinical Case 463

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 28-year-old man develops fever, headache, severe myalgia, nausea, and abdominal pain after cleaning a rodent-infested cabin.

Two days later, he develops abrupt dyspnea and hypotension.

Findings:

  • Oxygen saturation: 82%
  • Bilateral pulmonary edema
  • Thrombocytopenia
  • Hemoconcentration
  • Circulating immunoblasts
  • Lactate: elevated
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: B. Hantavirus pulmonary syndrome
Q2

Which epidemiologic exposure is most important?

Reveal answer and rationale
Correct answer: B. Rodent urine, droppings, saliva, or aerosolized contaminated dust
Q3

What is the main treatment?

Reveal answer and rationale
Correct answer: A. Early intensive supportive care
Q4

Why must intravenous fluids be used cautiously?

Reveal answer and rationale
Correct answer: A. Capillary leakage can rapidly worsen pulmonary edema
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Treatment principles

  • Immediate intensive-care admission
  • Oxygen and ventilation
  • Careful fluid administration
  • Vasopressor and cardiac support
  • Consider early ECMO at an experienced centre for refractory cardiopulmonary failure
  • Provide empiric antibiotics until alternative bacterial causes are excluded

Clinical Pearl: Thrombocytopenia and hemoconcentration can precede severe pulmonary edema.

NPLEX Trap: Large empiric fluid boluses can worsen respiratory failure in the capillary-leak phase.

CDC states that no specific antiviral treatment exists and early ICU supportive care is critical.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 464

SEVERE LEPTOSPIROSIS: WEIL DISEASEClinical Case 464

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 42-year-old sanitation worker develops fever, severe calf pain, headache, red eyes, jaundice, reduced urine output, and hemoptysis after working in floodwater.

Laboratory findings:

  • Bilirubin: markedly elevated
  • AST and ALT: moderately elevated
  • Creatinine: elevated
  • Platelets: reduced
  • Urinalysis: protein and blood
  • Chest imaging: diffuse alveolar infiltrates
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: C. Severe leptospirosis
Q2

Which physical finding is a classic clue?

Reveal answer and rationale
Correct answer: A. Conjunctival suffusion
Q3

What is appropriate treatment for severe disease?

Reveal answer and rationale
Correct answer: B. Intravenous penicillin or an appropriate third-generation cephalosporin
Q4

Does a negative antibody test during the first week exclude the diagnosis?

Reveal answer and rationale
Correct answer: C. No; early serology can be negative
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Severe manifestations

  • Jaundice
  • Acute kidney injury
  • Pulmonary hemorrhage
  • Meningitis
  • Myocarditis
  • Shock

Treatment principles

  • Start antibiotics when clinically suspected
  • Do not await laboratory confirmation
  • Provide dialysis, ventilation, and hemodynamic support when needed
  • Monitor for a Jarisch–Herxheimer reaction

Clinical Pearl: Bilirubin may be markedly elevated despite only moderate aminotransferase elevation.

NPLEX Trap: Do not dismiss conjunctival redness as ordinary conjunctivitis when fever, calf pain, renal failure, and floodwater exposure coexist.

CDC guidance recommends immediate treatment, using intravenous penicillin or ceftriaxone for severe disease.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 465

SEVERE DENGUE WITH SHOCKClinical Case 465

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 26-year-old woman returns from the Caribbean with four days of fever, severe myalgia, retro-orbital pain, nausea, and rash.

As her fever subsides, she develops severe abdominal pain, repeated vomiting, restlessness, and cool extremities.

Findings:

  • BP: 96/82 mmHg
  • Narrow pulse pressure
  • HR: 132/min
  • Platelets: 34 × 10⁹/L
  • Hematocrit: rising
  • Ultrasound: pleural fluid and ascites
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Severe dengue with plasma-leakage shock
Q2

When does the critical phase commonly begin?

Reveal answer and rationale
Correct answer: B. Around defervescence
Q3

What is the appropriate fluid strategy?

Reveal answer and rationale
Correct answer: A. Carefully titrated isotonic crystalloid with frequent reassessment
Q4

Which intervention is not recommended solely because the platelet count is low?

Reveal answer and rationale
Correct answer: C. Prophylactic platelet transfusion
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Warning signs

  • Severe abdominal pain
  • Persistent vomiting
  • Mucosal bleeding
  • Restlessness or lethargy
  • Hepatomegaly
  • Rising hematocrit with falling platelets
  • Clinical fluid accumulation

Treatment principles

  • Frequent hemodynamic reassessment
  • Judicious isotonic fluid replacement
  • Avoid fluid overload during recovery
  • Transfuse blood for clinically important hemorrhage
  • Avoid NSAIDs and aspirin

Clinical Pearl: A narrow pulse pressure may identify compensated shock before systolic hypotension develops.

NPLEX Trap: Falling fever does not necessarily indicate recovery.

Current CDC guidance emphasizes careful fluid titration and advises against prophylactic platelet transfusion.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 466

ROCKY MOUNTAIN SPOTTED FEVERClinical Case 466

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A seven-year-old child presents with fever, severe headache, vomiting, myalgia, and confusion five days after a camping trip.

A rash began on the wrists and ankles and has spread toward the trunk, including the palms and soles.

Laboratory findings:

  • Platelets: reduced
  • Sodium: reduced
  • AST and ALT: elevated
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: D. Rocky Mountain spotted fever
Q2

What is the treatment of choice?

Reveal answer and rationale
Correct answer: B. Doxycycline
Q3

Should doxycycline be withheld because the patient is younger than eight years?

Reveal answer and rationale
Correct answer: C. No; brief treatment is recommended for children of all ages
Q4

Should treatment wait for confirmatory serology?

Reveal answer and rationale
Correct answer: B. No; treatment should begin on clinical suspicion
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key points

  • Rash may be absent early
  • A remembered tick bite is not required
  • Early serologic testing may be negative
  • Delayed treatment substantially increases severe complications and death

Treatment principles

  • Start doxycycline immediately
  • Treat adults and children
  • Continue until clinically improved and afebrile for an appropriate period
  • Provide organ support for severe disease

Clinical Pearl: Palms-and-soles involvement is helpful but is often a later finding.

NPLEX Trap: Do not wait for the classic rash or a positive antibody result.

CDC recommends immediate doxycycline for suspected RMSF in patients of every age.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 467

FULMINANT CLOSTRIDIOIDES DIFFICILE COLITISClinical Case 467

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 71-year-old woman develops profuse diarrhea after broad-spectrum antibiotic treatment.

She subsequently becomes hypotensive and confused. Her abdomen is markedly distended, and bowel sounds are absent.

Investigations:

  • WBC: 46 × 10⁹/L
  • Creatinine: three times baseline
  • Lactate: 5.6 mmol/L
  • Abdominal imaging: colonic dilation consistent with toxic megacolon
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: B. Fulminant Clostridioides difficile infection
Q2

What antibiotic regimen is appropriate?

Reveal answer and rationale
Correct answer: A. High-dose oral or enteral vancomycin plus intravenous metronidazole
Q3

What additional treatment may be needed when ileus prevents adequate colonic drug delivery?

Reveal answer and rationale
Correct answer: A. Rectal vancomycin
Q4

What consultation should occur early?

Reveal answer and rationale
Correct answer: C. Surgery
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Fulminant findings

  • Hypotension or shock
  • Ileus
  • Toxic megacolon
  • Marked leukocytosis
  • Rising lactate and organ dysfunction

Treatment principles

  • Stop unnecessary inciting antibiotics
  • Enteral vancomycin
  • Intravenous metronidazole
  • Rectal vancomycin when ileus is present
  • Early surgical assessment
  • Avoid antimotility medication
  • Maintain enteric contact precautions

Clinical Pearl: Diarrhea may decrease after ileus develops even as the disease becomes more severe.

NPLEX Trap: Reduced stool output does not prove improvement in a distended, systemically toxic patient.

IDSA/SHEA guidance recommends oral vancomycin, intravenous metronidazole, rectal vancomycin with ileus, and surgical management when required.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 468

SEVERE HUMAN GRANULOCYTIC ANAPLASMOSISClinical Case 468

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 68-year-old man presents with fever, headache, myalgia, confusion, and dyspnea after hiking in an area with blacklegged ticks.

Laboratory findings:

  • Leukopenia
  • Thrombocytopenia
  • Elevated AST and ALT
  • Acute kidney injury
  • Peripheral smear: morulae within granulocytes
  • PCR: Anaplasma phagocytophilum
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: C. Human granulocytic anaplasmosis
Q2

Which blood cells characteristically contain morulae?

Reveal answer and rationale
Correct answer: B. Neutrophils and other granulocytes
Q3

What is the treatment of choice?

Reveal answer and rationale
Correct answer: A. Doxycycline
Q4

Should treatment be delayed until PCR confirmation?

Reveal answer and rationale
Correct answer: C. No; start treatment when clinically suspected
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Potential complications

  • Respiratory failure
  • Bleeding
  • Kidney injury
  • Neurologic dysfunction
  • Secondary opportunistic infection
  • Multiorgan failure

Treatment principles

  • Start doxycycline promptly
  • Assess for Lyme disease and Babesia coinfection
  • Monitor blood counts and organ function
  • Provide intensive support for severe disease

Clinical Pearl: Many patients do not recall a tick bite.

NPLEX Trap: Beta-lactam antibiotics used for Lyme disease do not adequately treat anaplasmosis.

CDC recommends doxycycline for suspected anaplasmosis in adults and children.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 469

SEVERE EHRLICHIOSIS WITH MENINGOENCEPHALITISClinical Case 469

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 56-year-old man receiving immunosuppressive therapy presents with fever, severe headache, confusion, vomiting, and a maculopapular rash after a lone-star tick exposure.

Laboratory findings:

  • Leukopenia
  • Thrombocytopenia
  • Elevated liver enzymes
  • Hyponatremia
  • CSF: lymphocytic pleocytosis
  • PCR: Ehrlichia chaffeensis
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Severe ehrlichiosis
Q2

Which cells may contain characteristic morulae?

Reveal answer and rationale
Correct answer: B. Monocytes
Q3

What is the first-line treatment?

Reveal answer and rationale
Correct answer: B. Doxycycline
Q4

Which statement is correct?

Reveal answer and rationale
Correct answer: C. Early treatment reduces progression to severe disease
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Severe manifestations

  • Meningoencephalitis
  • ARDS
  • Shock
  • DIC
  • Kidney failure
  • Hemophagocytic lymphohistiocytosis

Treatment principles

  • Begin doxycycline immediately
  • Do not wait for PCR or serology
  • Continue until the patient has improved and remained afebrile for the recommended period
  • Provide organ support

Clinical Pearl: Rash is more common in children and may be absent in adults.

NPLEX Trap: Ceftriaxone for presumed meningitis does not reliably treat ehrlichiosis.

CDC identifies doxycycline as first-line treatment for all ages and advises immediate empiric therapy.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 470

PNEUMONIC TULAREMIAClinical Case 470

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 49-year-old landscaper presents with high fever, dry cough, pleuritic chest pain, and profound fatigue.

Symptoms began after he accidentally mowed over a dead rabbit and inhaled contaminated dust.

Imaging demonstrates bilateral pneumonia and hilar lymphadenopathy. Routine cultures remain negative.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: D. Pneumonic tularemia
Q2

What organism causes this infection?

Reveal answer and rationale
Correct answer: A. Francisella tularensis
Q3

What treatment is appropriate for severe pneumonic disease?

Reveal answer and rationale
Correct answer: B. An appropriate aminoglycoside or fluoroquinolone regimen
Q4

What laboratory-safety action is important?

Reveal answer and rationale
Correct answer: A. Alert the microbiology laboratory when tularemia is suspected

F. tularensis is highly infectious, and laboratory personnel require appropriate precautions.

Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Routes of infection

  • Tick or deer-fly bite
  • Handling infected rabbits or rodents
  • Inhalation of contaminated dust
  • Ingestion of contaminated water
  • Laboratory exposure

Treatment principles

  • Begin appropriate antimicrobial treatment promptly
  • Notify public health and the laboratory
  • Provide respiratory and hemodynamic support
  • Consider exposure route and disease severity when selecting therapy

Clinical Pearl: Pneumonic tularemia may occur without a skin ulcer after aerosol exposure.

NPLEX Trap: Routine beta-lactams are unreliable because F. tularensis is intrinsically resistant to many commonly used agents.

CDC’s 2025 recommendations include aminoglycosides, fluoroquinolones, and tetracyclines, selected according to severity and clinical form.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 471

PNEUMONIC PLAGUEClinical Case 471

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 38-year-old wildlife biologist presents with abrupt fever, chest pain, cough, and bloody sputum after handling a sick prairie dog in an endemic region.

He rapidly develops hypoxemia and septic shock.

Sputum Gram stain shows bipolar-staining gram-negative bacilli.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: B. Pneumonic plague
Q2

What is the most appropriate immediate management?

Reveal answer and rationale
Correct answer: B. Begin appropriate antibiotics immediately and notify public health
Q3

Which agents are first-line treatment options in the United States?

Reveal answer and rationale
Correct answer: A. Gentamicin or an appropriate fluoroquinolone
Q4

What infection-control measure is required?

Reveal answer and rationale
Correct answer: B. Droplet precautions for pneumonic plague
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Treatment principles

  • Collect specimens if this does not delay therapy
  • Begin antibiotics immediately
  • Apply droplet precautions
  • Notify public health
  • Assess close contacts for postexposure prophylaxis
  • Provide septic-shock and respiratory support

Clinical Pearl: Pneumonic plague can spread person-to-person through respiratory droplets.

NPLEX Trap: Do not delay therapy while awaiting definitive laboratory identification.

CDC recommends prompt treatment—commonly with gentamicin or a fluoroquinolone—and immediate public-health notification.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 472

VIBRIO VULNIFICUS SEPSIS AND NECROTIZING WOUND INFECTIONClinical Case 472

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 61-year-old man with cirrhosis develops fever, severe leg pain, hypotension, and rapidly progressive hemorrhagic bullae.

The previous day, a leg wound was exposed to warm coastal seawater. He also ate raw oysters.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: C. Vibrio vulnificus sepsis with necrotizing wound infection
Q2

Which condition creates particularly high risk of severe disease?

Reveal answer and rationale
Correct answer: A. Cirrhosis or significant iron overload
Q3

Which antibiotic regimen is recommended?

Reveal answer and rationale
Correct answer: A. Doxycycline plus a third-generation cephalosporin
Q4

What additional treatment may be lifesaving?

Reveal answer and rationale
Correct answer: B. Early surgical exploration and debridement
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Exposure pathways

  • Raw or undercooked shellfish
  • Seawater contamination of an open wound

Treatment principles

  • Immediate antibiotic therapy
  • Early surgical assessment
  • Sepsis resuscitation
  • Culture blood and wound specimens
  • Notify public-health authorities as required

Nutrition and prevention: Patients with chronic liver disease should avoid raw oysters and protect wounds from coastal water exposure.

Clinical Pearl: Hemorrhagic bullae in a cirrhotic patient after shellfish or seawater exposure are a major diagnostic clue.

NPLEX Trap: Do not wait for culture confirmation before antibiotics and surgery.

CDC recommends doxycycline plus a third-generation cephalosporin and prompt surgical treatment.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 473

CAPNOCYTOPHAGA SEPSIS AFTER A DOG BITEClinical Case 473

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 64-year-old man with previous splenectomy presents with fever, vomiting, confusion, hypotension, and rapidly spreading purpura.

Three days earlier, his dog bit his hand. The wound appears relatively minor.

Laboratory findings:

  • Platelets: markedly reduced
  • INR and aPTT: prolonged
  • Creatinine: elevated
  • Lactate: 8.0 mmol/L
  • Blood smear: gram-negative fusiform organisms
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Fulminant Capnocytophaga canimorsus sepsis
Q2

Which patient factor creates particularly high risk?

Reveal answer and rationale
Correct answer: A. Asplenia
Q3

What is the appropriate immediate treatment?

Reveal answer and rationale
Correct answer: A. Sepsis resuscitation and broad intravenous antibiotic therapy active against Capnocytophaga
Q4

Which preventive action is appropriate after a dog or cat bite in a high-risk asplenic patient?

Reveal answer and rationale
Correct answer: B. Prompt wound cleansing and medical assessment for prophylactic antibiotics
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Risk groups

  • Asplenia
  • Heavy alcohol use
  • Immunocompromising illness
  • Older age

Potential complications

  • Septic shock
  • DIC
  • Meningitis
  • Endocarditis
  • Gangrene
  • Multiorgan failure

Treatment principles

  • Immediate sepsis care
  • Broad intravenous beta-lactam/beta-lactamase-inhibitor or other appropriate therapy
  • Wound management
  • Prolonged culture incubation or molecular identification when needed
  • Evaluate tetanus and rabies risk separately

Clinical Pearl: Severe infection can follow a seemingly trivial bite, scratch, or saliva exposure.

NPLEX Trap: A mild-looking bite wound does not predict the severity of systemic disease in an asplenic patient.

CDC warns that Capnocytophaga infection can progress rapidly after dog or cat exposure, particularly in high-risk patients.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 474

RESPIRATORY DIPHTHERIA WITH MYOCARDITISClinical Case 474

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

An unvaccinated 17-year-old presents with sore throat, fever, cervical swelling, and progressive difficulty breathing after international travel.

Examination:

  • Thick grey adherent pharyngeal pseudomembrane
  • Bleeding when the membrane is disturbed
  • “Bull-neck” swelling
  • Hoarse voice

Two days later, he develops heart block and ventricular ectopy.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: D. Respiratory diphtheria with toxin-mediated myocarditis
Q2

What treatment must be given promptly without waiting for laboratory confirmation?

Reveal answer and rationale
Correct answer: A. Diphtheria antitoxin
Q3

Which antimicrobial agents are recommended?

Reveal answer and rationale
Correct answer: A. Erythromycin or penicillin
Q4

Why should the pseudomembrane not be forcefully removed?

Reveal answer and rationale
Correct answer: A. It can provoke bleeding and airway compromise
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Treatment principles

  • Droplet isolation
  • Secure and monitor the airway
  • Administer diphtheria antitoxin urgently
  • Give erythromycin or penicillin
  • Monitor for myocarditis and peripheral neuritis
  • Notify public health
  • Culture and manage close contacts
  • Provide vaccination after recovery because illness may not confer reliable immunity

Clinical Pearl: Antitoxin neutralizes circulating toxin but cannot reverse toxin already bound to tissue.

NPLEX Trap: Antibiotics eradicate the organism and reduce transmission but do not replace antitoxin.

CDC recommends immediate antitoxin for respiratory diphtheria, plus erythromycin or penicillin and close cardiac and neurologic monitoring.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 475

INHALATION ANTHRAXClinical Case 475

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 45-year-old postal worker develops fever, profound fatigue, dry cough, chest discomfort, and nausea several days after handling a suspicious powder-containing package.

He briefly improves and then develops severe dyspnea, confusion, and shock.

Imaging demonstrates:

  • Widened mediastinum
  • Large bilateral pleural effusions
  • Mediastinal lymphadenopathy

Blood cultures grow large gram-positive rods.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: B. Inhalation anthrax
Q2

Which imaging finding is particularly suggestive?

Reveal answer and rationale
Correct answer: B. Widened mediastinum with pleural effusions
Q3

What is the appropriate treatment principle for systemic anthrax?

Reveal answer and rationale
Correct answer: B. Combination intravenous antimicrobial therapy with toxin-suppressing coverage
Q4

What additional therapy should be considered in severe systemic disease?

Reveal answer and rationale
Correct answer: A. Anthrax antitoxin
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • Blood cultures before antibiotics when feasible
  • Chest CT
  • Pleural-fluid studies
  • PCR and toxin testing through public-health laboratories
  • Immediate assessment for meningitis
  • Lumbar puncture when safe and indicated

Treatment principles

  • Do not delay treatment for confirmation
  • Use multidrug intravenous therapy for systemic disease
  • Include a protein-synthesis inhibitor to reduce toxin production
  • Add antitoxin in severe systemic disease when indicated
  • Drain clinically significant pleural effusions
  • Notify public health and law enforcement when intentional exposure is possible
  • Provide postexposure prophylaxis to appropriately exposed asymptomatic persons

Clinical Pearl: Early symptoms may resemble influenza before abrupt systemic deterioration.

NPLEX Trap: Inhalation anthrax typically causes hemorrhagic mediastinitis rather than a classic focal lobar pneumonia.

CDC guidelines recommend combination antimicrobial treatment and consideration of adjunctive antitoxin for systemic anthrax.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 476

VEXAS SYNDROMEClinical Case 476

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 68-year-old man presents with recurrent high fever, fatigue, painful ear swelling, inflammatory arthritis, tender skin nodules, and shortness of breath.

During the previous year, he has required repeated courses of prednisone. Symptoms recur whenever the dosage is reduced.

Laboratory findings:

  • Hemoglobin: 82 g/L
  • MCV: 111 fL
  • Platelets: 76 × 10⁹/L
  • CRP: markedly elevated
  • Vitamin B12 and folate: normal
  • Bone-marrow examination: cytoplasmic vacuoles in myeloid and erythroid precursors
  • Somatic UBA1 mutation: detected
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: C. VEXAS syndrome

Late-onset severe systemic inflammation, chondritis, skin disease, macrocytic anemia, thrombocytopenia, marrow vacuoles, and a somatic UBA1 mutation indicate VEXAS syndrome.

Q2

What does the genetic abnormality represent?

Reveal answer and rationale
Correct answer: B. A somatic mutation affecting hematopoietic cells

VEXAS is caused by an acquired UBA1 mutation within hematopoietic stem or progenitor cells. It is not usually an inherited childhood inflammatory syndrome.

Q3

Which laboratory abnormality is especially characteristic?

Reveal answer and rationale
Correct answer: B. Macrocytic anemia despite adequate vitamin B12 and folate
Q4

What is the appropriate management principle?

Reveal answer and rationale
Correct answer: B. Hematology–rheumatology assessment with steroid-sparing or clone-directed therapy
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Diagnosis: VEXAS syndrome—vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome.

Common manifestations

  • Recurrent fever
  • Chondritis
  • Neutrophilic dermatosis
  • Vasculitis
  • Arthritis
  • Pulmonary inflammation
  • Venous thrombosis
  • Macrocytic anemia
  • Thrombocytopenia
  • Myelodysplastic features

Key investigations

  • CBC and blood smear
  • B12 and folate
  • Inflammatory markers
  • Bone-marrow examination
  • UBA1 mutation testing
  • Thrombotic and organ-involvement assessment

Treatment principles

  • Control severe inflammation
  • Minimize prolonged glucocorticoid exposure
  • Consider targeted cytokine therapy or JAK inhibition
  • Consider hypomethylating therapy when associated myeloid disease is present
  • Assess selected patients for allogeneic stem-cell transplantation

Botanical safety: Immune-stimulating supplements are not appropriate substitutes for hematologic evaluation.

Clinical Pearl: New severe inflammatory disease in an older man with otherwise unexplained macrocytic anemia should prompt consideration of VEXAS.

NPLEX Trap: Do not attribute macrocytosis automatically to vitamin deficiency when B12 and folate are adequate.

Current reviews identify somatic UBA1 testing as confirmatory and emphasize combined hematologic and inflammatory management.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 477

TAFRO SYNDROMEClinical Case 477

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 43-year-old woman presents with fever, generalized edema, abdominal distension, fatigue, and rapidly declining urine output.

Findings:

  • Anasarca
  • Small-volume lymphadenopathy
  • Pleural effusions and ascites
  • Mild hepatosplenomegaly

Laboratory findings:

  • Platelets: 38 × 10⁹/L
  • Creatinine: 286 µmol/L
  • Alkaline phosphatase: elevated
  • CRP: markedly elevated
  • Albumin: reduced
  • Immunoglobulins: not markedly elevated

Lymph-node biopsy demonstrates Castleman-like changes. HHV-8 testing is negative.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. TAFRO syndrome

Thrombocytopenia, anasarca, fever or systemic inflammation, reticulin fibrosis or renal dysfunction, and organomegaly form the TAFRO clinical pattern.

Q2

TAFRO is commonly regarded as a severe phenotype within which disorder?

Reveal answer and rationale
Correct answer: A. HHV-8-negative idiopathic multicentric Castleman disease
Q3

Which feature helps distinguish TAFRO from many other Castleman presentations?

Reveal answer and rationale
Correct answer: B. Severe thrombocytopenia with anasarca and renal dysfunction
Q4

What is the appropriate treatment principle?

Reveal answer and rationale
Correct answer: A. Rapid specialist-directed immunomodulatory treatment
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • CBC and peripheral smear
  • CRP, albumin, renal and liver function
  • Immunoglobulins
  • HHV-8 and HIV testing
  • Lymph-node biopsy
  • Bone-marrow examination when indicated
  • Evaluation for infection, lymphoma, autoimmune disease, and POEMS

Treatment principles

  • Urgent hematology involvement
  • IL-6-directed treatment in appropriate patients
  • Glucocorticoids
  • Rituximab, calcineurin inhibition, or other immune-directed treatment in selected disease
  • Renal, respiratory, and fluid-balance support

Clinical Pearl: Lymph nodes may be relatively small despite severe systemic illness.

NPLEX Trap: Do not diagnose ordinary nephrotic syndrome when thrombocytopenia, intense inflammation, organomegaly, and Castleman-like pathology coexist.

Recent consensus work provides diagnostic and severity-based treatment frameworks for TAFRO syndrome.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 478

ERDHEIM–CHESTER DISEASEClinical Case 478

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 55-year-old man presents with bilateral leg pain, excessive thirst, retro-orbital discomfort, and progressive kidney dysfunction.

Imaging demonstrates:

  • Symmetric osteosclerosis of the distal femurs and proximal tibias
  • Perirenal soft-tissue infiltration producing a “hairy-kidney” appearance
  • Circumferential soft tissue around the aorta
  • Retro-orbital infiltration
  • Thickening of the pituitary stalk

Biopsy shows foamy CD68-positive, CD1a-negative histiocytes. A BRAF V600E mutation is detected.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: B. Erdheim–Chester disease
Q2

Which skeletal pattern is characteristic?

Reveal answer and rationale
Correct answer: A. Symmetric osteosclerosis of the long-bone metaphyseal and diaphyseal regions
Q3

What endocrine manifestation is suggested by polyuria, polydipsia, and pituitary-stalk involvement?

Reveal answer and rationale
Correct answer: B. Central diabetes insipidus
Q4

Which therapy directly targets this patient’s mutation?

Reveal answer and rationale
Correct answer: A. BRAF-inhibitor therapy
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Potential organ involvement

  • Long bones
  • Retroperitoneum
  • Kidneys and ureters
  • Cardiovascular system
  • Orbits
  • Central nervous system
  • Pituitary gland
  • Lungs
  • Skin

Key investigations

  • Whole-body imaging
  • Bone imaging
  • Cardiac MRI or echocardiography
  • Renal and endocrine assessment
  • Tissue biopsy
  • BRAF and MAPK-pathway mutation testing

Treatment principles

  • Target BRAF V600E when present
  • Consider MEK inhibition for other MAPK-pathway alterations
  • Relieve ureteral or cardiovascular obstruction
  • Replace deficient pituitary hormones
  • Monitor multiple organ systems longitudinally

Clinical Pearl: The combination of hairy-kidney infiltration and coated-aorta appearance is highly suggestive.

NPLEX Trap: Do not treat bone pain alone without assessing renal, cardiovascular, orbital, and neurologic involvement.

International consensus recommendations support molecular testing and MAPK-pathway-directed therapy.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 479

AUTOIMMUNE AUTONOMIC GANGLIONOPATHYClinical Case 479

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 39-year-old woman develops severe lightheadedness, dry mouth, blurred vision, constipation, urinary retention, and markedly reduced sweating over three weeks.

Findings:

  • Supine BP: 128/76 mmHg
  • Standing BP: 72/40 mmHg
  • Minimal compensatory heart-rate increase
  • Dilated, poorly reactive pupils
  • Normal limb strength and sensation

Ganglionic acetylcholine-receptor antibodies are strongly positive.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: B. Autoimmune autonomic ganglionopathy
Q2

Which pattern supports neurogenic orthostatic hypotension?

Reveal answer and rationale
Correct answer: A. Large blood-pressure fall with little compensatory tachycardia
Q3

Which additional assessment is important?

Reveal answer and rationale
Correct answer: A. Evaluation for an associated malignancy or autoimmune disorder
Q4

What treatment may be used for significant autoimmune disease?

Reveal answer and rationale
Correct answer: A. IV immunoglobulin or plasma exchange
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • Orthostatic vital signs
  • Formal autonomic testing
  • Sweat testing
  • Ganglionic AChR antibodies
  • Medication review
  • Diabetes and nutritional testing
  • Evaluation for paraneoplastic disease

Treatment principles

  • Fluid and sodium optimization when safe
  • Compression garments
  • Physical counter-maneuvers
  • Medications such as midodrine or droxidopa when appropriate
  • Immunotherapy in autoimmune disease
  • Manage gastrointestinal, bladder, ocular, and sweating dysfunction

Clinical Pearl: Diffuse autonomic failure can occur without major motor or sensory abnormalities.

NPLEX Trap: Do not diagnose POTS when the dominant abnormality is profound hypotension without adequate tachycardia.

Autoimmune autonomic ganglionopathy is associated with ganglionic AChR antibodies and may respond to IVIG, plasma exchange, or other immunotherapy.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 480

STIFF-PERSON SPECTRUM DISORDERClinical Case 480

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 45-year-old woman presents with progressive stiffness of the trunk and legs, painful spasms, exaggerated lumbar lordosis, and repeated falls.

Sudden noises or emotional stress trigger severe whole-body spasms. Strength is preserved between episodes.

Investigations:

  • Anti-GAD65 antibodies: markedly elevated
  • EMG: continuous motor-unit activity in agonist and antagonist muscles
  • MRI spine: no compressive lesion
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: B. Stiff-person spectrum disorder
Q2

Which feature is particularly characteristic?

Reveal answer and rationale
Correct answer: A. Stimulus-triggered painful muscle spasms
Q3

Which medication commonly provides symptomatic benefit?

Reveal answer and rationale
Correct answer: A. Diazepam or another GABA-enhancing antispasmodic
Q4

Which disease-modifying treatment has evidence for significant autoimmune SPS?

Reveal answer and rationale
Correct answer: A. Intravenous immunoglobulin
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key differentials

  • Tetanus
  • Dystonia
  • Myelopathy
  • Multiple sclerosis
  • Neuromyotonia
  • Functional neurologic disorder
  • Paraneoplastic rigidity syndromes

Key investigations

  • Anti-GAD65 and other relevant antibodies
  • EMG
  • Screening for autoimmune diabetes and thyroid disease
  • Cancer assessment when amphiphysin or other paraneoplastic antibodies are suspected

Treatment principles

  • GABA-enhancing symptomatic medication
  • IVIG for clinically important autoimmune disease
  • Consider plasma exchange, rituximab, or other therapy in selected refractory cases
  • Fall prevention and cautious rehabilitation

Physical medicine safety: Forceful manipulation can provoke severe spasms and injury.

Clinical Pearl: Anxiety may develop because patients fear unpredictable stimulus-triggered spasms; this does not make the disorder psychogenic.

NPLEX Trap: Do not attribute objective rigidity and continuous motor-unit activity to anxiety alone.

Stiff-person spectrum disorders are characterized by rigidity and stimulus-sensitive spasms and are treated with symptomatic GABAergic therapy plus immunotherapy when indicated.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 481

MOG-ANTIBODY–ASSOCIATED DISEASEClinical Case 481

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 27-year-old woman develops severe bilateral eye pain and visual loss following a viral-like illness.

MRI demonstrates:

  • Bilateral anterior optic-nerve enhancement
  • Perineural enhancement
  • Optic-disc swelling
  • No typical multiple-sclerosis brain lesions

Serum MOG-IgG is strongly positive on a cell-based assay.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: C. MOG-antibody–associated disease
Q2

Which test is preferred?

Reveal answer and rationale
Correct answer: A. Serum MOG-IgG using a validated cell-based assay
Q3

What is appropriate acute treatment?

Reveal answer and rationale
Correct answer: A. High-dose intravenous glucocorticoids
Q4

The patient has poor recovery after glucocorticoids. What should be considered?

Reveal answer and rationale
Correct answer: A. Plasma exchange
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Recognized presentations

  • Optic neuritis
  • Transverse myelitis
  • Acute disseminated encephalomyelitis
  • Brainstem syndrome
  • Cortical encephalitis with seizures

Treatment principles

  • Treat severe acute attacks promptly
  • Use plasma exchange or IVIG for inadequate response
  • Taper glucocorticoids carefully because rapid withdrawal may be followed by relapse
  • Consider maintenance immunotherapy for recurrent disease

Clinical Pearl: MOG-associated optic neuritis frequently causes optic-disc edema and may involve both eyes.

NPLEX Trap: A positive low-titre result without a compatible clinical syndrome should not automatically establish MOGAD.

International criteria require a compatible demyelinating event, appropriate MOG-IgG testing, and exclusion of better diagnoses.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 482

FABRY DISEASEClinical Case 482

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 36-year-old man presents with burning pain in his hands and feet, reduced sweating, heat intolerance, abdominal cramping, and early kidney dysfunction.

Examination:

  • Angiokeratomas around the groin and umbilicus
  • Corneal verticillata
  • Mild left-ventricular hypertrophy

His maternal uncle died from kidney failure at age 47.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Fabry disease
Q2

Which enzyme is deficient?

Reveal answer and rationale
Correct answer: A. Alpha-galactosidase A
Q3

Which inheritance pattern is typical?

Reveal answer and rationale
Correct answer: A. X-linked
Q4

What is the appropriate disease-specific treatment principle?

Reveal answer and rationale
Correct answer: A. Enzyme-replacement or appropriate chaperone therapy
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Potential manifestations

  • Acroparesthesias
  • Angiokeratomas
  • Hypohidrosis
  • Corneal changes
  • Proteinuria and kidney failure
  • Hypertrophic cardiomyopathy
  • Arrhythmia
  • Stroke
  • Gastrointestinal symptoms
  • Hearing abnormalities

Key investigations

  • Alpha-galactosidase A activity
  • GLA genetic testing
  • Lyso-Gb3
  • Urine protein and renal function
  • ECG, echocardiography, or cardiac MRI
  • Brain MRI when indicated

Treatment principles

  • Enzyme-replacement therapy
  • Chaperone therapy for amenable variants
  • Control proteinuria and cardiovascular risk
  • Screen relatives
  • Monitor kidney, cardiac, neurologic, auditory, and ocular disease

Clinical Pearl: Heterozygous women may have substantial disease because of variable X-chromosome inactivation.

NPLEX Trap: Normal enzyme activity in a woman does not reliably exclude Fabry disease; genetic testing may be required.

GeneReviews describes enzymatic and genetic diagnosis, family screening, and disease-specific treatment.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 483

CALCIPHYLAXISClinical Case 483

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 61-year-old woman receiving hemodialysis presents with excruciating thigh pain and rapidly progressive skin lesions.

Risk factors:

  • Diabetes
  • Obesity
  • Warfarin therapy
  • Hyperphosphatemia
  • Secondary hyperparathyroidism

Examination reveals indurated retiform plaques with central black necrosis.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: C. Calciphylaxis
Q2

Which feature is especially characteristic?

Reveal answer and rationale
Correct answer: A. Severe pain preceding or exceeding visible skin injury
Q3

What treatment approach is appropriate?

Reveal answer and rationale
Correct answer: A. Multidisciplinary wound care, risk-factor correction, analgesia, and consideration of sodium thiosulfate
Q4

What major complication drives mortality?

Reveal answer and rationale
Correct answer: A. Wound infection and sepsis
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • Calcium, phosphate, PTH, and alkaline phosphatase
  • Medication review
  • Wound and infection assessment
  • Imaging or biopsy in selected uncertain cases

Treatment principles

  • Optimize dialysis
  • Correct calcium-phosphate abnormalities
  • Reassess warfarin, calcium-containing binders, and activated vitamin D
  • Intensive wound care and pain control
  • Treat infection promptly
  • Consider sodium thiosulfate
  • Consider parathyroid-directed treatment in selected disease

Clinical Pearl: Normal serum calcium does not exclude calciphylaxis.

NPLEX Trap: Skin biopsy may worsen ulceration or infection and should be individualized when the clinical pattern is highly characteristic.

Recent nephrology guidance emphasizes early recognition, wound and infection management, modification of risk factors, and multidisciplinary care.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 484

ENTERIC HYPEROXALURIA WITH OXALATE NEPHROPATHYClinical Case 484

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 49-year-old man with previous Roux-en-Y gastric bypass presents with recurrent calcium-oxalate stones and rapidly worsening kidney function.

He reports chronic fatty diarrhea.

Laboratory findings:

  • Creatinine: 312 µmol/L
  • Twenty-four-hour urine oxalate: markedly elevated
  • Urine calcium: low
  • Kidney biopsy: extensive calcium-oxalate deposition
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: B. Enteric hyperoxaluria causing oxalate nephropathy
Q2

What is the underlying mechanism?

Reveal answer and rationale
Correct answer: A. Unabsorbed fat binds intestinal calcium, leaving more free oxalate available for absorption
Q3

Which nutrition strategy is appropriate?

Reveal answer and rationale
Correct answer: A. Low-oxalate, lower-fat diet with adequate calcium taken with meals
Q4

Which supplement can worsen oxalate production?

Reveal answer and rationale
Correct answer: A. High-dose vitamin C
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Risk settings

  • Bariatric surgery
  • Crohn disease
  • Short-bowel syndrome
  • Pancreatic insufficiency
  • Chronic fat malabsorption

Treatment principles

  • Increase fluid intake when clinically safe
  • Lower dietary oxalate
  • Moderate dietary fat
  • Maintain normal calcium intake with meals
  • Consider citrate
  • Treat the underlying malabsorption
  • Avoid excessive vitamin C

Clinical Pearl: Calcium restriction can paradoxically increase intestinal oxalate absorption.

NPLEX Trap: Recurrent stones after bariatric surgery should not automatically be managed with a low-calcium diet.

Kidney Health Initiative reviews support dietary oxalate and fat reduction, calcium with meals, hydration, and treatment of malabsorption.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 485

CALCIUM-ALKALI SYNDROMEClinical Case 485

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 72-year-old woman presents with nausea, confusion, constipation, and reduced urine output.

She takes:

  • Calcium carbonate for osteoporosis
  • Calcium-containing antacids for reflux
  • Vitamin D
  • Hydrochlorothiazide

Laboratory findings:

  • Corrected calcium: 3.34 mmol/L
  • Bicarbonate: 36 mmol/L
  • Creatinine: 278 µmol/L
  • PTH: suppressed
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: B. Calcium-alkali syndrome
Q2

What is the classic triad?

Reveal answer and rationale
Correct answer: A. Hypercalcemia, metabolic alkalosis, and kidney injury
Q3

Which medication likely increased susceptibility?

Reveal answer and rationale
Correct answer: A. Hydrochlorothiazide
Q4

What is the initial treatment principle?

Reveal answer and rationale
Correct answer: A. Stop calcium and alkali sources and provide carefully monitored isotonic fluid
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • Total and ionized calcium
  • Blood gas or bicarbonate
  • Creatinine and electrolytes
  • PTH
  • Vitamin D metabolites when indicated
  • Complete supplement and antacid inventory

Treatment principles

  • Stop calcium and absorbable alkali
  • Stop contributing vitamin D or thiazide when appropriate
  • Restore intravascular volume
  • Treat severe hypercalcemia
  • Dialyze selected patients with refractory toxicity or severe renal failure

Clinical Pearl: Patients may count their osteoporosis supplement but forget calcium-containing antacid use.

NPLEX Trap: Suppressed PTH in hypercalcemia should trigger a search for supplements, medications, malignancy, and vitamin D-related disease.

Calcium-alkali syndrome is defined by hypercalcemia, metabolic alkalosis, and renal impairment from excessive calcium with absorbable alkali.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 486

VITAMIN D TOXICITY WITH HYPERCALCEMIC KIDNEY INJURYClinical Case 486

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 58-year-old man presents with nausea, polyuria, dehydration, weakness, and confusion.

For six months, he has taken 50,000 IU of vitamin D every day after misunderstanding a weekly prescription.

Laboratory findings:

  • Corrected calcium: 3.52 mmol/L
  • Creatinine: 246 µmol/L
  • PTH: suppressed
  • 25-hydroxyvitamin D: markedly elevated
  • 1,25-dihydroxyvitamin D: low-normal
  • Renal imaging: nephrocalcinosis
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: C. Exogenous vitamin D toxicity
Q2

Which vitamin D measurement best reflects exogenous intoxication?

Reveal answer and rationale
Correct answer: A. 25-hydroxyvitamin D
Q3

What is the first treatment step?

Reveal answer and rationale
Correct answer: A. Stop vitamin D and calcium exposure and restore hydration
Q4

Which treatment may be used for persistent significant hypercalcemia?

Reveal answer and rationale
Correct answer: A. Glucocorticoid or antiresorptive treatment based on the clinical setting
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Potential complications

  • Nephrolithiasis
  • Nephrocalcinosis
  • Acute or chronic kidney injury
  • Arrhythmia
  • Neuropsychiatric dysfunction
  • Pancreatitis
  • Soft-tissue calcification

Treatment principles

  • Stop vitamin D and calcium products
  • Intravenous isotonic fluid when appropriate
  • Treat clinically significant hypercalcemia
  • Monitor renal function and electrolytes
  • Recognize that toxicity may persist because vitamin D is fat soluble

Clinical Pearl: Sunlight exposure does not ordinarily cause vitamin D intoxication; supplement dosing errors are the usual exogenous cause.

NPLEX Trap: Do not use 1,25-dihydroxyvitamin D as the principal screening test for supplement-induced toxicity.

Vitamin D toxicity management focuses on stopping exposure, hydration, and treatment of hypercalcemia.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 487

ADULT HYPOPHOSPHATASIAClinical Case 487

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 41-year-old woman presents with recurrent metatarsal stress fractures, chronic musculoskeletal pain, and premature loss of several adult teeth.

Laboratory findings:

  • Alkaline phosphatase: repeatedly very low
  • Calcium: normal
  • Phosphate: normal
  • Pyridoxal-5′-phosphate: elevated
  • ALPL pathogenic variant: detected

She was recently advised to begin a bisphosphonate.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: C. Hypophosphatasia
Q2

Which laboratory clue is most important?

Reveal answer and rationale
Correct answer: A. Persistently low alkaline phosphatase
Q3

Which medication should generally be avoided?

Reveal answer and rationale
Correct answer: A. Bisphosphonates

Bisphosphonates are pyrophosphate analogues and may worsen impaired mineralization or atypical-fracture risk in hypophosphatasia.

Q4

Which therapy may be considered in selected clinically significant disease?

Reveal answer and rationale
Correct answer: A. Asfotase alfa
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Potential manifestations

  • Premature tooth loss
  • Poor fracture healing
  • Metatarsal stress fractures
  • Pseudofractures
  • Chondrocalcinosis
  • Musculoskeletal pain
  • Early loss of deciduous teeth in childhood disease

Key investigations

  • Repeat alkaline phosphatase using age-appropriate reference ranges
  • Pyridoxal-5′-phosphate
  • Urinary phosphoethanolamine
  • ALPL genetic testing
  • Skeletal imaging
  • Dental history

Clinical Pearl: Low alkaline phosphatase is often overlooked because clinicians focus primarily on elevated results.

NPLEX Trap: Do not label low-ALP fracture disease as routine osteoporosis and prescribe bisphosphonates without further assessment.

GeneReviews describes low alkaline phosphatase, elevated enzyme substrates, ALPL testing, and avoidance of bisphosphonates.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 488

TUMOUR-INDUCED OSTEOMALACIAClinical Case 488

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 52-year-old man presents with progressive bone pain, proximal weakness, difficulty walking, and several insufficiency fractures.

Laboratory findings:

  • Phosphate: markedly low
  • Calcium: normal
  • Alkaline phosphatase: elevated
  • 1,25-dihydroxyvitamin D: inappropriately low
  • Urinary phosphate excretion: elevated
  • FGF23: elevated

Somatostatin-receptor imaging identifies a small tumour in the left foot.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: B. Tumour-induced osteomalacia
Q2

What is the principal mechanism?

Reveal answer and rationale
Correct answer: A. FGF23-mediated renal phosphate wasting
Q3

What is the definitive treatment?

Reveal answer and rationale
Correct answer: A. Complete surgical removal of the responsible tumour
Q4

What therapy may be considered when the tumour cannot be found or removed?

Reveal answer and rationale
Correct answer: A. Burosumab or medically supervised phosphate and active-vitamin-D treatment
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • Fasting phosphate
  • Urinary phosphate and tubular reabsorption calculations
  • FGF23
  • 1,25-dihydroxyvitamin D
  • Functional somatostatin-receptor imaging
  • Targeted anatomical imaging
  • Selective venous sampling in difficult cases

Clinical Pearl: Serum phosphate is not always included in routine chemistry panels and may remain unchecked for years.

NPLEX Trap: Recurrent fractures with normal calcium do not automatically represent osteoporosis.

Global guidance emphasizes confirmation of renal phosphate wasting, tumour localization, surgical removal, and medical therapy when unresectable.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 489

GOOD SYNDROMEClinical Case 489

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 59-year-old man with a known thymoma presents with recurrent bacterial sinus infections, chronic diarrhea, oral candidiasis, and cytomegalovirus retinitis.

Laboratory findings:

  • IgG: markedly reduced
  • IgA and IgM: reduced
  • Peripheral B cells: nearly absent
  • CD4 T cells: reduced
  • Poor vaccine-antibody responses
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: B. Good syndrome
Q2

What combination defines this syndrome?

Reveal answer and rationale
Correct answer: A. Thymoma with adult-onset immunodeficiency
Q3

Which immunologic finding is characteristic?

Reveal answer and rationale
Correct answer: A. Low immunoglobulins with markedly reduced or absent B cells
Q4

What long-term treatment is generally required?

Reveal answer and rationale
Correct answer: A. Immunoglobulin-replacement therapy
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Potential infections

  • Encapsulated bacteria
  • Cytomegalovirus
  • Candida
  • Pneumocystis
  • Chronic gastrointestinal infection

Treatment principles

  • Immunoglobulin replacement
  • Treat and prevent opportunistic infection
  • Manage the thymoma
  • Monitor blood counts and autoimmune complications
  • Use specialist-directed vaccination planning

Clinical Pearl: Removing the thymoma does not usually reverse the immunodeficiency.

NPLEX Trap: Opportunistic infection in a patient with thymoma should not be attributed solely to chemotherapy or age.

Good syndrome is an adult immunodeficiency associated with thymoma, hypogammaglobulinemia, and profound B-cell reduction.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 490

COMMON VARIABLE IMMUNODEFICIENCYClinical Case 490

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 31-year-old woman presents with recurrent sinusitis, pneumonia, chronic giardiasis, and intermittent diarrhea.

Chest CT shows bronchiectasis.

Laboratory findings:

  • IgG: markedly reduced
  • IgA: reduced
  • IgM: reduced
  • Poor response to pneumococcal vaccination
  • B-cell count: present
  • HIV testing: negative
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: B. Common variable immunodeficiency
Q2

What diagnostic principle is essential?

Reveal answer and rationale
Correct answer: A. Exclude secondary causes of hypogammaglobulinemia
Q3

What is the central long-term treatment?

Reveal answer and rationale
Correct answer: A. Immunoglobulin replacement
Q4

Which noninfectious complication requires surveillance?

Reveal answer and rationale
Correct answer: A. Autoimmune disease, granulomatous lung disease, or lymphoma
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • Quantitative immunoglobulins
  • Vaccine-antibody responses
  • Lymphocyte subsets
  • Evaluation for protein loss, medication effects, malignancy, and HIV
  • Chest imaging and pulmonary function
  • Gastrointestinal assessment

Treatment principles

  • Immunoglobulin replacement
  • Prompt antimicrobial treatment
  • Bronchiectasis management
  • Monitor autoimmune cytopenias, enteropathy, liver disease, lymphoproliferation, and malignancy

Clinical Pearl: B cells are usually present, but effective antibody production is impaired.

NPLEX Trap: Recurrent sinus infection plus low IgG should not automatically be called selective IgA deficiency.

The ICON consensus defines CVID through low immunoglobulins, impaired antibody responses, appropriate age, and exclusion of secondary causes.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 491

TERMINAL COMPLEMENT DEFICIENCYClinical Case 491

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 20-year-old university student develops meningococcal meningitis for the second time.

He was fully vaccinated and has no history of recurrent pneumonia or chronic sinus disease.

Immunologic testing:

  • CH50: absent
  • AH50: absent
  • C3 and C4 concentrations: normal
  • Immunoglobulins: normal
Q1

What is the most likely underlying condition?

Reveal answer and rationale
Correct answer: A. Terminal complement-pathway deficiency
Q2

Which organisms are particularly associated with C5–C9 deficiency?

Reveal answer and rationale
Correct answer: A. Neisseria species
Q3

What does absence of both CH50 and AH50 with normal C3 and C4 suggest?

Reveal answer and rationale
Correct answer: A. A defect in the shared terminal complement pathway
Q4

What prevention plan is appropriate?

Reveal answer and rationale
Correct answer: A. Meningococcal vaccination plus specialist consideration of antimicrobial prophylaxis
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • CH50
  • AH50
  • Individual complement components
  • Genetic testing
  • Review of meningococcal vaccination
  • Evaluation for complement-inhibiting medications

Clinical Pearl: Recurrent meningococcal infection is a classic clue even when other infection history is limited.

NPLEX Trap: Vaccination reduces risk but does not eliminate meningococcal disease in patients with complement defects.

CDC reports emphasize complement testing after recurrent meningococcal disease and continued vaccination and prevention planning.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 492

CHRONIC GRANULOMATOUS DISEASEClinical Case 492

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 24-year-old man presents with recurrent pneumonia, skin abscesses, lymphadenitis, and a new liver abscess.

Previous cultures have grown:

  • Staphylococcus aureus
  • Serratia marcescens
  • Burkholderia cepacia
  • Aspergillus

A dihydrorhodamine-flow-cytometry assay demonstrates severely impaired neutrophil oxidative burst.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Chronic granulomatous disease
Q2

What cellular function is impaired?

Reveal answer and rationale
Correct answer: A. NADPH-oxidase-mediated respiratory burst
Q3

Which test is preferred for diagnosis?

Reveal answer and rationale
Correct answer: A. Dihydrorhodamine oxidative-burst testing
Q4

Which preventive regimen is commonly used?

Reveal answer and rationale
Correct answer: A. Antibacterial and antifungal prophylaxis
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Characteristic pathogens

  • S. aureus
  • Serratia
  • Burkholderia
  • Nocardia
  • Aspergillus
  • Other catalase-positive organisms

Treatment principles

  • Obtain microbiologic diagnosis
  • Treat infections aggressively and for adequate duration
  • Drain abscesses when indicated
  • Use TMP-SMX and antifungal prophylaxis
  • Consider interferon-gamma
  • Consider curative hematopoietic stem-cell transplantation

Clinical Pearl: Autosomal-recessive forms may present later than classic X-linked disease.

NPLEX Trap: A normal neutrophil count does not mean neutrophil function is normal.

GeneReviews and current diagnostic reviews support DHR testing, antimicrobial prophylaxis, and transplantation assessment.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 493

CLOSTRIDIUM PERFRINGENS SEPSIS WITH MASSIVE HEMOLYSISClinical Case 493

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 65-year-old woman with diabetes and a recently diagnosed hepatic mass presents with fever, severe abdominal pain, jaundice, and rapidly progressive shock.

Laboratory findings:

  • Hemoglobin falls from 112 to 54 g/L within hours
  • LDH: extremely elevated
  • Haptoglobin: undetectable
  • Potassium: 7.0 mmol/L
  • Blood smear: spherocytes, ghost cells, and marked hemolysis
  • Blood specimens appear grossly hemolyzed

CT demonstrates a gas-forming liver abscess.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: B. Clostridium perfringens sepsis with massive intravascular hemolysis
Q2

Which bacterial toxin drives the hemolysis?

Reveal answer and rationale
Correct answer: A. Alpha toxin with phospholipase activity
Q3

What is the appropriate treatment?

Reveal answer and rationale
Correct answer: A. Immediate broad anaerobic antimicrobial therapy and urgent source control
Q4

Which complication requires immediate treatment in addition to infection control?

Reveal answer and rationale
Correct answer: A. Hyperkalemia from massive hemolysis
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Treatment principles

  • Immediate sepsis resuscitation
  • High-dose active antimicrobial therapy
  • Consider penicillin plus a toxin-suppressing agent such as clindamycin
  • Drain or surgically remove the infectious focus
  • Treat hyperkalemia, DIC, kidney failure, and severe anemia
  • Provide massive-transfusion support when required

Clinical Pearl: Laboratory analyzers may repeatedly reject specimens because of extreme in-vivo hemolysis.

NPLEX Trap: Do not assume every grossly hemolyzed sample represents collection error when the patient is jaundiced and rapidly deteriorating.

Published reviews describe C. perfringens septicemia as a rare, rapidly fatal cause of massive intravascular hemolysis requiring immediate antimicrobial and source-control treatment.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 494

LEMIERRE SYNDROMEClinical Case 494

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 21-year-old man presents with fever, rigors, neck pain, and shortness of breath one week after a severe sore throat.

Examination:

  • Tender swelling along the left sternocleidomastoid muscle
  • Pleuritic chest pain
  • Reduced breath sounds at the right base

CT demonstrates left internal-jugular-vein thrombosis and multiple peripheral cavitating lung nodules.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: B. Lemierre syndrome
Q2

Which organism is classically associated?

Reveal answer and rationale
Correct answer: A. Fusobacterium necrophorum
Q3

What do the cavitating lung nodules represent?

Reveal answer and rationale
Correct answer: A. Septic pulmonary emboli
Q4

What is appropriate treatment?

Reveal answer and rationale
Correct answer: A. Prolonged intravenous antimicrobial therapy with anaerobic coverage and source control
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • Blood cultures
  • Contrast CT of the neck
  • Chest imaging
  • Assessment for peritonsillar or deep-neck infection
  • Evaluation for pleural infection

Treatment principles

  • Beta-lactamase-stable therapy with anaerobic coverage
  • Drain abscesses or empyema
  • Support sepsis and respiratory failure
  • Individualize anticoagulation for extensive or progressive thrombosis

Clinical Pearl: A patient may appear to recover from pharyngitis before developing septic thrombophlebitis.

NPLEX Trap: Do not diagnose uncomplicated pneumonia without investigating the neck when pulmonary septic emboli follow a recent throat infection.

Reviews identify internal-jugular septic thrombophlebitis, F. necrophorum, and prolonged anaerobic antimicrobial therapy as defining features.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 495

Q FEVER ENDOCARDITISClinical Case 495

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 62-year-old sheep farmer with a prosthetic aortic valve presents with prolonged fever, night sweats, weight loss, and worsening heart failure.

Repeated routine blood cultures are negative.

Findings:

  • Splenomegaly
  • Microscopic hematuria
  • Elevated liver enzymes
  • Echocardiography: new paravalvular regurgitation
  • Phase I Coxiella burnetii IgG: markedly elevated
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: B. Q fever endocarditis
Q2

Which exposure is most relevant?

Reveal answer and rationale
Correct answer: A. Livestock and birth products from sheep or goats
Q3

Which serologic pattern supports persistent Q fever?

Reveal answer and rationale
Correct answer: A. Markedly elevated phase I IgG
Q4

What is standard long-term treatment for adult endocarditis?

Reveal answer and rationale
Correct answer: A. Doxycycline plus hydroxychloroquine for prolonged therapy
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

High-risk settings for persistent disease

  • Prosthetic or abnormal heart valve
  • Vascular graft or aneurysm
  • Immunocompromising illness
  • Pregnancy in certain contexts

Treatment principles

  • Prolonged combination antimicrobial therapy
  • Monitor serologic response
  • Monitor hydroxychloroquine eye and cardiac safety
  • Assess need for valve surgery
  • Follow patients long term for relapse

Clinical Pearl: Vegetations may be very small or absent on routine echocardiography.

NPLEX Trap: Culture-negative endocarditis does not mean noninfectious endocarditis.

CDC recommends doxycycline plus hydroxychloroquine for at least 18 months for adult Q fever endocarditis or vascular infection.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 496

COMPLICATED BRUCELLOSISClinical Case 496

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 47-year-old veterinarian presents with undulating fever, drenching sweats, severe back pain, headache, and progressive hearing difficulty.

He regularly consumes unpasteurized goat cheese.

Findings:

  • Hepatosplenomegaly
  • Lumbar-spine tenderness
  • New cardiac murmur
  • CSF lymphocytic pleocytosis
  • MRI: lumbar spondylodiscitis
  • Blood cultures: Brucella melitensis
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Brucellosis with neurologic, vertebral, and possible cardiac involvement
Q2

Which exposure is most characteristic?

Reveal answer and rationale
Correct answer: A. Unpasteurized dairy or infected livestock
Q3

Which laboratory safety action is important?

Reveal answer and rationale
Correct answer: A. Notify the microbiology laboratory because cultures create an aerosol-exposure risk
Q4

What treatment principle applies to complicated disease?

Reveal answer and rationale
Correct answer: A. Prolonged combination antimicrobial therapy with specialist management
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Potential focal complications

  • Spondylitis
  • Neurobrucellosis
  • Epididymo-orchitis
  • Hepatitis
  • Endocarditis
  • Osteoarticular infection

Treatment principles

  • Use combination therapy to reduce relapse
  • Extend treatment for neurologic, vertebral, or cardiac disease
  • Assess for surgery in endocarditis
  • Notify public-health and laboratory personnel
  • Evaluate potentially exposed laboratory workers

Clinical Pearl: Endocarditis is uncommon but accounts for a large proportion of brucellosis-related deaths.

NPLEX Trap: Temporary improvement does not justify early treatment discontinuation.

Brucellosis is a zoonotic infection associated with unpasteurized dairy and animal exposure and requires combination antibiotics, with longer therapy for focal disease.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 497

DISSEMINATED MELIOIDOSISClinical Case 497

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 58-year-old man with poorly controlled diabetes returns from Thailand with fever, productive cough, weight loss, and confusion.

Imaging demonstrates:

  • Multilobar pneumonia
  • Multiple small liver and splenic abscesses
  • Prostatic abscess

Blood cultures grow Burkholderia pseudomallei.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: A. Disseminated melioidosis
Q2

Which comorbidity is a major risk factor?

Reveal answer and rationale
Correct answer: A. Diabetes mellitus
Q3

Which treatment is appropriate during the intensive phase?

Reveal answer and rationale
Correct answer: A. Intravenous ceftazidime or meropenem
Q4

What must follow the intensive intravenous phase?

Reveal answer and rationale
Correct answer: A. A prolonged oral eradication phase, commonly using TMP-SMX
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Potential presentations

  • Pneumonia
  • Septic shock
  • Skin infection
  • Bone or joint infection
  • Neurologic disease
  • Multiple internal abscesses
  • Chronic tuberculosis-like illness

Treatment principles

  • Begin appropriate treatment immediately when suspected
  • Intensive intravenous phase
  • Drain accessible abscesses
  • Follow with prolonged eradication therapy
  • Optimize diabetes and other risk factors
  • Ensure laboratory awareness because of biosafety concerns

Clinical Pearl: Multiple liver and splenic abscesses may produce a characteristic clustered appearance.

NPLEX Trap: Clinical improvement after intravenous therapy does not remove the need for prolonged eradication treatment.

CDC guidance recommends an intravenous intensive phase followed by several months of oral eradication therapy.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 498

DISSEMINATED NOCARDIOSIS WITH BRAIN ABSCESSClinical Case 498

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 64-year-old man receiving long-term prednisone for vasculitis presents with cough, fever, headache, and new left-arm weakness.

Imaging reveals:

  • Cavitating pulmonary nodules
  • Two ring-enhancing brain lesions

Modified acid-fast staining shows branching, weakly acid-fast gram-positive organisms.

Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: B. Disseminated nocardiosis
Q2

What important imaging should be performed in invasive nocardiosis even without neurologic symptoms?

Reveal answer and rationale
Correct answer: A. Brain MRI
Q3

Which antimicrobial is a common component of treatment?

Reveal answer and rationale
Correct answer: A. Trimethoprim-sulfamethoxazole
Q4

What treatment approach is appropriate for severe CNS disease?

Reveal answer and rationale
Correct answer: A. Initial multidrug therapy followed by prolonged susceptibility-directed treatment
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Risk factors

  • Prolonged glucocorticoid therapy
  • Transplantation
  • Hematologic malignancy
  • Advanced HIV
  • Chronic lung disease

Treatment principles

  • Obtain cultures and request prolonged incubation
  • Identify species and susceptibility
  • Use combination treatment for severe, disseminated, or CNS disease
  • Drain large or poorly responsive brain abscesses
  • Treat for an extended duration
  • Reduce immunosuppression when feasible

Clinical Pearl: Nocardia has a particular tendency to spread from the lungs to the brain.

NPLEX Trap: Routine culture disposal after a few days may miss the organism; the laboratory must be alerted.

CDC notes that nocardiosis commonly presents as invasive pulmonary disease, dissemination, or brain abscess and requires extended culture incubation.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 499

BRASH SYNDROMEClinical Case 499

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 78-year-old woman with chronic kidney disease presents with weakness, dizziness, and reduced urine output after several days of diarrhea.

Medications:

  • Metoprolol
  • Diltiazem
  • Ramipril
  • Spironolactone

Findings:

  • BP: 68/40 mmHg
  • HR: 28/min
  • Potassium: 6.0 mmol/L
  • Creatinine: markedly elevated
  • ECG: severe junctional bradycardia without the expected dramatic hyperkalemic pattern
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: C. BRASH syndrome
Q2

What does BRASH represent?

Reveal answer and rationale
Correct answer: A. Bradycardia, renal failure, AV-node blockade, shock, and hyperkalemia
Q3

Why may bradycardia be profound when potassium is only moderately elevated?

Reveal answer and rationale
Correct answer: A. Hyperkalemia and AV-nodal blockade act synergistically
Q4

What is the best management principle?

Reveal answer and rationale
Correct answer: A. Treat hyperkalemia, perfusion failure, bradycardia, renal dysfunction, and medication accumulation simultaneously
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Common precipitants

  • Dehydration
  • Gastrointestinal illness
  • Acute kidney injury
  • Medication dosage change
  • Addition of RAAS-blocking or potassium-retaining medication

Treatment principles

  • Stop AV-nodal-blocking and potassium-raising medications
  • Stabilize the myocardium with intravenous calcium
  • Shift and remove potassium
  • Restore perfusion with appropriate fluids and vasopressor or chronotropic support
  • Treat renal failure
  • Consider dialysis when indicated

Clinical Pearl: The bradycardia is often more severe than expected from either the potassium level or AV-blocker dose alone.

NPLEX Trap: Atropine may be ineffective because the syndrome is not primarily caused by excessive vagal tone.

Canadian emergency guidance stresses simultaneous treatment of every component of BRASH rather than focusing on bradycardia alone.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
NPLEX Part II • Phase 5 • Clinical Case 500

NITROUS-OXIDE–INDUCED FUNCTIONAL VITAMIN B12 DEFICIENCYClinical Case 500

4 questionsAnswers + rationalesDisease overview + exam traps

Case Presentation

A 24-year-old man presents with progressive numbness, gait instability, leg weakness, and urinary urgency.

He reports recreational inhalation of large quantities of nitrous oxide several times each week.

Examination:

  • Loss of vibration and joint-position sensation
  • Sensory ataxia
  • Spastic leg weakness
  • Positive Romberg sign

Laboratory findings:

  • Serum vitamin B12: low-normal
  • Methylmalonic acid: markedly elevated
  • Homocysteine: elevated
  • MRI cervical spine: symmetric posterior-column signal abnormality
Q1

What is the most likely diagnosis?

Reveal answer and rationale
Correct answer: B. Nitrous-oxide–induced functional vitamin B12 deficiency with myeloneuropathy
Q2

What is the toxic mechanism?

Reveal answer and rationale
Correct answer: A. Oxidation and functional inactivation of cobalamin
Q3

Why can a serum B12 concentration appear normal?

Reveal answer and rationale
Correct answer: A. The measured vitamin may be present but metabolically inactive
Q4

What is the appropriate treatment?

Reveal answer and rationale
Correct answer: A. Stop nitrous oxide and begin prompt parenteral vitamin B12 replacement
Reveal Disease Review & Exam TrapsHide Disease Review & Exam Traps

Disease Review & Exam Traps

Key investigations

  • Full exposure history
  • CBC and blood smear
  • Serum B12
  • Methylmalonic acid
  • Homocysteine
  • Folate and copper
  • Spinal MRI
  • Nerve-conduction testing when indicated

Treatment principles

  • Stop nitrous-oxide exposure completely
  • Administer parenteral vitamin B12
  • Correct coexisting folate deficiency after B12 treatment begins
  • Provide neurologic rehabilitation
  • Address substance-use risk and relapse prevention
  • Monitor for incomplete recovery

Clinical Pearl: Neurologic disease may be severe even without macrocytic anemia or a frankly low serum B12 result.

NPLEX Trap: Do not delay treatment while waiting for serum B12 to fall below the laboratory reference range.

Repeated nitrous-oxide exposure can inactivate vitamin B12 and produce myelopathy, neuropathy, and megaloblastic changes.

Educational exam-preparation content. Emergency findings in these cases require urgent medical assessment and should not be managed solely with complementary care.
Protected BoardQBank content — copying and printing are disabled.